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Summary 
 Cellular division is the basis for the continuation of life and is regulated by the 
careful progression of events known as the cell cycle. The primary drivers behind the cell 
cycle are the Cyclins and their Cyclin-dependent kinases, however many regulatory 
mechanisms act to balance their activity in order to avoid unscheduled cell division. 
Cdk1 has been identified as the essential Cdk for mammalian cell cycle progression and 
is capable of compensating for the lack of other cell cycle Cdks. In order to better 
understand the role of Cdk1 in early embryonic development and adult homeostasis, we 
have developed a germ-line and conditional knockout mouse for Cdk1. In addition we 
investigated the role of Cdk1 in a tissue and cell type-specific manner. This work 
provides novel insight on the regulation of the mammalian cell cycle as well as the 
potential therapeutic advantages of targeting Cdk1 in hyperproliferative diseases, such as 
cancer.  
 
 
 
Resumen 
 La división celular es la base para la continuación de la vida y está regulada 
mediante una cuidadosa progresión de eventos conocidos como ciclo celular. Las 
impulsoras primarias del ciclo celular son las ciclinas y sus quinasas dependientes de 
ciclinas (Cdks), sin embargo son muchos los mecanismos que actúan para equilibrar su 
actividad con el objetivo de evitar divisiones celulares no programadas.  Cdk1 ha sido 
identificada como la Cdk esencial en la progresión del ciclo celular en mamíferos y es 
capaz de compensar la ausencia de las demás Cdks implicadas en el ciclo celular. Para 
mejorar la comprensión de las funciones de Cdk1 en el desarrollo embrionario temprano 
y en la homeostasis en adultos, hemos desarrollado un ratón knock-out en línea germinal 
y condicional de Cdk1. Asimismo hemos investigado el papel de Cdk1 a nivel específico 
de tejido y célula. Este trabajo proporciona nuevos conocimientos en la regulación del 
ciclo celular en  mamíferos así como de las potenciales ventajas de utilizar Cdk1 como 
diana terapéutica en enfermedades hiperproliferativas, tales como el cáncer. 
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1.1  The Eukaryotic cell cycle 
Cellular division is the basis for the continuation of life. For single-cell 
prokaryotic organisms, cell division represents reproduction and is simply a replication of 
genetic material equally divided between two daughter cells by binary fission with very 
limited molecular regulation. In eukaryotes there are two forms of cellular division, 
mitotic cell division and meiosis. Mitotic cell division is the process by which a cell will 
faithfully replicate its genetic material and divide it between two daughter cells; this can 
be done either in a symmetric or asymmetric fashion determining the fate of the 
daughter cells. Whereas meiosis is the specialized process by which a diploid cell will 
replicate its genetic material and divide into haploid gametes for sexual reproduction. 
The intricacy of cellular division varies among organisms; in mammals the process is 
carried out in four active phases (G1, S, G2 and M)(Sisken & Morasca 1965) that are 
tightly regulated by the cyclins and their respective cyclin-dependent kinases (Cdks). This 
regulation ensures proper replication of genetic material and safeguards against 
mutations and damage that could harm the fitness of the organism. The ordered 
molecular mechanisms underlying the proper progression of mitotic cell division are 
generally described as the cell cycle.  
1.1.1  Exit from quiescence (G0) and entry into the cell cycle (G1) 
Mammalian mitotic cell division begins from fertilization and continues 
throughout adulthood. However, upon terminal differentiation, specialized cells become 
post-mitotic and irreversibly lose their proliferative capability, such as neurons and 
muscle cells. Rather, mitotic cells constitute renewable tissues and organs, including 
epithelial, stromal and hematopoietic cells, and will maintain their proliferative 
capabilities. Mitotic cells can also enter a reversible non-proliferative state, termed 
quiescence, where they maintain transcriptional activity, downregulate cell cycle genes, 
inhibit terminal differentiation to ensure their re-entry into the cell cycle. Quiescence 
(also termed G0) is an essential process in tissue homeostasis and many factors can 
induce quiescence, including mitogen starvation, stress, and contact inhibition. Many 
essential cell cycle regulators are significantly downregulated or completely inhibited 
during quiescence. Cyclin dependent kinases (Cdks), a family of up to 21 protein kinases 
and five Cdk-like kinases (Malumbres et al. 2009), first identified as the primary kinetic 
regulators of the cell cycle are completely inactive during quiescence. As such, the 
Retinoblastoma (Rb) family of pocket proteins, direct substrates of Cdks, remain 
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hypophosphorylated and bound to the E2F family of transcription factors, inhibiting 
transcriptional activation of genes necessary for the progression of the cell cycle.  
Re-entry into the cell cycle requires the activation of the mitogen-activated 
protein kinase (MAPK) and the extracellular-signal-regulated kinase (ERK) pathway. The 
presence of extracellular mitogens or growth factor, cytokine and hormone ligands 
results in binding and activation of their respective transmembrane receptor tyrosine 
kinases (RTKs)(Jones & Kazlauskas 2001). RTKs can induce multiple downstream 
pathways, but for cell cycle entry the activation of Ras (H-Ras, N-Ras, or K-Ras) family 
member G proteins (guanosine-nucleotide-binding proteins) is essential (Pulciani et al. 
1982; Shih & Weinberg 1982; Goldfarb et al. 1982; Robinson & Cobb 1997). Ras 
proteins are GTPases bound to the inner cell membrane and can hydrolyze guanosine 
triphosphate (GTP) into guanosine diphosphate (GDP)(Scolnick et al. 1979). Under 
physiological conditions the transfer of the phosphate group is aided by guanine 
nucleotide exchange factors (GEFs)(Panniers & Henshaw 1983) during the activation of 
Ras (to the GTP-bound state) and GTPase activating proteins (GAPs) in the inactivation 
of Ras (to the GDP-bound state)(Gibbs et al. 1988). GTP-bound Ras proteins can bind 
and activate Raf proteins (a-Raf, b-Raf and c-Raf) subsequently activating the 
MAPK/ERK signal transduction pathway. Raf is a serine/threonine protein kinase 
which, when active, phosphorylates members of the mitogen activated protein kinase 
kinase (MAPKK) family, or mitogen/extracellular signal-regulated kinase proteins (Mek1 
and Mek2)(Rapp et al. 1983; Anderson et al. 1991). Phosphorylated Mek proteins will 
then phosphorylate the downstream Erk or MAPK family of proteins (Erk1 and Erk2). 
Erk serine/threonine kinases are responsible for activating a milieu of downstream 
cytoplasmic, membranous and nuclear protein cascades that are crucial in cell fate 
decisions including cell cycle entry. Specifically, Erk can act in various ways to promote 
Cyclin D1 transcription via activation of the Elk and Myc transcription factors (Gille et 
al. 1995; Murphy et al. 2004; Murphy et al. 2002; Volmat et al. 2001; Seth et al. 1991; 
Daksis et al. 1994) as well as aid in Cdk activation (Keenan et al. 2001; Lents et al. 2002). 
Furthermore, Erk can transcriptionally repress anti-proliferative genes throughout the 
G1 phase of the cell cycle (Yamamoto et al. 2006). 
The initial observation that resting cells could be stimulated by serum to enter 
into the cell cycle and divide by Todaro et al. in 1965, piqued the interest to understand 
the molecular regulatory mechanisms governing G0 arrest and exit. Tobey and Ley 
(1970) demonstrated the ability to synchronously stimulate a population of arrested cells 
Catherine Evangeline Symonds  Introduction 
 
17 
to enter into the cell cycle. From these studies the restriction point (R point) was 
suggested as a shifting point from a state of low metabolic activity to that of active 
proliferation (Pardee 1974). The R point was mapped to 2-3 hours prior to S phase 
(Tobey & Ley 1970; Pardee 1974; Campisi et al. 1982). These studies made clear that 
when cells are exposed to unfavorable conditions for proliferation (e.g. high cell density, 
nutrient or serum insufficiency, and high levels of cAMP) they would become quiescent, 
however when sufficient stimulation with serum or growth factors was provided, cells 
would exit quiescence and if the cell passed the R point, it was committed to completing 
the cell cycle.  
Quiescence is a long-term resting phase of the cell and is characterized by no 
Cdk activity and hypophosphorylated Rb inhibition of E2F factors. However, in cellular 
populations cell cycling is not homogeneous and not all cells immediately enter the cell 
cycle after division. The decision on whether to continue proliferating or to enter 
quiescence seems to be due to signaling during the prior cell cycle. Cells can actually 
incorporate mitogenic information during a “restriction window” at the end of the 
previous cell cycle in order to decide between continued proliferation and entrance into 
quiescence (Spencer et al. 2013). This bifurcation upon mitotic exit is dependent upon 
levels of Cdk2 and its inhibitor p21/Cip1 (cyclin dependent kinase inhibitor 1, Cdkn1a), 
where no active Cdk2 results in quiescence and measurable levels of Cdk2 activity result 
in the re-entry of the cell into the cell cycle.  
Cdks work in heterodimeric complexes with their Cyclin family counterparts, 
initially named for their cyclic expression during the cell cycle but now identified for their 
conserved 100 amino acid cyclin box domain (Noble et al. 1997).  Commitment to the 
cell cycle is based on the sequential activation of Cdks4/6 and Cyclin D, phosphorylation 
of Rb family proteins, release of E2F transcription factors, further transcriptional 
induction of Cyclin D, ubiquitination and degradation of the Cdk-inhibitor p21 and 
eventual expression of Cyclin E and Cdk2/3, which allow for S phase entry (Dou et al. 
1993; Chen et al. 1995). Without sufficient activation of Cdks, cells will be unable to 
counteract inhibitory anti-proliferative signals. Therefore, in either scenario, exit from 
quiescence or progression from a previous cell cycle, the cell requires enough signaling to 
commit to the energy- and resource-demanding process of cellular division.  
1.1.2  Interphase - G1  
 Interphase is the growth phase of the cell cycle leading up to mitosis and is 
comprised of gap phase 1 (G1), the DNA synthesis phase (S), and gap phase 2 (G2). 
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During G1, mitogens signal to induce Ras/Mek/Erk signaling and downstream cell cycle 
initiation. Expression of Cyclin D, encoded as three genes in vertebrates (Cyclins D1, D2 
and D3), increases along with its associated Cdk4 and Cdk6 activity. Under highly 
mitogenic conditions several Cdk-inhibitors from the Cdkn2a or Ink4a/Arf tumor 
suppressor locus can act as a break mechanism towards cell cycle progression (Quelle et 
al. 1995; Serrano et al. 1993; Hiebert et al. 1992). In fact many tumor types are associated 
with mutations in the Ink4a/Arf locus. The increased Cdk activity during G1 is also 
essential for the phosphorylation and inactivation of the Rb family of tumor suppressor 
proteins.  
The Rb family of tumor suppressors contains three members, Rb/p105, p107 
and Rb2/p130, which are collectively referred to as pocket proteins for the conserved 
pocket region where they bind viral oncoproteins that possess an LXCXE motif (Lee et 
al. 1998), E2F transcription factors (Hiebert et al. 1992; Nevins 1992), the D-type cyclins 
(Ewen et al. 1993) and other cellular factors. Initially identified as a biallelic driver 
mutation in Retinoblastoma, RB mutations have also been identified in osteosarcoma, 
melanoma, lung and breast cancers (Dunn et al. 1988). When wild-type Rb proteins are 
overexpressed in cells they can induce growth arrest (Harrington et al. 1998). Therefore, 
Rb proteins are critical guardians of cell cycle induction and must be regulated 
accordingly. Rb proteins are believed to be inactivated in two stages, primarily by 
phosphorylation of the C-terminal domain by Cdk4 and Cdk6 bound by Cyclin D, 
followed by phosphorylation of the pocket domain by Cyclin E/Cdk2. Only when Rb is 
hyperphosphorylated will it fully release the E2F transcription factor allowing for 
progression of the cell cycle.  
The family of E2F transcription factors is made up of three activators, E2F1, 
E2F2, and E2F3a, as well as six repressors E2F3b, E2F4, E2F5, E2F6, E2F7 and E2F8. 
All are involved in cell cycle regulation binding a TTTCCCGC consensus sequence (or 
similar) in the promoters of genes involved in cell cycle regulation, nucleotide synthesis, 
DNA replication and repair. The activators, in particular E2F1 dimerizes with 
transcription factor Dp-1 and promotes transcription of cell cycle genes (Helin et al. 
1993), whereas the repressors are active in cells during quiescence. The function of the 
E2F activators is somewhat redundant as mouse embryos develop normally when 
lacking E2F1, E2F2, and one of the E2F3 isoforms (Tsai et al. 2008). E2F activators are 
most active during the G1/S phase of the cell cycle, whereas the repressors remain 
expressed at constant levels and actively repress once the activators are displaced. 
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Multiple positive feedback loops are in place for the E2F activators, including the 
inhibition of the tumor suppressor p53 and activation of Cyclin E, demonstrating that 
the Rb-E2F axis acts as a bistable switch to ensure commitment of cells to the cell cycle 
(Wong et al. 2011).  
Both the exit of mitosis as well as G0 represent states of little to no Cdk activity, 
allowing for Rb hypophosphorylation and E2F transcription factor repression. For the 
cell to ensure proper exit from mitosis and inhibit premature entry into a new cell cycle 
the phosphorylation levels of Rb proteins are further regulated by serine/threonine 
protein phosphatases PP1 and PP2A. These phosphatases acquire cell cycle specific 
functions upon holoenzyme assembly with their various catalytic subunits (PP1a, 
PP1b/d, PP1c1 and PP1c2 for PP1 and the Ca and Cb isoforms of PP2A). PP1 has been 
noted to form complexes with as many as 650 mammalian proteins (Hendrickx et al. 
2009) and PP2A represents a family of four dimeric and over 90 heterotrimeric 
holoenzymes (Bollen et al. 2010). PP2A is believed to be functionally regulated by the B-
type subunit that is present within the complex (Shi 2009; Slupe et al. 2011), however the 
complexity of the activation and regulation of the protein phosphatases has yet to be 
fully elucidated. During mitotic exit and G1, PP1 is the primary inhibitor of Rb family 
member phosphorylation and can directly bind to Rb. Upon mitogen activation and 
induced Cdk activity, PP1 will become phosphorylated by Cdks allowing for Rb 
hyperphosphorylation and cell cycle entry. However, this negative feedback mechanism 
allows for cells to require a threshold of Cdk activation in order to completely inhibit 
PP1 and induce hyperphosphorylation of Rb family member proteins, adding yet another 
level of regulation for entry into the cell cycle (Kolupaeva & Janssens 2012; Novak et al. 
2010). 
The anaphase promoting complex (APC) and the Skp, Cullin, F-box containing 
complex (SCF), are both multimeric E3 ubiquitin ligases that provide an extra layer of 
regulation to the cell cycle, by targeting cell cycle proteins for degradation by the 26S 
proteasome. APC and its cofactor Cdh1 are mainly active during mitotic exit and early 
G1 to degrade mitotic and S phase cyclins. APC-Cdh1 also targets the APC co-factor 
Cdc20, which is active during mitosis, for degradation during the exit of mitosis in order 
to further promote G1. As G1 cyclin and cdk activity increases Cdh1 is phosphorylated 
and inactivated allowing for entry into S phase where the Cdc20 co-factor will once again 
bind to the APC. The SCF ubiquitin ligase when bound with its cofactors S-phase 
kinase-associated protein 2 (Skp2) and Cyclin-dependent kinase regulatory subunit 1 
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(Cks1) will ubiquitinate and degrade cyclin dependent kinase inhibitors, such as p21 and 
p27. During G1 the APC-Cdh1 complex will target Skp2 for degradation and maintain 
Cdk2-specific CKI levels until necessary kinase activity is present for Cdh1 to be 
inactivated (Bashir et al. 2004). Upon Cdh1 inactivation, Skp2 can then activate the SCF 
inducing degradation of CKIs and allowing Cdk2 and Cyclins A and E to promote S 
phase progression.  
1.1.3  Interphase – S Phase 
 The G1 phase of the cell cycle is critical in ensuring proper preparation and 
energy requirements for S phase progression. Mitogenic signaling and sufficient activity 
of protein phosphatases, protein degradation and CKIs all cooperate in maintaining low 
Cdk activity allowing for pre-replication complex formation for DNA synthesis to occur.  
The synthesis, or S phase of the cell cycle is where genetic DNA is accurately replicated 
with a host of regulatory mechanisms in order to avoid mutations, which could result in 
disease or death. The human diploid genome is composed of 46 chromosomes, 
approximately 6x109 base pairs of DNA, requiring around 50,000 origins of replication. 
In simple eukaryotes, each replication origin has a consensus sequence where the origin 
recognition complex (ORC) can bind and recruit pre-replication complexes (pre-RCs) 
during late M phase and early G1, while Cdk activity is low, increased Cdk activity allows 
for the initiation of DNA synthesis at the proper time. In higher eukaryotes the 
replication origins are not well defined, but are believed to be topologically regulated by 
epigenetic chromatin modifications. In order to ensure one round of DNA replication 
per cell cycle the origins are licensed by the loading of the pre-RCs. ORC1-6 bind to 
origins during M phase and are bound and inhibited by Cyclin B1/Cdk1 to prevent re-
replication until mitosis is complete (Wuarin et al. 2002). The degredation of Cyclin B1 
and inactivation of Cdk1 allows for ORC1-6 to recruit cell division cycle 6 (Cdc6), an 
ATP binding protein which then recruits DNA replication factor Cdt1 and helps load 
the minichromosome maintenance complex Mcm2-7. The MCM proteins form a 
hexamer around the DNA and act as DNA helicases initiating the unwinding of the 
DNA for synthesis and elongation. Cdc6 is essential for the initiation of DNA 
replication. Mammalian Cdc6 protein levels peak in late G1 and are destabilized during 
G2-M by SCF-Skp2 (Williams et al. 1997; Méndez & Stillman 2000). In order to prevent 
re-replication of the DNA during S phase and G2, SCF-Skp2 polyubiquitinates Orc1 and 
the DNA replication inhibitor Geminin is induced during S phase to inhibit the 
replication factor Cdt1 until mitosis. During late mitosis and G1 the APC complex 
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ubiquitinates Geminin allowing for pre-RC formation. These regulatory mechanisms and 
feedback loops ensure only one round of replication per cell cycle.  
 Once DNA replication has been initiated the pre-RC is no longer needed and 
thus inactivated. However the hexameric Mmc2-7 remains and forms a functional 
helicase, the CMG complex, with cell division cycle protein 45 (Cdc45) and GINS (Go, 
Ichi, Ni and San; Japanese for “five, one, two and three” which refers to the annotation 
of the genes that encode the complex)(Moyer et al. 2006). The CMG complex interacts 
with DNA polymerase alpha/primase, DNA polymerase delta and epsilon, 
topoisomerases 1 and 2, Mcm10, chromosome transmission fidelity protein 4 (Ctf4), 
proliferating cell nuclear antigen (PCNA), single stranded binding proteins (SSB), and the 
many other factors required to faithfully execute DNA replication at the replication forks 
(Zhu et al. 2007; Solomon et al. 1992; Merchant et al. 1997; Yeeles et al. 2015). 
Replication terminates when two replication forks meet and the nascent DNA strands 
are ligated together. 
 Progression of the S phase is associated with an increase in both Cdk2 and Cdk1 
activity, which act congruently with both Cyclin A2 and B1 to inhibit re-replication of 
the DNA (Nguyen et al. 2001).  During S phase, Cdk1 will interact with both Cyclin A2 
as well as Cyclin B1, inherent mechanisms control Cdk-cyclin binding in terms of 
specificity and timing (Merrick et al. 2008). The activation of Cdk1 in late S phase allows 
for inhibitory phosphorylation of PCNA co-regulators and the termination of DNA 
replication. However, negative regulators of Cdk1 kinase activity including Wee1 protein 
kinase and myelin transcription factor 1 (Myt1) remain present during S phase to ensure 
that cells do not prematurely enter into mitosis.  
1.1.4  Interphase – G2 
 The second gap phase of the cell cycle, G2, is the most robust checkpoint of the 
cell cycle, where cells ensure that DNA replication has been properly completed to allow 
for mitosis. The primary regulator of the G2/M transition is the Cyclin B1 - Cdk1 
complex, also referred to as maturation promoting factor (MPF). Unlike all other cyclins, 
Cyclin B1 has a significant peak in expression at the G2/M transition, reaching very high 
levels, allowing sufficient Cdk1 kinase activity to induce mitosis. If mitosis is initiated and 
cells have not fully resolved the replication complexes or DNA is damaged, mitotic 
defects or cell death can occur. Therefore, the G2/M transition maintains the necessary 
control via the requirement for high levels of Cdk1 activity along with numerous 
feedback regulatory mechanisms.  
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 Cdk1 is a highly conserved serine/threonine kinase, with the human CDK1 
sharing 63% amino acid identity with its yeast homologue. Cdk1 is a small protein, 
primarily made-up of the protein kinase domain. It has an ATP cleft in the active site 
close to where its substrates bind allowing for the catalysis of the gamma-phosphate of 
ATP to the oxygen of the hydroxyl serine/threonine residue of the substrate. Cdk1 also 
contains a PSTAIRE alpha helix motif, which is shared among major Cdks and is 
responsible for interacting with Cyclin binding. When the Cyclin binds to the Cdk, the 
PSTAIRE helix is reoriented, resulting in a conformational change in the active site. 
Cdk1 also has a Cdk-activation loop or T-loop, which is shared among several Cdks. The 
T-loop blocks the active site on the Cdk until it is phosphorylated by the Cdk-activating 
kinase (CAK), a trimeric protein complex made up of Cdk7, Cyclin H and Mat1. When 
the CAK phosphorylates the T-loop at the threonine residue (Thr161 in Cdk1), the T-
loop is re-oriented allowing for substrates to access the active site.  Thus Cdk1 must 
undergo substantial conformational reorganization for it to be activated at the G2/M 
transition.  
 In order for Cdk1 to induce mitotic entry it must be bound to Cyclin B1 as well 
as be phosphorylated on a residue of its T-loop (Threonine 161, Cdk1Thr161). During G2 
Cdk1 is maintained in an inactive state by phosphorylation of the Tyrosine 15 (Cdk1Tyr15) 
residue by Wee1 and the Threonine 14 (Cdk1Thr14) residue by Myt1. Cdk1 in turn will 
phosphorylate Wee1, as well as polo-like kinase 1 (Plk1) and casein kinase 1(CK1), this 
phosphodegron targets Wee1 to degradation by SCFB-TrCP. Plk1 is activated at the G2/M 
transition by Aurora A kinase and Bora, which accumulate during G2 forming an 
activation complex. Plk1 will then further activate Cdk1 by phosphorylating the cell 
division cycle protein 25 (Cdc25), a dual-specificity phosphatase, which then activates 
Cdk1 by removing the inhibitory phosphorylations. Moreover, Cdk1 will activate Cdc25 
itself creating a positive-feedback loop. Myt1 activity is also inhibited during mitosis by 
phosphorylation by both Plk1 and Cdk1. These feedback loops represent a bistable 
switch system (Lindqvist et al. 2009), which will become autocatalytic once threshold 
activation has been reached.   
 Mitosis requires the phosphorylation of numerous Cdk1 substrates and in order 
to prevent aberrant mitotic entry the PP2A phosphatase along with its B55 subunit is 
primarily responsible for dephosphorylating Cdk1 substrates at the end of mitosis and 
during interphase. In order to bypass this inhibition at the G2/M transition Cdk1-
dependent activation of the kinase greatwall (Gwl, also known as MastL in mammals) 
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activates Arpp-19 or ENSA, which is a specific PP2A-B55 inhibitor, resulting in 
decreased PP2A-B55 levels and an increase in Cdk1 activity and phosphorylated mitotic 
substrates (Gharbi-Ayachi et al. 2010; Mochida et al. 2010). This represents yet another 
regulatory mechanism of the Cdk1 bistable switch at the G2/M transition. 
 Lastly, the active Cyclin B1-Cdk1 complex must be translocated into the nucleus 
in order to fully induce mitosis. While Cyclin B1 can shuttle between the nucleus and 
cytoplasm during interphase, mitotic onset requires the phosphorylation of Cyclin B1 in 
its cytoplasmic retention sequence (CRS) along with an inhibition of its nuclear export 
signal (NES). Initial studies in Xenopus have suggested that Erk and Plk1 phosphorylate 
Cyclin B1 in the CRS (Walsh et al. 2003), however, further studies in mammalian cells 
demonstrated that initial phosphorylation of Cyclin B1 by Plk1 occurs on the 
centrosomes during prophase but phosphorylation was not specific to the nuclear export 
sequence (NES) and did not result in nuclear translocation (Jackman et al. 2003). Recent 
reports demonstrates that self phosphorylation of Cdk1-Cyclin B1 at the centrosome 
promotes its nuclear translocation and that nuclear translocation further activates Cdk1-
Cyclin B1 complexes in a autoregulatory positive-feedback mechanism (Gavet & Pines 
2010b; Gavet & Pines 2010a). This mechanism ensures that once Cdk1-Cyclin B1 
complexes are activated, cells are committed to enter into mitosis.  
1.1.5  Mitosis 
 Mitosis is the process by which the cell divides its chromosomes into two 
daughter cells. Mitosis is characterized by six phases including prophase, prometaphase, 
metaphase, anaphase, telophase and cytokinesis.  
During prophase the loosely organized heterochromatin organizes itself and 
condenses into the sister chromatids that are attached at the centromere. The 
multisubunit Cohesin complex regulates this process. Namely multimeric protein 
complex formed between Scc1/RAD21, Scc3/STAG1 (stromal antigen 1, SA1), Smc1 
and Smc3 (structural maintenance of chromosomes). SMC proteins are a family of 
ATPases that catalyze higher order chromosome structure and dynamics.  Smc-1 and 
Smc3 dimerize forming the hinge domain and are connected to the ATP-binding 
cassette-like head domain via long anti-parallel coiled-coils. Scc1 and Scc3 bind to the 
head domain of the Smc proteins forming a closed loop structure when ATP is bound. 
ATP hydrolysis can control the opening and closing of the cohesin structure. Scc1 or 
RAD21 is a nuclear phosphoprotein binding to the head regions of Smc-1 and Smc-3 
stabilizing their interaction and recruiting the remaining SA-1, Pds5, and Wap1 
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interacting proteins. Cohesin acts to hold the sister chromatids together during mitosis 
until anaphase and sister chromatid separation. It also facilitates spindle attachment onto 
chromosomes. During prophase the centrosomes, which were duplicated during G1 and 
S phase, are separated to opposite poles of the cell forming a bridge of spindle fibers. 
Finally the nucleolus dissolves.  
Prometaphase is marked by nuclear membrane dissolution, the formation of the 
kinetochore and attachment of microtubules to the kinetochores. Kinetochores are 
highly specialized structures that form around the centromere of the chromosome and 
allow for microtubule attachment. The kinetochore is formed by an inner plate 
chromatin structure containing nucleosomes, specialized histones, auxiliary proteins and 
DNA. Outside of the inner plate is the outer plate composed primarily of protein (Cooke 
et al. 1993).   The kinetochore forms at the time of nuclear envelope breakdown. Once 
the microtubules from the centrosomes have attached to all the chromosomes’ 
kinetochores the mitotic spindle is formed and the cell will enter into metaphase.  
Metaphase is characterized by the polar orientation of the centrosomes and the 
alignment of the chromosomes at the equatorial axis. Until all chromosomes are properly 
aligned and attached to the centrosomes, the Spindle Assembly Checkpoint (SAC) is 
active. The SAC will be active even if one unattached chromosome is present in the cell 
and improper regulation of chromosome segregation during mitosis can cause 
aneuploidy leading to serious health defects such as cancer. The SAC is primarily 
regulated by the protein complex Cohesin. Cohesin forms a ring like structure around 
sister chromatids and protects them from separation until the SAC has been deactivated. 
The SAC inhibits primarily the Anaphase Promoting Complex/Cyclosome (APC/C) 
ubiquitin ligase by catalyzing the association of its coactivator, Cdc20, into the mitotic 
checkpoint complex (MCC). Moreover, active Cdk1 will phosphorylate Securin inducing 
binding to and inactivation of Separase, the kinase responsible for dissolving the Cohesin 
rings to allow separation of sister chromatids. These forces act congruently to inhibit 
anaphase from progressing until all sister chromatids are properly aligned.  
 Anaphase progression occurs upon proper chromosome alignment. The induced 
activation of the APC/C-Cdc20 ubiquitin ligase is responsible for the degradation of 
Cyclin B and securin. This in turn deactivates Cdk1 and releases separase, which will 
hydrolyze the cohesin rings allowing for chromatid separation. The centromeres are split 
and the daughter chromosomes are pulled towards opposite poles by the microtubules 
attached to the kinetochore. Non-kinetochore microtubules are also active during 
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anaphase in elongating the cell. Once the daughter chromosomes reach the poles the cell 
undergoes a reversal of the prophase and prometaphase events, termed telophase. The 
microtubules attached to the chromosomes will release and a new nuclear envelope will 
form around the two sets of daughter chromosomes. The chromosomes will then relax 
or decondense. At this stage mitosis is complete and the cell will most likely continue 
into the final stage of cellular division, cytokinesis, or the separation of the cell into two 
equal daughter cells.  
1.2  Genetically modified mouse models targeting Cdk alleles 
 Initial cell cycle studies performed in S. pombe identified cdc2 (Cdk1 yeast mue) as 
the key regulator of the mitotic cell cycle (Nurse 1990; Gould & Nurse 1989). Cdc2 is the 
only Cdk family member in yeast and together with the nine encoded cyclins, it is capable 
of performing all necessary kinase functions throughout the cell cycle. Recent studies 
have demonstrated the capability to manipulate the progression of the cell cycle in yeast 
by varying the levels of cdc2 kinase activity, lending to the kinase activity threshold 
model of cell cycle progression (Coudreuse & Nurse 2010). Under this theory it is 
believed that the stage and cyclin-specific expression, concentration and localization act 
to engage cdc2 activity at the proper threshold necessary to progress through the cell 
cycle. A steady increase in cdc2 activity is required for initial entry and G1 and S phase 
progression. For the cell to enter into Mitosis, a high-energy and consequential stage of 
the cell cycle, cdc2 activity must significantly increase in order to overcome inhibitory 
signals from Cdk inhibitors and phosphatases. Once the cell has fully entered into 
mitosis all Cdk activity must be eliminated for proper completion of mitosis and 
cytokinesis.  
 In higher eukaryotes, however, there is more than just one Cdk. In humans there 
are up to 21 CDK family proteins and at least 5 CDK-like family proteins. Traditionally 
the Cdks responsible for mammalian cell cycle progression have been Cdk2, Cdk3, Cdk4, 
Cdk6 and Cdk1. While there has been significant research on the roles of Cdk1, Cdk2, 
Cdk4 and Cdk6, the role of Cdk3 has yet to be fully elucidated. Cdk3 is a homologue of 
Cdk2 and cdc2 and ectopic expression of human Cdk3 suggests a role in G1/S 
transition. Studies have been difficult due to low levels of endogenous protein. 
Moreover, in commonly utilized laboratory Mus musculus strains a point mutation was 
found to generate a stop codon, functionally acting as a Cdk3-null allele (Ye et al. 2001). 
Therefore, all genetic analysis performed in laboratory mouse strains has been done in 
the absence of Cdk3. Given that these laboratory strains are viable and present with no 
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identified phenotypic change, Cdk3 is not required for normal cell cycle or mouse 
homeostasis and its absence can be compensated for by the remaining Cdks. To further 
analyze the functional characteristics of these Cdks in homeostasis and the cell cycle, 
genetically modified knockout mice have been generated.  
1.2.1  Cdk2 
A conditional Cdk2 knockout mouse was generated using the Cre-loxP strategy. 
When the investigators generated a full germline knockout, they observed no effect on 
mitotic cell cycle progression or vitality of the mice. However, mice lacking Cdk2 were 
sterile and the authors reported a defect in Prophase I of the meiotic cell cycle(Ortega et 
al. 2003). Previous to this study, general belief was that Cdk2 was the major regulator for 
the mammalian cell cycle. In fact many anticancer drugs were being developed to target 
Cdk2 activity in tumors. However, these findings established, that when absent, Cdk2 
mitotic cell cycle activity can be fully compensated for by the remaining Cdks. Moreover, 
further research demonstrated this to be true in tumors lacking the Cdk inhibitors p21 
and/or p27 (Martín et al. 2005).  
1.2.2  Cdk4 
 A conditional Cdk4 knockout mouse was generated using the Cre-loxP strategy. 
Mice devoid of Cdk4 were found to be viable but small in size (Rane et al. 1999). Similar 
to the mice lacking Cdk2, Cdk4-null mice were also sterile. Furthermore, it was reported 
that the lack of Cdk4 resulted in insulin-deficient diabetes due to a reduction of β-islet 
pancreatic cells (Rane et al. 1999). When looking specifically at mitotic cell cycle 
progression, mouse embryonic fibroblasts could proliferate normally in the absence of 
Cdk4 but portrayed a delayed entry into S phase upon re-entry into the cell cycle (Rane et 
al. 1999).  
1.2.3  Cdk6 
 Cdk6 knockout mice were generated by targeting the first coding exon with a 
PGK-neo cassette by homologous recombination in ES cells. Similar to other interphase 
Cdk knockout mice, Cdk6 knockout mice were viable showing a slight anemia and 
defective proliferation of some hematopoietic cell types. However, the majority of 
mitotic cell types proliferated normally without Cdk6 (Malumbres et al. 2004).  
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1.2.4  Combined knockout models 
 Given that mice are viable in the absence of individual interphase Cdks, it can be 
concluded that cell cycle functions are compensated for by the remaining interphase 
Cdks. In order to understand this compensation better, combined knockout models were 
generated of the interphase Cdks.  
 Double knockout Cdk2, Cdk4 mice complete embryonic development 
successfully but die shortly after birth presumably due to heart failure (Barrière et al. 
2007). However, when Cdk2 was conditionally ablated from adult mice lacking Cdk4 
there were no obvious phenotypes and mice could recover from partial hepatectomy. 
Double knockout embryonic fibroblasts could be immortalized, showed robust 
phosphorylation of Rb and had normal cell cycle kinetics (Barrière et al. 2007).  
 Double knockout Cdk4, Cdk6 mice are unable to fully complete embryonic 
development, dying at late stages due to severe anemia and improper hematopoiesis. 
However, embryonic fibroblasts lacking Cdk4 and Cdk6 proliferate normally, can be 
immortalized, and can re-enter the cell cycle with normal kinetics but a lower efficiency 
(Malumbres et al. 2004).  
In light of the double knockout mouse models, it was clear that interphase Cdks 
were capable of compensating for each other. Thus to determine the necessity of 
interphase Cdks a triple knockout mouse was generated. Mice lacking Cdk2, Cdk4 and 
Cdk6 were found to develop and undergo organogenesis until midgestation (Santamaría 
et al. 2007). Mice show similar phenotypes as the double and single knockout models, 
including anemia and hematopoietic defects. Cells lacking interphase Cdks proliferate 
albeit with an elongated cell cycle due to delayed phosphorylation of Rb and 
compensation for the lack of interphase Cdks is carried out by Cdk1, which is capable of 
binding to all cyclin counterparts and phosphorylating Rb (Santamaría et al. 2007). These 
findings demonstrate the similarities between simple eukaryotic cell cycles and 
mammalian mitotic cell cycles in that a single cell cycle Cdk, namely Cdk1 is capable of 
maintaining essential cell cycle progression. 
1.2.5  Cdk1 
Further evidence demonstrating that Cdk1 is the only essential Cdk1 was 
generated using mice lacking all Cdk1 expression, by the insertion of a β-geo cassette (a 
proviral β-galactosidase and neomycin resistance fusion gene) into the Cdc2a locus 
upstream of exon 3 (Santamaría et al. 2007). These mice were not viable, being unable to 
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develop to even the morula stage of embryonic development (Santamaría et al. 2007). 
Therefore, Cdk1 is capable of compensating for all interphase Cdk activity, whereas 
interphase Cdks are not able to compensate for the loss of Cdk1. This could result from 
an inability to reach threshold kinase levels necessary, or simply an inability to 
phosphorylate mitotic substrates.  
 In an effort to further clarify the role of Cdk1 both in vivo and in cell cycle 
regulation, a conditional knockout mouse was generated (Diril et al. 2012). Mice lacking 
Cdk1 did not develop past the blastocyst stage. Moreover, cells depleted of Cdk1 were 
unable to progress through the cell cycle, completing S phase but undergoing multiple 
rounds of endoreplication. Liver-specific depletion of Cdk1 was well tolerated and mice 
were able to fully regenerate their livers after partial hepatectomy through cell growth 
without cell division (Diril et al. 2012). Moreover, the findings show that in the absence 
of Cdk1, the liver is completely refractory to tumorigenesis by loss of p53 or activation 
of Ras (Diril et al. 2012). These findings taken together with those of the interphase Cdks 
demonstrate the essential role of Cdk1 in the mammalian cell cycle. However, there are 
clearly Cdk-specific functions that have been associated to interphase Cdks, and the role 
of Cdk1 in the adult cell cycle as well as cell-type specific cell cycles has yet to be 
addressed. Importantly it is still unclear why Cdk1 cannot be functionally replaced by 
interphase Cdks, especially Cdk2 which is expressed during S and G2 phases and has 
been found to both bind Cyclin B1 as well as phosphorylate mitotic targets (Brown et al. 
2007). Thus further investigation is required to address the specific role of Cdk1 in 
regulating the essential mammalian cell cycle. 
1.3  Cell cycle and development 
 The cell cycle has long been studied in model cell lines such as 3T3 fibroblasts 
and human cancer cell lines (e.g. HeLa). However, the mechanisms regulating the cell 
cycle of these cell types may not hold true across all mammalian cells. In fact, the 
findings from the interphase knockout mouse models demonstrate just that, with the 
specific roles for interphase Cdks in hematopoiesis and heart development. Moreover, 
there is increasing evidence for substantial regulatory differences in early embryonic or 
stem cell cycles and those of differentiated cell types.  
 During early embryonic development the mammalian cell cycle has distinct 
progression and regulatory mechanisms. As cells differentiate the cell cycle becomes 
longer and thus more complex (Figure 1). For pluripotent stem cells (ES cells) that will 
go on to form all somatic tissues, the first differentiation occurs at peri-implantation or 
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approximately embryonic day 5 in mice (E5), when the cells differentiate into the 
endodermal, mesodermal and ectodermal lineages (Lawson et al. 1991; O’Farrell et al. 
2004). This differentiation restricts cells to the respective germ layer thus losing 
pluripotent capabilities. Within each organ system, a subset of cells will retain stem cell 
properties (multipotent stem cells) and be capable of maintaining tissue homeostasis and 
regeneration. During organogenesis, multipotent stem cells will give rise to two major 
subsets of cells, progenitor cells that will be more restrictive in their proliferative 
potential and capacity to generate different cell types as well as post-mitotic cells that will 
provide the structural and physiological requirements necessary for the tissue. During 
organogenesis multipotent stem cells are actively proliferating, however once 
organogenesis is complete and throughout adulthood, multipotent stem cells will exit the 
cell cycle and remain quiescent.  
 
Figure 1: Cell cycle complexity through mouse development. Initial cell cycles are rapid 
lasting less than 4 hours and are composed primarily of synthesis and mitotic phases. As the 
embryo develops and cells differentiate into specific cellular lineages the regulatory mechanisms 
increase and the cell cycle lengthens, gap phases are introduced and cells will take up to 24 hours 
or longer to progress through the cell cycle. 
 
 Mouse ES cells are generated from the inner cell mass of the developing 
blastocyst (E3.5) and express the transcription factors Nanog, Oct-4 and Sox-2, which 
are essential in maintaining self-renewal and pluripotency. When cultured under proper 
conditions ES cells are capable of differentiating into any of the three germ layers. 
Throughout differentiation there is a progressive lengthening of the cell cycle and many 
Catherine Evangeline Symonds  Introduction 
30 
reports have linked cell cycle length to differentiation (Singh & Dalton 2009; Salomoni & 
Calegari 2010; Orford & Scadden 2008). The cell cycle phase that varies the most 
throughout development is G1. Pluripotent ES cells have little to no G1 phase and have 
been shown to have constitutively high levels of cyclin E and cyclin A associated Cdk 
activity (Stead et al. 2002). The Cdk inhibitors p16, p21 and p27 are silenced in 
pluripotent ES cells, allowing for uninhibited interphase Cdk activity (Faast et al. 2004). 
Moreover, due to continuous Cdk2 activity, Rb is maintained in its hyperphosphorylated 
form, rendering the cells independent of Rb cell cycle regulation and the R point 
(Savatier et al. 1994). As cells differentiate the G1 phase of the cell cycle lengthens 
(White & Dalton 2005; Bryja et al. 2008). Inhibition of Cdk2 in ES cells was found to 
lengthen G1 and induce differentiation and cells with elevated levels of Cdk2 show 
impaired differentiation (Koledova et al. 2010; Kim et al. 2009). These findings illustrate 
significant differences between cell cycle regulation in stem versus differentiated cell 
types. Given the increasing use of embryonic stem cells in research and potential 
therapeutic applications, the understanding of the basic molecular pathways regulating 
the cell cycle and differentiation will be needed and may shed light on key biological and 
evolutionary roles of cell cycle proteins. 
 
  
 
 
 
 
 
2. Objectives 
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 The kinase threshold model of cell cycle progression argues that a single Cdk is 
capable of interacting with all Cyclins and Cdk-substrates necessary to progress the cell 
through the mitotic cell cycle. Previous studies genetically targeting interphase Cdks, 
have identified Cdk1 as the essential Cdk for mammalian cell cycle progression and its 
ability to compensate for the loss of other cell cycle Cdks. However, if the threshold 
model holds true, other Cdks should be able to compensate for the loss of Cdk1, unless 
Cdk1 holds a specific function that has yet to be elucidated. While research has focused 
on the role of Cdk1 in the mitotic cell cycle, much remains to be understood about the 
role of Cdk1 in development and homeostasis. 
 
 
Hence the objectives of this thesis are the following: 
 
1. Generate a conditional Cdk1lox allele for the study and characterization of the 
role of Cdk1 in mouse embryonic development and adult homeostasis. 
 
2. Utilizing the Cdk1lox conditional allele, identify cell specific or novel functions of 
Cdk1 in vivo. 
 
3. Characterize the effect of genetic disruption of Cdk1 on mitotic cell cycle 
progression both in vitro and in vivo. 
 
4. Identify the potential for interphase Cdks to compensate for loss of Cdk1 in the 
progression of the mitotic cell cycle.  
 
5. Analyze the effect of genetic disruption of Cdk1 on cell cycle progression of 
embryonic and adult stem cell populations.  
 
6. Identify the therapeutic potential for targeting Cdk1 in tumoral cell populations. 
 
 
 
 
  
 
 
 
 
 
3. Materials and Methods 
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3.1  Mouse Generation and Maintenance 
3.1.1  Generation of Cdk1lox allele  
 For the generation of the murine Cdk1lox allele, the genomic region encoding 
mCdk1 was cloned from the BAC clone RP23-178K6. The BAC-encoded fragments of 
interest were then subcloned by recombineering into a minimal vector pMV with a 
ColE1 origin of replication and an apR resistance marker. The insertion of FRT-PGK-
gb2-neo/km-FRT-loxP cassette and the distal loxP site into the mCdk1-locus of the 
corresponding subclone was performed by one Red/ET step (“triple recombination”). 
Finally, the functional regions (FRT and loxP sites, restriction sites and resistance 
cassette) were verified by sequencing. These steps were carried out by Gene Bridges 
(P238.03.11.09). The linearized targeting vector was electroporated into mouse 
embryonic stem (ES) cells by the Transgenic Mice Unit of the CNIO. ES cell clones 
having undergone proper homozygous recombination with both arms of the targeting 
vector were identified by Southern Blot as described below. Single cell suspensions of 
two independent and positive ES cell clones (ESSD12.188 and ESSD12.193) were 
microinjected into FVB donor blastocysts which were then implanted into hormonally 
induced pregnant C57Bl/6J females. Two male founder chimera pups (with 100% 
penetrance of coat color) were utilized to generate germline transmission and were 
backcrossed to C57Bl/6J mice to establish pure genetic background.  
3.1.2  Previously generated mouse strains 
Other lines utilized in this thesis include: The Tg.Flpe line (Rodríguez et al. 2000), 
which was generated in Susan M. Dymecki’s laboratory (Harvard Medical School, 
Boston, MA, USA); The EIIa-Cre line (Clausen et al. 1999), which was generated in 
Irmgard Foster’s laboratory (Institute for Genetics, University of Cologne, Germany); 
The Rosa26lslLacZ line (Mao et al. 1999), which was generated in Stuart H. Orkins’ 
laboratory (Dana Farber Cancer Institute, Boston, MA, USA); The RERT line (Guerra et 
al.2003), which was generated in Mariano Barbacid’s laboratory (Spanish National Cancer 
Research Centre, Madrid, Spain); The Tg.hUBC-CreERT2 line (Ruzankina et al. 2007), 
which was generated in Eric J. Brown’s laboratory (University of Pennsylvania School of 
Medicine, Philadelphia, PA, USA); The Tie2-CreERT2 line (Rodrigo Dieguez-Hurtado 
unpublished data), which was generated in Sagrario Ortega’s laboratory (Spanish 
National Cancer Research Centre, Madrid, Spain); The Tg.Pcp-2-Cre line (Barski et al. 
2000), which was generated in Michael Meyer’s laboratory (Max-Plank Institute of 
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Neurobiology, Martinsried, Germany); Wild-type C57Bl-6J and Hsd:Athymic Nude-
Foxn1nu provided by the Animal Facility at CNIO.  
3.1.3  Mouse maintenance 
All mice used were housed in the animal facility of the CNIO (Spanish National 
Cancer Centre, Madrid, Spain), where mice are submitted to 12 hour light/dark cycles. 
All mouse work and maintenance was performed in accordance with the Federation of 
European Laboratory Animal Science Association’s recommendations and following the 
European Union legislation. All experiments described in this thesis were previously 
approved by the Bioethics and Animal Welfare Committee of the Health Institute Carlos 
III (CBA PA 04_2013-v2). Mice were fed ad libidum the Harlan diet except in cases where 
the Tamoxifen inducible Cre recombinase was induced, then animals were fed a high-fat 
transition diet for 10 days (Harlan) followed by a Tamoxifen-containing diet (Harlan). 
3.1.4  Standard Necropsy 
Animals were sacrificed in a CO2 chamber and samples of interest were collected 
in tissue sample blocks and fixed in formalin. Samples were processed in paraffin, cut 
and stained as needed by the Comparative Pathology Unit at CNIO. Some organs were 
frozen in OCT (Sakura) and stored at -80 °C for later cryostat sectioning. Partial tissue 
samples were collected for biochemical analysis in eppendorf tubes, flash frozen in dry 
ice powder and stored at -80 °C for later processing. 
3.1.5  Wound Healing Assay 
 Mice were fed a high-fat transition diet (Harlan) for 10 days followed by a 
Tamoxifen-containing diet (Harlan) for indicated time period up-to and during the 
wound healing assay. Mice were housed individually for the duration of the assay. To 
induce wound healing mice were first anesthetized using isofluorane while maintaining 
5% oxygen. The backs of the mice were shaved, treated with hair-removal cream for 30 
seconds and skin was sterilized with iodine. A circular 4 mm or 6 mm skin hole punch  
was utilized to make a circular incision (as indicated below) in the epidermis and dermis 
of the back skin. Hair was routinely removed either by shaving or hair-removal cream to 
avoid possible interference with wound healing process. Wound was measured at the 
time of incision and daily to monitor healing process. Mice were sacrificed in a CO2 
chamber at the indicated day of interest and wound was collected including 0.5-1 cm of 
surrounding back skin and placed on an index card to maintain tissue architecture. 
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Peritoneum and diaphragm samples were collected on glass slides and dried for several 
hours. They were then fixed in formalin and processed for X-gal staining (described 
below).  
3.1.6  Genotyping  
Mice were routinely genotyped by extracting DNA from tail samples. 
1. 490 μl of lysis buffer (20mM Tris/HCl pH 8.0, 100 mM NaCl, 0.5% SDS, 10 
mM EDTA pH 8.0) and 10 μl of proteinase K were added to each tail, and left 
overnight (o.n.) at 55°C. 
2. 300 μl of saturated NaCl was added. 
3. The solution was mixed and incubated for 10 min on ice. 
4. The samples were centrifuged at 13000 rpm for 10 min. 
5. The supernatant was transferred to a clean eppendorf. 
6. 800 μl of isopropanol was added, then the solution was mixed vigorously. 
7. The mixture was incubated for at least 1 hour at -20°C. 
8. The samples were centrifuged at 13000 rpm for 10 min. 
9. The supernatant was discarded. 
10. 400 μl of 70% ethanol (EtOH) was added. 
11. The samples were centrifuged at 13000 rpm for 10 min. 
12. The supernatant was discarded. 
13. The pellets were left to dry. 
14. The pellets were resuspended in 200 μl of MilliQ-filtered H2O. 
 
Once the DNA was isolated we performed polymerase chain reaction (PCR) in a volume 
of 20 μl with the following sample conditions: 
• 1.25 μl MgCl2 (25 mM) 
• Taq Polymerase Buffer (1X) 
• 0.5 μl dNTPs (10 mM) 
• 0.1 μl BSA (10 mg/ml) 
• 0.1 μl Taq Polymerase (5 units/μl EcoTaq, Ecogen) 
• 1 μl of each of the primers (10 μM, Sigma) 
• 1 μl of DNA 
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The oligonucleotides used for genotyping were:  
 
Cdk1 
Cdk1 F: 5’ CATAGATAGCTAGGGAATCCGCA 3’ 
Cdk1 R: 5’ AGGCATTGAAGATAACTACGATCT 3’ 
 
Cdk1-null 
Cdk1-null-F: 5’ GAGATGTAGGATGACTCAGTG 3’ 
Cdk1-null-R: 5’ TAGCTTATCTACCTCAGCCTG 3’ 
 
Cdk1-Flp 
Cdk1Flp F: 5’ CAGAGTCACTGGCCAGATAG 3’ 
Cdk1Flp R: 5’ GGTGAGCTAGAGTAATATCCTG 3’ 
 
RERT  
Polr2aR_10B6: 5’ CCTCTCTGAGCCTCAATTAAGCAG 3’ 
ESRF1f_10B7: 5’ TGAGTAACAAAGGCATGGAGCA 3’ 
Polr2aF_14B5: 5’CCAGATGACAGCGATGAGGA 3’ 
KI allele: Polr2aR_10B6-ESRF1f_10B7, 390bp. 
WT allele: Polr2aR_10B6-Polr2aF_14B5, 480bp. 
 
Rosa26LSLLacZ  
oIMR8052: 5’ GCGAAGAGTTTGTCCTCAACC 3’ 
oIMR8545: 5’ AAAGTCGCTCTGAGTTGTTAT 3’ 
oIMR8546: 5’ GGAGCGGGAGAAATGGATATG 3’ 
KI allele: oIMR8052-oIMR8545, 340bp. 
WT allele: oIMR8545-oIMR8546, 650bp. 
 
The PCR program used was: 
94°C 1 min 
94°C 30 sec 
60°C 30 sec    x 35 cycles 
72°C 1 min 
72°C 10 min 
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The length of the amplified fragments was assessed by 2% agarose gel electrophoresis. 
 
Alternatively, the mice were genotyped by Transnetyx (Cordova, TN, USA). 
3.1.7  Southern Blot 
1. Sample DNA was prepared to be 30-50 μg in a 50 μl volume. 
2. To perform digestion the following was added to sample: 
a. 5 μl of Restriction Enzyme of interest 
b. 1 μl RNase, DNase-free 
c. 5 μl Spermidine 
d. 7 μl of 10x Buffer 
e. 2 μl of 100x BSA 
f. Total = 20 μl 
3. The final mix of 70 μl was mixed well and incubated at 37°C o.n. 
4. 250 ml of 0.7% agarose gel was prepared 
5. 6 μl of 6x loading dye was added to each sample and samples were loaded into 
gel wells. 
6. Gel was run at 100 V until the blue dye front of the loading dye ran off the gel. 
7. To ensure proper digestion of DNA samples a picture of the gel was taken using 
the transilluminator. 
8. Gel was washed with dH2O. 
9. Gel was incubated with 0.25 N HCl for 15 min in light agitation. 
10. Gel was washed with dH2O. 
11. Gel was incubated with Denaturing Solution (0.5 M NaOH + 1.5 M NaCl) for 
20 min with light agitation. 
12. Gel was incubated with Neutralizing Solution (0.5 M Tris-HCl pH 8.0; 1.5 M 
NaCl). 
13. Gel was then equilibrated with transfer buffer (10x SSC). 
14. The gel was then capillary transferred in 10x SSC placing first 3mm Whatman 
blotting paper on a face-down plastic gel mold with the edges emerged in the 10x 
SSC buffer. The following order was followed from bottom up: Gel, nylon 
Hybond N+ membrane (Amersham), two pieces of Whatman paper (cut to size 
of gel and membrane), and a pack of paper towels. The entire transfer is wrapped 
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in plastic wrap to avoid evaporation of buffer. A weight is placed on top and the 
gel is transferred o.n. 
15. The next day top weight and papers are removed, and the membrane is marked 
with a pencil where the gel’s wells were positioned. 
16. Membrane was autocrosslinked 2x. 
17. Membrane was incubated with 10 ml of Hybridization buffer for at least 4 hours 
or o.n in glass tube (with the DNA side facing inwards) incubated in a rotisserie 
oven at 42°C. 
18. The DNA probe was prepared as follows: 
a. 2μl of the probe were added to 43 μl of water or TE buffer and boiled 
for 5 min.  
b. Sample was placed on ice for 2 min. 
c. Sample was spun. 
d. Sample was kept on ice. 
e. The probe sample was added to a tube with glass beads and 50 μCi (5 μl) 
of α32dCTP was added. 
f. Sample was incubated at 37°C for 5 min for the probe to be radioactively 
labeled.  
g. The reaction was stopped by adding 5 μl of NaOH. 
h. The sample was filtered on a spin column.  
i. The filtered radioactively labeled probe was then added to the glass tube 
with the membrane and incubated o.n. 
j. The following day the membrane was washed  
i. 30 min with 2x SSC, 0.1% SDS. 
ii. 30 min with 1x SSC, 0.1% SDS 
iii. 30 min with 0.1% SSC, 0.1% SDS 
k. The membrane was then placed in a plastic sleeve and exposed to a 
Phosphoimager screen. 
l. The screen was then developed using the Phosphoimager and its 
software. 
3.2  Staining and processing of tissue samples 
3.2.1  X-Gal whole mount staining 
1. Tissues were fixed at RT for 60-90 min in fixative solution: 
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! 0.2% glutaraldehyde (Sigma) 
! 1.5% formalin solution (Sigma) 
! 2 mM MgCl2 
! 5 mM EGTA 
! 100 mM sodium phosphate pH 7.3 
2. The tissues were washed 3 times (20 min each at RT) in washing solution: 
! 0.2% NP-40 
! 0.1% sodium deoxycolate (Sigma) 
! 2 mM MgCl2 
! 100 mM sodium phosphate pH 7.3 
3. Following the washes, the tissues were stained for 48 hours at 37°C in the 
staining solution: 
! 0.2% NP-40 
! 0.1% sodium deoxycolate (Sigma) 
! 2 mM MgCl2 
! 100 mM sodium phosphate pH 7.3 
! 5 mM K3Fe(CN)6 (ProLab) 
! 5 mM K4Fe(CN)6 (ProLab) 
! 1 mg/ml X-Gal (dissolved in dimethylformamide) 
4. The tissues were washed 3 times and for 10 min with the above mentioned 
washing solution. 
5. The samples were postfixed o.n. in phosphate buffered 10% formaldehyde. 
6. The fixed and stained tissues were washed twice with 1X PBS for 5 min. 
7. The tissues were washed twice with 50% EtOH and twice with 70% EtOH (1 
hour each). 
8. At this point tissues were processed by the Comparative Pathology Unit at 
CNIO, which produced 4 μm sections on a 3-aminopropyltrethoxylan coated 
slides and counter-stained with Nuclear Fast Red (NFR). 
3.2.2  X-Gal staining on cryostat sections  
1. Samples were cut in the cryostat at a 10 μm thickness and placed on a slide. 
2. The slides were stored at 4°C o.n. or 1 hour at RT. 
3. Sections were washed with PBS 1X. 
4. Sections were fixed for 10 min at RT in the following solution: 
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! 0.2% glutaraldehyde (Sigma) 
! 5 mM EGTA 
! 2 mM MgCl2 
! 0.1 M phosphate buffer pH 7.3 
5. The sections were washed 3 times with the following washing solution: 
! 2 mM MgCl2 
! 0.1 M phosphate buffer pH 7.3 
! 0.02% NP-40 
! 0.01% sodium deoxycolate (Sigma) 
6. After the washes, the sections were stained o.n. at 37°C with: 
! 2 mM MgCl2 
! 0.1 M phosphate buffer pH 7.3 
! 0.02% NP-40 
! 0.01% sodium deoxycolate (Sigma) 
! 1 mg/ml X-Gal 
! 5 mM K3Fe(CN)6 (ProLab) 
! 5 mM K4Fe(CN)6 (ProLab) 
7. The sections were washed 3 times with washing solution. 
8. Sections were counter-stained with NFR 
3.2.3  Nuclear Fast Red Staining (NFR)  
1. The NFR solution was prepared: 
! 25 g aluminum sulphate (Sigma) 
! 0.5 g NFR (Sigma) 
! 500 ml milli-q H2O 
! Solution was boiled for 2-3 min and then filtered 
2. The samples were washed with H2O. 
3. The sections were stained with NFR for 1 min and 30 sec. 
4. The sections were washed with H2O. 
5. The sections were washed twice for 2 min with 70% EtOH. 
6. The sections were washed twice for 2 min with 100% EtOH. 
7. The sections were rinsed with Xilol (Merck) for 1 min. 
8. The sections were mounted with coverslip. 
Catherine Evangeline Symonds  Materials & Methods 
 
45 
3.2.4  Immunofluorescence  
1. Sections were deparaffinized (see 1a). Or cells were seeded on poly-d-lysine 
coated glass coverslips,  glass bottom 96-well plates or human recombinant 
Lamin and 0.1% gelatin coated Ibidi μ-Slide 8 well chamber. 
a. The deparaffinized sections were treated with sodium citrate 10 mM (pH 
6) at 95°C for 20 min (antigen retrival). 
2. The samples were permeabilized for 30 min at RT with: 
! 0.4% Triton 
! 0.04% SDS 
! 1X PBS 
3. The slides were washed twice with 1X PBS. 
4. The slides were blocked for 45 min in 5% BSA at 37°C. 
5. The primary antibodies were diluted in 5% BSA (mouse anti-γH2AX 1:500 
Millipore 05-636, rabbit anti-Histone H3 Ser10 Phospho 1:500 Upstate 06-570, 
mouse anti-MPM2 Ser/Thr-Pro Phospho 1:500 Millipore 05-368) and incubated 
with sample for 1 hour at 37°C or o.n. at 4°C. 
6. The slides were washed twice with 1X PBS. 
7. The secondary antibodies were diluted in 5% BSA (Alexa Flour 647 chicken anti-
mouse 1:200 Invitrogen A21463, Alexa Fluor 488 goat anti-mouse 1:200 
Invitrogen A11029, Alexa Fluor 488 chicken anti-rabbit 1:200 Invitrogen 
A21441) and incubated with the samples 45 min at 37°C. 
8. The first wash was done with diluted DAPI or 670 Phalloidin 1:1000 in 1X PBS. 
9. Two additional washes were performed with 1X PBS. 
10. The slides were mounted with mowiol and the coverslip. 
11. The slides were analyzed on the Leica SP5, DeltaVision (Time Lapse) or Opera 
High Throughput (Perkin Elmer) confocal microscopes. 
12. For the Opera a 20x magnification lens was used and pictures were taken at non-
saturating conditions. Images were segmented using the DAPI staining to 
generate masks matching cell nuclei from with the average fluorescence signal 
was calculated using scripts developed by Diego Megias from CNIO’s 
Microscopy Unit. Statistical analysis was computed with SPSS software. All other 
confocal images and time-lapse videos were processed using ImageJ/Fiji 
software. 
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3.2.5  Extraction of early-stage embryos (E1.5-E3.5) 
Female mice between 5 and 8 weeks of age were superovulated by priming with PMSG 
and hCG (provided by CNIO animal facility) at 14:00 hours two days prior to mating 
and at 13:00 hours on the day of mating respectively. Female mice were mated with stud 
males and checked for plugs the following morning. Plug positive females were sacrificed 
by cervical dislocation on day of interest. The uterus and oviducts were carefully 
separated by teasing away from mesometrium with closed scissors or forceps. The uterus 
was cut half-way between oviduct and uterine horn joining. Another cut was made 
between the oviduct and the ovary. Isolated uterus and oviducts were placed in 50 μl of 
M2 media. Using a dissection microscope the embryos were flushed from the ampule of 
the oviduct through the uterus and collected in M2 media. Embryos were micropipetted 
with a mouth pipette in three drops of M2 media and then either processed for DNA 
extraction, immunofluorescence staining or continued culture. 
3.2.6  Early embryo culture 
 Embryos extracted as previously described (3.2.5) were washed by micropipette 
transfer through three drops of KSOM media. Individual embryos were then transferred 
to 50 μl drops of KSOM media (preheated to 37°C for proper pH adjustment) and 
partially covered with glycerol. Once transferred, KSOM drops were completely covered 
with glycerol and maintained at 37°C with 5% CO2. Embryos were maintained in 
KSOM until blastocyst formation (approximately day 4). Embryos were then transferred 
to individual wells of 96-well plates with mitomycin C mitotically-inactivated feeder cells 
and grown with DMEM+LIF (provided from CNIO’s Transgenic Mouse Unit).   
3.2.7  Genotyping of early embryos 
Early embryos were washed and collected in 10 or 20 μl of PCR-K buffer with 
Proteinase K and incubated at 55°C for 2 hours. Proteinase K was inactivated by 
incubation at 95°C for 15 min. One microliter of digest was utilized for PCR reaction.  
PCR-K buffer was composed of: 
! 50 mM KCl 
! 1.5 mM MgCl2 
! 10 mM Tris-HCl pH 8.5 
! 0.01% gelatin 
! 0.45% Nonidet P-40 
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! 0.45% Tween 20 
! 100 μg/ml Proteinase K 
PCR was performed as previously described and following the previously published 
protocol (Malumbres et al. 1997). 
3.2.8  Immunofluorescence of mouse embryos 
1. Preimplantation embryos were isolated as described (3.2.5).  
2. Embryos were fixed in methanol at -20°C for 1h or o.n. 
3. Embryos were washed in 3 drops of M2 media. 
4. Embryos were washed in 3 drops of PBS + 0.1% BSA. 
5. To permeabilize, embryos were incubated for 5 min in PBS + 0.1% BSA + 0.1% 
Triton X-100. 
6. Embryos were washed in 3 drops of PBS + 0.1% BSA. 
7. To block embryos were incubated in blocking solution (PBS + 0.1% BSA + 10% 
goat serum) for 1-2 hours. 
8. Primary Antibody: Embryos were incubated with 1st antibody for 2-4 hours at 
RT (mouse anti-γH2AX 1:100 Millipore 05-636, mouse anti-Cdx2 1:100 
Biogenix MU392A-UC) diluted in blocking solution. 
9. Embryos were washed in 3 drops of PBS + 0.1% BSA. 
10. Secondary Antibody: Embryos were incubated with secondary antibody for 2 h at 
RT (Alexa Fluor 488 chicken anti-rabbit 1:200 Invitrogen A21441) diluted 1:500 
in blocking solution. 
11. Embryos were washed in 3 drops of PBS + 0.1% BSA. 
12. DNA Staining: Embryos were incubated with DAPI (1mg/ml) diluted 1:500 in 
PBS + 0.1% BSA. 
13. Embryos were washed in 3 drops of PBS + 0.1% BSA. 
14. Embryos were washed in 2 drops of PBS. 
15. Embryos were imaged in drops of PBS in microwells on the confocal microscope 
Leica SP5. 
3.2.9  Histopathology and immunohistochemistry  
Tissues including pancreas, spleen, thymus, liver, kidney, lung, heart, skeletal muscle, 
intestine, stomach, colon, skin, ovary, uterus, prostate, testis, mammary gland, white 
adipose tissue, brown adipose tissue, brain, eye, and femur were dissected, fixed in 10%-
buffered formalin (Sigma) and embedded in paraffin. 4 μm thick sections were cut and 
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stained with haematoxylin and eosin (H&E). Antibodies used for immunohistochemistry 
included mouse anti-Cdk1 (BD Biosciences 610038), rabbit anti-CD31 (Abcam 
ab28364), rat monoclonal anti-β-Galactosidase (produced by the Monoclonal Antibody 
Unit at CNIO), mouse monoclonal anti-bromo-deoxyuridine (GE Healthcare RPN202), 
rabbit polyclonal anti-caspase 3 Asp175(Cell Signaling 9661), rat monoclonal anti-Tpx-2 
(produced by the Monoclonal Antibody Unit at CNIO), rabbit anti-Ki67 (Master 
Diagnostica 0003110QD), rabbit anti-FVIII Von Willebrand Factor (Dako A9982). 
 
3.3  Quantitative real time RT-PCR 
3.3.1  RNA Extraction 
 Total RNA was extracted from samples using RNeasy Mini Kit (Qiagen) 
following manufacturers instructions. Briefly, cells were resuspended in provided lysis 
buffer and RNA was purified using the provided columns. On-column DNase digestion 
was performed to eliminate residual genomic DNA. RNA was eluted into 50 μl of 
elution buffer and quantified using the nano-drop spectrophotometer. RNA quality for 
sequencing experiments was assessed on the Agilent 2100 Bioanalyzer. 
3.3.2  cDNA synthesis 
cDNA synthesis was performed using SuperScript II RT kit from Invitrogen following 
the manufacturer’s instructions. 
For each sample the following mix was prepared: 
! 200 ng random primers 
! 40-100 ng total RNA 
! 1 µl dNTP mix (10mM each) 
! Sterile, distilled H2O 
1. The mixture was incubated at 65°C for 5 min. 
2. The samples were chilled on ice. 
3. For each sample the following mix was added: 
! 4 μl 5X First Strand Buffer 
! 2 μl 0.1 M DTT 
! 1 μl RNaseOUT (40 units/μl) 
4. The content of the tubes was gently mixed.  
5. Samples were incubated at 25°C for 2 min. 
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6. 1 μl of SuperScript II RT enzyme was added and samples were mixed by 
pipetting. 
7. Samples were incubated at 25°C for 10 min. 
8. Samples were incubated at 42°C for 50 min. 
9. The reaction was inactivated by heating at 70°C for 10 min. 
3.3.3  Real time PCR 
3.3.3.1  Primer design criteria 
1. Tm: 58°C to 61°C 
2. Primer length: 19-24 bp  
3. Guanine cytosine (GC) content: 45-55%  
4. PCR amplicon length: 100-200 bp  
5. Cover an exon-exon junction (to avoid the problem of possible residual 
genomic DNA contamination) 
6. Order primers with standard desalting purification 
 
3.3.3.2  Primers 
 mCdk1 5’ 
 mCdk1 5’ F: 5’ GAGAAGGTACTTACGGTGTG 3’ 
 mCdk1 5’ R: 5’ GACAGGAACTCAAAGATGAG 3’ 
 
 mCdk1 3’ 
 mCdk1 3’ F: 5’ CAGGATCTTCAGAGCTCTG 3’ 
 mCdk1 3’ R: 5’ GGCAGGATCATAGACTAGCA 3’ 
 
 PPP2R2D 
 PPP2R2D RT For: 5’ GCGGAAGCCGACATCATC 3’ 
 PPP2R2D RT Rev: 5’ CATGACTCTGAAAGGTACTG 3’ 
 
 PCP2 
 PCP2 RT For: 5’ CAGTTAATTCCCTGCCTG 3’ 
 PCP2 RT Rev: 5’ GTTTTCAGGGGCCAGTGG 3’ 
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 Myt1 
 Myt1 RT For: 5’ GACATCGAAGCTTACAGAG 3’ 
 Myt1 RT Rev: 5’ CCTTCTGATTCATCTGAAACAG 3’ 
 
 Wee1 
 Wee1 RT For: 5’ CACTCCCAAGAGTTTGCTTTCC 3’ 
 Wee1 RT Rev: 5’ CTGAGGAATGGAGCAGTACAGG 3’ 
 
 PPP2R2A 
 PPP2R2A RT For: 5’ ATTCAGCCATAGCGGTCGTT 3’ 
 PPP2R2A RT Rev: 5’ TGACAACACTGTCAGACCCA 3’ 
 
 Casp2 
 Casp3 Rt For: 5’ GGAGCAGGATTTTGGCAGTGT 3’ 
 Casp3 Rt Rev: 5’ GCCTGGGGTCCTCTCTTTG 3’ 
 
 Akt1 
 Akt1 Rt For: 5’ ATGAACGACGTAGCCATTGTG 3’ 
 Akt Rt Rev: 5’ TTGTAGCCAATAAAGGTGCCAT 3’ 
 
 Bag3 
 Bag3 Rt For: 5’ CTGGGAGATCAAAATCGACCC 3’ 
 Bag3 Rt Rev: 5’ GCTGAAGATGCAGTGTCCTTAG 3’ 
 
 Bak1 
 Bak1 Rt For: 5’ CAACCCCGAGATGGACAACTT 3’ 
 Bak1 Rt Rev: 5’ CGTAGCGCCGGTTAATATCAT 3’ 
 
 Bcl2l1 
 Bcl2l1 Rt For: 5’ GACAAGGAGATGCAGGTATTGG 3’ 
 Bcl2l1 Rt Rev: 5’ TCCCGTAGAGATCCACAAAAGT 3’ 
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 Birc5 
 Birc5 Rt For: 5’ GAGGCTGGCTTCATCCACTG 3’ 
 Birc5 Rt Rev: 5’ CTTTTTGCTTGTTGTTGGTCTCC 3’ 
 
 Cide-A 
 Cidea Rt For: 5’ TGACATTCATGGGATTGCAGAC 3’ 
 Cidea Rt Rev: 5’ GGCCAGTTGTAGATGACTAAGAC 3’ 
 
 Mcl-1 
 Mcl1 Rt For: 5’ AAAGGCGGCTGCATAAGTC 3’ 
 Mcl1 Rt Rev: 5’ TGGCGGTATAGGTCGTCCTC 3’ 
 
 Klf-4 
 RT Klf4 Endo. For: 5’ GCGAACTCACACAGGCGAGAAACC 3’ 
 RT Klf4 Endo. Rev: 5’ TCGCTTCCTCTTCCTCCGACACA 3’ 
 
 Sox-2 
 RT Sox2 Endo. For: 5’ TAGAGCTAGACTCCGGGCGATAGA 3’ 
 RT Sox2 Endo. Rev: 5’ TTGCCTTAAACAAGACCACGAAA 3’ 
 
 Oct3/4 
 RT Oct3/4 Endo. For: 5’ TCTTTCCACCAGGCCCCCGGCTC 3’ 
 RT Oct3/4 Endo. Rev: 5’ TGCGGGCGGACATGGGGAGATCC 3’ 
 
 Gata-6 
 RT Gata6 For: 5’ ACCTTATGGCGTAGAAATGCTGAGGGTG 3’ 
 RT Gata6 Rev: 5’ CTGAATACTTGAGGTCACTGTTCTCGGG 3’ 
 
 Brachyury 
 RT Brachyury For: 5’ ATGCCAAAGAAAGAAACGAC 3’ 
 RT Brachyury Rev: 5’ ACGAGTGGCAGTTTCTTCTTGGGA 3’ 
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 Cdx-2 
 RT Cdx2 For: 5’ GGCGAAACCTGTGCGAGTGGATGCGGAA 3’ 
 RT Cdx2 Rev: 5’ GATTGCTGTGCCGCCGCCGCTTCAGACC 3’ 
  
 Nanog 
 RT Nanog For: 5’ AGGGTCTGCTACTGAGATGCTCTG 3’ 
 RT Nanog Rev: 5’ CAACCACTGGTTTTTCTGCCACCG 3’ 
 
 p21 
 p21Cip1-F: 5’ TTCCGCACAGGAGCAAAGT 3’ 
 p21Cip1-R: 5’ CGGCGCAACTGCTCACT 3’ 
 
GAPDH 
GAPDH forward: 5’TGCACCACCAACTGCTTAG 3’ 
GAPDH reverse: 5’GGATGCAGGGATGATGTTT 3’ 
 
β-actin 
β-actin forward: 5’GACGGCCAGGTCATCACTATT 3’ 
β-actin reverse: 5’AGGAAGGCTGGAAAAGAGCC 3’  
 
 3.3.3.3  qRT-PCR 
The PCR mix was prepared as follows: 
! 10 μl SYBR Green Mix 2X (Roche) 
! 0.5 μl primer forward primer (10 μM - Sigma) 
! 0.5 μl primer reverse (10 μM – Sigma) 
! 1 μl template cDNA 
! 8 μl H2O  
Samples were prepared in a 96-well plate, sealed with optical adhesive 
film and processed in the AB 7900HT Fast Real Time PCR System. 
The settings were as follows: 
! Stage 1: 2 min at 50°C 
! Stage 2: 10 min at 95°C 
! Stage 3: 15 sec at 95°C then 1 min at 60°C (repeat 40 cycles) 
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! Dissociation stage: 95°C for 15 seconds, 60°C for 15 seconds, 
followed by a slow ramp to 95°C 
 
3.3.3.4  Data analysis 
The data were analyzed using the SDS software (Applied Biosystems). 
The relative mRNA expression was calculated using the comparative Ct 
(cycle threshold) method: 
ΔΔCt = ΔCt,sample - ΔCt,reference 
ΔCT,sample is the Ct value for any sample normalized to the 
endogenous housekeeping gene and ΔCt, reference is the Ct value for the 
calibrator also normalized to the endogenous housekeeping gene. 
 
3.4  RNA Sequencing 
 RNA was isolated from samples as previously described (3.3.2) and 1 μg of RNA 
with an RNA integrity number (RIN) of 10 was provided to the Genomics Unit at 
CNIO. The PolyA+ fraction was purified and randomly fragmented, converted to 
double stranded cDNA and processed through subsequent enzymatic treatments of end-
repair, dA-tailing, and ligation to adapters as in Illumina’s “TruSeq Stranded mRNA 
Sample Preparation Part #15031047 Rev. D” (this kit incorporates dUTP during 2nd 
strand cDNA synthesis, which implies that only the cDNA strand generated during 1st 
strand synthesis is eventually sequenced). Adapter-ligated library was completed by PCR 
with Illumina PE primers (8 cycles). The resulting purified cDNA library was applied to 
an Illumina flow cell for cluster generation (TruSeq cluster generation kit v5) and 
sequenced on the Genome Analyzer IIx with SBS TruSeq v5 reagents by following 
manufacturer's protocols. Image analysis and per-cycle basecalling was performed with 
Illumina Real Time Analysis software (RTA1.13). Conversion to FASTQ read format 
and sequence alignment with the ELAND algorithm (v2e) was performed with 
CASAVA-1.8 (Illumina). 
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3.5  Western Blot 
3.5.1  Protein extraction 
1. Either tissues or cells were resuspended in lysis buffer: 50 mM Tris-HCl (pH 7.4) 
solution, containing 150 mM NaCl, NP-40 0.5% and protease (PMSF 100 mM, 
Roche) and phosphatase inhibitors (100 mM vanadate sodium, Roche and 1 mM 
NaF, Sigma). 
2. For tissue protein extraction we used a homogenizer to mechanically breakdown 
the tissue samples and maximize the efficiency of lysis. 
3. The samples were incubated on ice for a minimum of 15 min. 
4. The extracts were centrifuged for 15 min at 13000 rpm to remove the undigested 
membranes. 
5. The supernatant was transferred to a new tube. 
6. In order to quantify the amount of protein obtained, we used the Bradford 
method (1 μl of the protein extract was added to 1 ml of Bradford reagent and 
the absorbance was read on a spectrophotometer). 
3.5.2  Acrylamide Gel 
1. The quantity of tissue/cell extracts needed to load the same total amount of 
protein was estimated (30-50 μg). 
2. 4X loading buffer and 20X reducing agent (Biorad) were added. 
3. The samples were boiled for 5 min. at 95°C. 
4. The samples were placed on ice for 5 min. 
5. Criterion XT precast gels were run into with running buffer (MES 1X, Biorad). 
6. The samples were loaded into the gel. 
7. 10 μl of the molecular weight color marker was loaded as well. 
8. The gel was run with a constant voltage of 120 V for approximately 1.5 hours. 
3.5.3  Transfer 
1. Nitrocellulose transfer membrane and Whatman paper were sized to gel and pre-
wet in transfer buffer (1X Tris-Glycine and 20% MeOH). 
2. The transfer “sandwich” was assembled in a wet blotter as follows: 
Cathode – 3x Whatman – gel – nitrocellulose membrane – 3x Whatman – Anode  
3. The gel was transferred for 1 hour and 10 min at 450 mAmp 
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4. When the transfer was finished, the amount of protein transferred was checked 
by staining with Ponceau S solution (Sigma). 
3.5.4  Blocking and antibodies 
1.  The membrane was incubated in the blocking solution (5% BSA in 1X TBS-T) 
for 1 hour at RT. 
2. The membrane was incubated with the primary antibody diluted in the blocking 
solution o.n. at 4°C. Primary antibodies included: mouse anti-Cdk1 (Santa Cruz 
sc-54), rabbit anti-Cdk2 (Santa Cruz sc-163), mouse anti-Cyclin A2 (Sigma 
C4710), mouse anti-Cyclin B1 (Millipore MAB3684), mouse anti-β-actin (Sigma 
A5441), mouse anti-GAPDH (Sigma G8795), rabbit anti-Caspase 3 (Cell 
Signaling 9662), rabbit anti-Cleaved Caspase 3 (Cell Signaling 9661), anti-Chk2, 
rabbit anti-pChk1 (Cell Signaling 2348), mouse anti-Chk1 (Novocastra NCL-
ChK1), mouse anti-γH2AX (Millipore 05-636), anti-Smc1, anti-Kap1, rabbit anti-
pRPA RPA32 S4/S8 (Bethyl A300-245A), and rabbit anti-Nanog (Novus 
Biologicals NB100-58842).  
3. The membrane was washed twice with 1X TBS-T. 
4. The membrane was incubated with the appropriate HRP-conjugated secondary 
antibody (1:2000, Dako). 
5. The membrane was washed twice with 1X TBS-T. 
6. Protein visualization was carried out with ECL detection reagent (Amersham) 
using different exposure times depending on the antibody. 
 
3.6  Stem Cell Protocols 
3.6.1  iPS Generation 
1. Day 1: Transfection 
a. 5 x 106 293T cells were seeded per 10 cm plate in DMEM + 10% FBS + 
Antibiotics and transfected with 4 μg of pMX plasmid (either Sox2, 
Oct4, Klf4 or cMyc) + 4 μg of pCL Eco plasmid and 24 μl of Fugene 6. 
b. Same day as transfection primary MEFs (Passage 2 or 3) were thawed. 
2. Day 2: Seeding 
a. Media was changed for 293T cells. 
b. MEFs were seeded at 2.5 x 105 per 6 well plate. 
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3. Day 3: Infection 
a. Morning: Viral media was from individual transfections and spun at 1000 
rpm for 5 min.  
b. Viral media was filtered through 0.45 mm filters and 8 μl/ml of 
polybrene was added. 
c. Equal parts of viral media were mixed and 1 ml of each viral media was 
added to every well of primary MEFs (so each well had 4 ml of media, 1 
ml from each viral prep.). 
d. Afternoon: Steps a-c were repeated. 
4. Day 4: The infection was repeated both in the morning and in the afternoon for 
a total of 4 infections. 
5. Day 5: Media was changed to DMEM + 15% KSR + 1000 U/ml LIF + 
Antibiotics (Transgenic Mouse Unit). 
6. Following Days: Media was changed daily.  
7. 10 days following infection iPS colonies started to appear. 
8. 14 days following infection iPS colonies had ES morphology and were 
individually picked and transferred to 96-well feeder plate (see below 3.6.2).  
9. Once the 96-well plate was confluent clones were passed to 24-well feeder plates 
and then 6-well feeder plates.  
10. Cells were frozen down at 6-well feeder passage in 60% ES Cell Media + 30% 
KSR + 10% DMSO. 
3.6.2  Feeder generation 
1. Primary MEFs (passage 2 or 3) were thawed in a 15 cm plate with DMEM + 
10% FBS + Antibiotics. 
2. Once confluent they were passed to 5, 15 cm plates (1:5). 
3. Once the 5, 15 cm plates were confluent they were passed 1:5 to generate 25, 15 
cm plates. 
4. Once confluent plates were treated with 10 μg/ml of Mitomycin C for 2-3 hours. 
5. Mitomycin C containing media was removed and cells were washed twice with 
PBS. 
6. Cells were trypsinized and spun at 1250 rpm 
7. Cells were frozen at a density of 2 x 106 per vial (so 1 vial can be used for 1 6-
well plate). 
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3.6.3  Generation of Embryonic Stem Cells 
1. Female mice were superovulated as previously described (3.2.5) and mated with 
stud males. 
2. Embryos were extracted at E2.5 (as previously described 3.2.5.). 
3. Embryos were grown in KSOM media in vitro for one day to allow blastocyst 
formation. 
4. Outer zona pelucida was removed using Tyrode’s Solution (acidic pH 2.5). 
5. Embryos were plated on 6-well feeder plates (10-20 embryos per well) in DMEM 
+ 100 U/ml LIF + 15% KSR (Transgenic Mouse Unit). 
6. We waited 4-6 days for ICM outgrowth, changing media daily. 
7. Using a dissecting microscope we picked colonies. 
8. Colonies were dissociated using a 1:3 dilution of 0.5% Trypsin in PBS. 
9. Clones were then individually plated in 96-well feeder wells. 
10. Once confluent they were passed to 24-well feeder plates and then to 6-well 
feeder plates. 
11. At 6-well passage clones were frozen in 60% ES Cell Medium + 30% KSR + 
10% DMSO. 
3.6.4  Alkaline Phosphatase Assay 
1. ES/iPS cells were plated at 1.5 x 103 cells per well of a 6-well plate coated with 
1% (w/v) porcine gelatin in DMEM + 10% (v/v) FBS and 1000 U/ml LIF and 
cultured for five days. 
2. Cells were washed twice with PBS and fixed with 100% methanol (3-5 ml) for 10 
minutes.  
3. Methanol was aspirated and fixed cells were allowed to air dry. 
4. Colonies were incubated for 15-20 minutes with a solution of 0.1 M Tris-HCl pH 
9.2, 200 μg/ml Naphthol AS-MX (Sigma N4875) and 1 mg/ml Fast Red TR Salt 
(Sigma F2768). To make the solution we dissolved 2 mg of Naphthol AS-MX in 
10 ml of 0.1 M Tris-HCl pH 9.2 and this was added to a tube containing 10 mg 
Fast Red TR Salt and mixed to dissolve. We added 2 ml/well of this solution and 
incubated for 15-20 minutes.  
5. Reaction was stopped by rinsing cells twice with dH2O and allowed to air dry. 
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3.6.5  Teratoma Assay 
1. Early passage ES cells were grown on feeder plates and when 80% confluent 
clones were trypsinized and counted. 
2. 2.0 x 106 cells were suspended into 100 μl total volume of PBS and injected 
subcutaneously into the back hind-side of Hsd:Athymic Nude-Foxn1nu mice.  
3. Mice were monitored for tumor growth and upon palpable tumor size mice were 
placed on a Tamoxifen-containing diet for five days. 
4. After five days of Tamoxifen-containing diet, mice were sacrificed and tumors 
were collected for histopathological analysis.  
 
3.7  Tissue Culture and Cell Maintenance 
3.7.1  MEFs 
 Mouse embryonic fibroblasts were isolated from E13.5 day old embryos. 
Pregnant females were sacrificed and embryos were isolated into PBS. Heads of embryos 
were removed for genotyping. Fetal liver and heart were removed from embryos. 
Embryos were mechanically dissociated and then enzymatically with 0.5% Trypsin. 
Cellular suspensions were then plated in 15 cm plates with DMEM + 10% FBS. Once 
confluent MEFs were frozen into four vials.  
3.7.2  Immortalization of MEFs 
 To immortalize primary MEFs we followed the traditional 3T3 protocol. We 
continuously plated 1.0 x 106 cells in a 10 cm tissue culture plate with DMEM + 10% 
FBS + Antibiotics every 3 days for 12-15 passages. Cells would tend to enter a crisis 
stage around passage 5-6 ,where they would not actively proliferate between passages. 
Once crisis stage had passed and cells continuously proliferated to more than double the 
seeded density they were considered immortal and frozen down. Each clone was tested 
for active p53 by treating with Doxorubicin and probing for increased p53 and p21 
protein levels. Clones that had a defective p53 pathway were noted and not utilized for 
further analysis. 
3.7.3  Keratinocytes 
 Keratinocytes were isolated from neonate heterozygous or homozygous mutant 
Cdk1lox; Tg.hUBC-CreERT2 mice according to previously described protocols (Lichti et 
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al. 2008). Briefly, tail was isolated from euthanized mice and bone was removed. Tail skin 
was then incubated in 0.75% trypsin with the dermis down in a petri dish for 1h at 37°C 
with 5% CO2. The dermis and epidermis were separated with forceps and the epidermis 
was then treated with 250 μg/ml DNaseI (Sigma DN25-IG)), 2% Chelated FCS in 
MEM (Sigma M8167) in a 37°C water bath for 30 minutes with gentle agitation. Solution 
was then filtered through a 70 μm cell strainer and centrifuged. Cells were resuspended 
in culture media: MEM, 8% chelated FCS, Pen/Strep/Glu, 0.05 mM CaCl. Cells were 
plated on tissue culture plates previously coated for 1h at 37°C with coating matrix from 
Cascade Biologicals kit (R-011-K). 
3.7.4  Mammary Tumor Cell Lines 
 Mammary tumor cell lines were established from Tg.MMTV-PyMT tumors by 
dissecting out tumor. Tumor was mechanically dissociated using a blade and scissors. 
Dissociated tumors were treated with 0.5% trypsin for 30 minutes. Cell suspensions were 
then plated in 15 cm plates with DMEM + 10% FBS + Antibiotics. The following day 
the media was changed and once confluent cells were passaged 1:2. Cells were frozen 
down at passage two. Not all clones continued proliferating after several passages, we 
utilized those that maintained proliferative capacity in vitro. 
 
3.8  Flow Cytometry  
3.8.1  DNA and Cell Cycle Analysis by Flow Cytometry 
1. Cells grown in culture were trypsinized and washed to have a single cell 
suspension resuspended into 300 μl of PBS. 
2. Cells were then fixed by adding 700 μl 100% EtOH dropwise to the 300 μl 
cellular suspension in a 15 ml falcon tube while vortexing and incubated at 4°C 
o.n. 
3. Fixed cells were then centrifuged 5 min at 2000 rpm to remove EtOH. 
4. Cells were washed 1x in  PBS-Tween 0.05%  
5. Cells were incubated with 100 μl of primary antibody diluted 1:500 in PBS-
Tween 0.05% for 45 min at RT. 
6. Cells were washed with 5 ml of PBS-Tween 0.05%. 
7. Cells were then incubated with 100 μl of secondary antibody diluted 1:500 in 
PBS-Tween 0.05% for 45 minutes at RT in the dark. 
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8. Cells were washed with 5 ml of PBS-Tween 0.05%. 
9. Cells were then resuspended in 300-500 μl of PBS + 10 μg of propidium iodide 
(PI) and 100 μg of RNase.  
10. Samples were incubated at least 1 hour at 4°C before analyzing. 
11. Samples were analyzed on a BD FACS Calibur or BD LSR Fortessa. 
12. Samples were analyzed using FloJo software. 
3.8.2  HSC Analysis  
 Bone marrow from mice was isolated from the femur and tibia of both hind legs. 
All cell isolation and processing was performed by R. Sanchez Dominguez at the 
CIEMAT (Madrid, Spain) following standard protocols. LSK (Lin-, c-Kit-, Sca1-), c-Kit 
(Lin-, c-Kit+) and GMP (granulocyte and monocyte progenitors) cells were isolated by 
standardized live cell surface marker fluorescence associated cell sorting (FACS) into 96-
well plates with the following media (Stem Spam 7% Hyclone, 100 nm/ml SCF, 100 
ng/ml IL-3, and 100 ng/ml Il-11). Two wells were isolated per cell type per mouse. One 
well was treated with 400 nM 4-OHT for five days. After five days of culture with 4-
OHT all samples were processed for cell cycle and apoptosis. Samples analysis was 
performed with FlowJo software.  
3.8.3  MMTV-PyMT Stem Cell Analysis 
 Cell lines from Tg.MMTV-PyMT tumors were infected with 50 MOI of cre-
expressing adenovirus (Adeno-cre) and analyzed 3-5 days post infection. Live cells were 
probed with the following cell surface marker profile: APC-Lin, AF-488 Annexin V, 
APC-780 anti-CD24, PerCP-Cy5.5 anti-Sca-1, PE anti-CD49f, and PE-Cy7 anti-CD44. 
DAPI was included as a live cell marker. Cells were processed on the BD LSR Fortessa 
and analyzed using FlowJo software.  
 
 
 
 
 
  
 
 
 
 
 
4. Results 
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4.1 Generation and characterization of Cdk1lox  allele 
In order to analyze the role of Cdk1 in adult tissue proliferation, homeostasis and 
pathology we generated mice with a conditional Cdk1 allele. Previous results, obtained by 
the gene-trap insertion of a β-geo cassette (a proviral β-galactosidase and neomycin 
resistance fusion gene) into the Cdc2a locus upstream of exon 3, demonstrated efficient 
disruption of the locus and production of a Cdk1-β-geo fusion protein expressing only 
the 12 amino-terminal residues of Cdk1 (Santamaría et al. 2007). Therefore, we designed 
a targeting vector (Figure 2a) with a floxed exon 3 and a frt-flanked neomycin resistance 
 
Figure 2: Cdk1 targeted allele and generation of chimera mice. A) Mouse Cdk1 wild-type 
allele, targeted allele, and targeted allele post cleavage with Flpase (frt) and Cre (loxP). B) 
Southern blot analysis of ES cell clones positive for homologous recombination with Cdk1 
targeting vector. C) Litter of Cdk1 Chimera mice. 
 
cassette in order to select recombined ES cell clones. We identified by southern blot 
two unique ES cell clones (clones ESSD12.188 and ESSD12.193) which successfully 
recombined with the targeting vector (Figure 2b). Cells from each clone were 
microinjected into FVB donor blastocysts (agouti fur color), which were then 
implanted into hormonally induced pregnant C57Bl/6J females. From clone 
ESSD12.188, sixty-four microinjected blastocysts were transferred to six pseudo-
pregnant female surrogates resulting in eighteen pups and eleven chimeras (with 
varying penetrance as identified by coat color, see Figure 2c and Table 1). From 
clone ESSD12.193, fifty-two microinjected blastocysts were transferred to five 
pseudo pregnant female surrogates resulting in seven pups and one male chimera 
with 90% penetrance (Table 1). In order to eliminate the frt-flanked neomycin 
selection cassette, male founder chimeras from each ES cell clone were crossed to 
transgenic female mice expressing the Flpe recombinase under the control of the 
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pCAG element (beta-actin promoter-CMV enhancer)(Rodríguez et al. 2000). 
Excission was assessed by PCR and the F1 generation of mice from these crosses 
was then backcrossed to C57Bl/6J mice and we observed transmission of the 
Cdk1lox allele at normal Mendelian ratios. 
 
Table 1: ES cell clone number and generation of chimeras. ES cell clones, date of 
microinjection, number of female donors, date of birth, chimeras/pups born and the number of 
males (M) from litters with respective percentage of aguti coat color. 
 
 
Figure 3: Validation of Cdk1lox  allele in  v i t ro . A) Western blot analysis of Cdk1 expression 
from four unique clones from respective genotypes of primary MEFs, extracted at E13.5 and 
infected at passage 2 with 100 MOI (multiplicity of infection) of either control Adenovirus (Ad-
empty) or Adenovirus-expressing Cre-recombinase (Ad-cre) and analyzed 72 hours post-
infection, GAPDH was analyzed as a control for protein loading.  B) Cell cycle analysis (DNA 
content via PI) by flow cytometry of samples analyzed above, the four histograms (orange, green, 
blue and red) represent each individual clone for the respective genotype/condition.  
 
ES Cell 
Clone 
Date of 
Injection 
Number 
of Donors DOB 
Chimeras/Pups 
Born 
Chimeras % 
coat color 
(agouti) 
ESSD12.188 1/10/10 10 20/10/10 11/18 
5 (M) – 100% 
4 (M) – 90%       
1 (M) – 70%     
1 (M) – 30% 
ESSD12.193 29/10/10 10 17/11/10 1/4 1 (M) – 90% 
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In order to validate the functionality of the Cdk1lox allele, Cdk1+/lox animals were 
crossed and MEFs were extracted at E13.5. Cdk1+/lox and Cdk1lox/lox clones were seeded at 
equal densities and at passage 2 were infected with 100 MOI (multiplicity of infection) of 
Adenovirus (empty or Cre recombinase expressing) in order to analyze the ability of Cre 
recombinase in cleaving the Cdk1lox allele.  The cells were then collected 72 hours post-
infection to analyze for proper Cdk1lox recombination, protein expression of Cdk1 by 
western blot, and cell cycle distribution as determined by DNA content (incorporation of 
propidium iodide) by flow cytometry (Figure 3a,b).  Our results show that upon Adeno-
Cre infection the Cdk1lox allele is successfully cleaved resulting in a complete ablation of 
protein expression and an accumulation of cells with a 4n DNA content. 
 
4.2  Generation and characterization of Cdk1  knockout mice 
 The previously characterized Cdk1 gene-trap mice resulted in early embryonic 
lethality at E1.5 (Santamaría et al. 2007). Therefore, to determine the effect of cleavage 
of the Cdk1lox allele on mouse homeostasis and viability, we crossed the Cdk1+/lox mice 
to the transgenic mouse strain expressing Cre recombinase under the control of the EIIa 
promoter. These mice transiently express Cre in the oocyte and fertilized embryos early 
during embryonic development (Clausen et al. 1999). Indeed the F1 generation of mice 
demonstrated efficient cleavage of the Cdk1lox allele (Figure 4a). We backcrossed 
Cdk1+/Δ mice to C57Bl/6J and observed germline transmission and normal Mendelian 
ratios of the Cdk1null allele in heterozygosity. Crosses between heterozygous Cdk1+/- 
mice did not yield homozygous Cdk1-/- animals. Therefore, we set crosses between 
heterozygous Cdk1+/- superovulated female and stud male mice to extract early embryos. 
When embryos were extracted at E3.5 we could detect homozygous Cdk1-/- embryos by 
PCR (Figure 4b). However, when embryos were extracted at E1.5 and allowed to grow in 
vitro, the Cdk1-/- embryos were unable to progress past the two-cell stage, arresting and 
undergoing cell death (Figure 4c). This is congruent with the observation by 
immunofluorescence of an accumulation of phosphorylated γH2AX in the Cdk1-/- 
embryos extracted at E3.5 (Figure 4d,e). Moreover, Cdk1-/- E3.5 embryos had fewer and 
larger nuclei and did not appear to properly undergo compaction nor blastocyst 
formation. When we stained for Cdx-2 (trophoblast marker) and Oct4 (inner-cell mass 
marker) we observed no specific lineage pattern in the Cdk1-null embryos (Figure 4f). 
These findings, when taken together demonstrate that germline elimination of Cdk1 in 
vivo results in early embryonic lethality. 
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Figure 4: Cdk1-null mice are embryonic lethal. A) PCR identifying wild type (wt), Cdk1lox 
and cleaved Cdk1lox alleles from wild-type (Wt), Cdk1+/lox and Cdk1+/lox; EIIa-Cre+/T mouse tail 
DNA. B) Representative images of embryos extracted at E3.5 and genotyped by PCR, inset 
showing Cdk1 wild-type (Cdk1+), and Cdk1-null (Cdk1-) amplicons. C) Images of embryos 
extracted at E1.5 and grown in vitro up to hatching, photos are of E1.5, E3.5 and E6.5 respective 
to days post-coitum (genotypes as detected by PCR, n=number of embryos detected). D) 
Representative immunofluorescence of embryos extracted and stained at E3.5 for 
phosphorylated γH2AX (green) and DAPI (blue). E) High magnification of nuclei from two 
independent E3.5 embryos from each genotype stained for phosphorylated γH2AX (green) and 
DAPI (blue). F) Representative images of embryos extracted and stained at E3.5 for DAPI and 
lineage markers Cdx2 (green) and Oct4 (red). 
Catherine Evangeline Symonds  Results 
 
67 
4.3  Characterization of ubiquitous elimination of Cdk1 in adult mice 
Cell division is essential for early embryonic development, therefore, the inability 
of Cdk1-null embryos to progress past several cell divisions was not surprising. However, 
in adult tissues and general homeostasis the role of Cdk1 had yet to be defined. Utilizing 
the conditional Cdk1lox mouse strain along with a conditionally induced and ubiquitously 
expressed Cre recombinase, our aim was to address this.  
4.3.1 Comparison of Tg.hUBC-CreERT2 and RERT Cre recombinase activity 
We first analyzed the efficiency of two commonly utilized Tamoxifen-inducible 
Cre recombinase strains: a transgenic line expressing the tamoxifen-inducible Cre-ERT2 
recombinase (Brocard et al. 1997) under the control of the human Ubiquitin C promoter 
(Tg.hUBC-CreERT2)(Ruzankina et al. 2007) and a knockin strain expressing the inducible  
Cre-ERT2 recombinase under the control of the locus encoding the large subunit of 
RNA polymerase II (RERT)(Guerra et al. 2003). In order to assess the efficiency and 
expression of Cre recombinase activity, we utilized a β-geo reporter strain (Gt-Rosa26-
LSL-lacZ)(Mao et al. 1999). This strain has a floxed stop cassette integrated downstream 
of exon 1 of the Rosa26 locus and upstream of the β-geo (lacZ) reporter and antibiotic 
resistance fusion gene. Upon Cre-mediated excision of the stop cassette, transcription of 
the proviral geo gene is initiated from exon 1 of the Rosa26 allele and is expressed 
ubiquitously during embryonic development and also in adult tissues (Mao et al. 1999; 
Zambrowicz et al. 1997). 
 We compared expression of the reporter allele by performing X-gal staining of 
tissues from Gt-Rosa+/lsllacZ; Tg.hUBC-CreERT2+/T and Gt-Rosa26+/lsllacZ; RERT+ert mice fed a 
Tamoxifen-containing diet ad libitum for two, four and eight weeks post weaning. We 
observed a more rapid and ubiquitous induction of expression in the Gt-Rosa+/lsllacZ; 
Tg.hUBC-CreERT2+/T mice as compared to the Gt-Rosa26+/lsllacZ; RERT+/ert mice (Figure 5 
and Supplementary Figure 1a-c). Moreover, we found no expression of the lacZ reporter 
gene in the brain of RERT mice. Given that the expression and Cre recombinase 
efficiency of the Tg.hUBC-CreERT2 was found to be superior to that of the RERT mice, 
we utilize this strain to determine the effect of Cdk1 elimination in adult tissue 
homeostasis.  
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Figure 5: Comparison of RERT  and Tg.hUBC-CreERT2  inducible Cre cleavage 
efficiency. X-gal stained sections from liver and brain of 1) Rosa26+/lslLacZ, Tg.hUBC-CreERT2+/T 
(Tg.hUBC-CreERT2+/T), 2) Rosa26+/lslLacZ, RERT+/ert (RERT+/ert) or 3) Rosa26+/lslLacZ (-Cre) control 
mice at 2, 4 and 8 weeks of Tamoxifen-containing diet ad libidum. 
4.3.2  Characterization of ubiquitous deletion of Cdk1 in adult mice 
Wild-type, heterozygous and homozygous Cdk1lox mice were generated with the 
Tg.hUBC-CreERT2 allele in heterozygosity. At post-natal day 30 (P30) mice were fed a 
Tamoxifen-containing diet ad libitum and placed under observation. Within two weeks of 
diet, homozygous Cdk1lox/lox mice presented at humane end-point with significant weight 
loss, hunched back, ruffled fur and decreased motility, whereas both wild-type and 
heterozygous animals appeared healthy (Figure 6a,b). We found that all homozygous 
Cdk1lox/lox mice would either die in their cage or need to be euthanized at humane end-
point between seven and fifteen days in diet (Figure 6c). When histopathological analysis 
was performed on tissues collected at humane end-point (and respective time point in 
control animals), we observed significant atrophy and disorganization of all proliferative 
tissue compartments (Figure 6d). Specifically, in the gastrointestinal tract we observed an 
absence of crypts and villi in the stomach, intestine and colon, indicative of an inability 
to absorb nutrients which will lead to malnourishment and weight loss. In the skin we 
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observed a reduction in the epidermal layer as well as a thinning in the keratinized 
epithelium (Figure 6d). Bone marrow of mice depleted of Cdk1 presented with a 
depletion in the majority of cell types and the thymi were significantly reduced in size 
and showed disorganization of the cortex and medulla cellular compartments (Figure 
6d). Isolated tissues processed for DNA extraction and assessed by southern blot 
showed near to complete Cdk1lox cleavage (Figure 6e). These results demonstrate that 
Cdk1 is essential for adult mouse tissue homeostasis and viability.  
 When Cdk1 is depleted from MEFs we observed an arrest at the G2-M transition 
of the cell cycle (Figure 3), thus we attempted to address the cell cycle arrest of cells in a 
proliferative tissue compartment (colon) of mice lacking Cdk1 by nuclear volume 
quantification. Samples were stained with DAPI and imaged by confocal microscopy to 
analyze for nuclear volume. When cells were divided into quartiles by nuclear size, we 
observe an decrease in the number of nuclei in the first quartile (with smaller nuclear 
size) as well as a significant increase in quartile 4 (with larger nuclear size)(Figure 7). This 
demonstrates that cells in vivo also acquire higher ploidy upon ablation of Cdk1. 
 To address the effect of Cdk1 elimination on proliferative cells in vivo, we 
performed immunohistochemical analysis of molecular markers associated with 
proliferation and cell death in proliferative tissue compartments. In mice depleted of 
Cdk1, we observed that cells in the intestine and colon were positive for both Ki-67 and 
Tpx-2 and unlike control heterozygous and wild-type animals, positive cells were 
distributed throughout the tissue and not restricted to the basal layer of the crypts 
(Figure 8 a,b). Ki-67 is a proliferative cell antigen and is present during all active phases 
of the cell cycle (G1, S, G2 and M)(Scholzen & Gerdes 2000). Tpx-2 is a microtubule 
binding protein and is expressed during S, G2 and M phases of the cell cycle. Given the 
significant disorganization of tissue structure it is difficult to conclude if there is an 
increase of positive staining cells or mainly a re-distribution of positive cells through the 
tissue compartment. We utilized 5-bromo-2’-deoxyrudine (BrdU), a synthetic nucleoside 
analog of thymidine that when injected into the peritoneum (IP) of mice will spread 
through the body and incorporate into the DNA of actively replicating cells. In mice 
lacking Cdk1, we also observed that BrdU positive cells were spread throughout the 
tissue and delocalized from the basal layer of the intestine and colon (Figure 8 a,b). 
Proliferation in the colon and intestine has been thoroughly investigated and is known to 
occur in the basally located crypts. Once the cells have divided they move up the villi 
towards the lumen where they are eventually shed. 
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Figure 6: Cdk1 is essential for adult homeostasis and viability. A) Representative images of 
heterozygous and homozygous mutant Cdk1lox; Tg.hUBC-CreERT2 mice at sacrifice (2 weeks of 
Tamoxifen containing diet). B) Average weight at sacrifice of Cdk1 wild-type, heterozygous and 
homozygous mutant mice. C) Kaplan-Meier survival curve of Cdk1lox; Tg.hUBC-CreERT2 mice 
from start of Tamoxifen-containing diet. D) Hematoxylin and Eosin staining of proliferative 
tissues. Scale bars are the following lengths: 200μm for colon & stomach, 50μm for skin and 
500μm for thymus. E) Southern blot of Cdk1lox excision in two respective tissue sample lysates 
from independent mice after treatment with Tamoxifen-containing diet (TAM) for two weeks. 
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Figure 7: Cdk1 ablation in  v ivo  results in an increase in ploidy. DAPI stained colon sections 
were assessed for nuclear size by confocal microscopy analysis and nuclei were divided into four 
size quartiles. Graph depicts the percentage of cells in each quartile (Q1-4) for the wild-type and 
KO respectively. The standard deviation was calculated between 2 WT and 3 KO respective 
independent samples. Representative images of DAPI-stained nuclei from a WT and KO sample 
of the same scale.  
 
 The delocalization of cells positive for proliferative markers (Ki-67, Tpx-2 and 
Brd-U) could suggest that cells are arresting in the cell cycle and being displaced from the 
crypts, although with the significant atrophy that we observe it is difficult to conclude. 
To determine if elimination of Cdk1 resulted in cell death, we also stained for cleaved 
Caspase-3 in proliferative tissue compartments. We observed an increase in positive cells 
in the spleen, thymus and bone marrow of mice depleted of Cdk1 (Figure 8 c,d). When 
taken together, these data demonstrate that Cdk1 is essential for proliferative tissue 
compartment homeostasis and that upon depletion of Cdk1 cells will increase in ploidy, 
stain positive for proliferative cell markers and functionally disrupt the homeostatic 
tissue architecture. Moreover, we observe an increase in cleaved Caspase-3 a molecular 
marker for apoptosis.  
When analyzing the samples, we also observed a significant depletion of bone 
marrow, with the exception of megakaryocytes, which appeared to be unaffected by the 
loss of Cdk1 (Figure 9a,b). Megakaryocytes undergo endomitosis, a process of 
polypoloidization where cells enter mitosis but exit without segregation. In collaboration 
with Marianna Trakala and Marcos Malumbres, further genetic analysis of Cdk1 using a 
megakaryocyte-specific Cre (Pf4-Cre)(Tiedt et al. 2007) demonstrated that 
megakaryocytes lacking Cdk1 cannot undergo endomitosis but rather undergo 
endoreplication as an alternative to polyploidization (Trakala et al. 2015, Appendix 2). 
Endoreplication is a process of polypoloidization where the cell undergoes multiple 
rounds of replication without entering mitosis and can be a result of Cdk1 inhibition 
(Zielke et al. 2015).  
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Figure 8: Ablation of Cdk1 in  v ivo  results in proliferative tissue atrophy and functional 
disorganization of tissue architecture along with inducing apoptosis. A) Representative 
images of colon samples from Cdk1+/lox and Cdk1lox/lox mice sacrificed at humane end-point and 
stained for Cdk1, Ki-67, Caspase 3, BrdU, and Tpx2. B) Representative images of intestine 
samples from Cdk1+/lox and Cdk1lox/lox mice sacrificed at humane end-point and stained for Cdk1, 
Ki-67, Caspase 3, BrdU, and Tpx2. C) Representative images of thymus and spleen samples 
stained for cleaved Caspase 3. D) Quantification of Caspase 3 positive cells in the bone marrow 
of Cdk1+/lox and Cdk1-/lox mice (at least 1100 cells were counted per sample, n=2 for each 
genotype). 
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These findings are consistent with the observation that in vivo, Cdk1 is dispensable for 
entry into the cell cycle as well as S phase progression and can lead to increased ploidy in 
proliferative cell types. 
  
 
Figure 9: Cdk1 is dispensable for Megakaryocytes. (Top panel) Hematoxylin and Eosin 
staining of bone marrow samples from Cdk1+/lox and Cdk1lox/lox mice sacrificed after two weeks of 
Tamoxifen-containing diet, scale bar 200μm. (Middle and lower panel) Von Willebrand Factor 
staining in bone marrow of samples from Cdk1+/lox and Cdk1lox/lox mice after two weeks of 
Tamoxifen-containing diet. 
 
 
4.4  Analysis of tissue-specific roles of Cdk1 in v ivo 
4.4.1  Cdk1 expression in the Purkinje cells of the cerebral cortex 
 Given that Cdk1 was initially identified as a regulator of cellular division, its role 
in proliferative tissues and the cell cycle was to be expected. With the aim of determining 
if Cdk1 plays a tissue-specific or physiological role in vivo aside from its cell cycle 
associated kinase activity, we prepared a tissue microarray from three 8 week old females, 
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three 60 week old females and six males from the respective ages for testis samples. All 
mice were from a C57Bl6/129 background and samples were collected from the central 
nervous system (brain and cerebellum), epithelial organs (back and tail skin, stomach, 
intestine, colon, lung bronchi and alveoli, bladder, kidney and mammary gland), 
hematopoietic and lymphatic systems (bone marrow, thymus, lymph node from 
mammary gland and spleen), endocrine system (pituitary, pancreas, suprarenal and 
thyroid) and others (white adipose tissue, brown adipose tissue, liver, heart, ovary and 
testis). We then performed immunohistochemical analysis on TMA sections for the 
colocalization of Cdk1 and Ki-67 or lack thereof (Figure 10a). While almost all tissues 
showed the expected colocalization of Cdk1 and Ki-67 (Figure 10b), we identified Cdk1 
expression to be independent of Ki-67 in Purkinje cells of the cerebellum of both young 
and old mice (Figure 10b). Purkinje cells are GABAergic neurons located in the cortex of 
the cerebellum and play a fundamental role in controlling motor movement. To identify 
if there is active transcription of Cdk1 in the Purkinje cells, we isolated RNA from laser-
capture microdissected Purkinje cells. The expression of Cdk1 in Purkinje cells was only 
identified in one out of nine samples of microdissected Purkinje cells by RT-PCR 
(positive and representative negative samples shown in Figure 10c), whereas we were 
able to detect PCP-2 (Purkinje cell protein 2) in all samples. While inconclusive, this 
could be a result of low levels of Cdk1 active transcription or a technical difficulty in 
detecting the transcript in this tissue type. 
The expression of Cdk1 has not been previously associated with Purkinje cells, 
however, Purkinje cells do have a distinct transcriptional profile. In Cyclin D1 and D2 
knockout mice Purkinje cells were found to be abnormally positioned resulting in 
problems with coordinated movement (Ciemerych et al. 2002). Moreover, cell cycle 
proteins, including Cyclins A, B, D and E along with Cdks 1, 2 and 4, have been shown 
to be expressed and form functional complexes in differentiated, post-mitotic neurons of 
the neocortex in adult mouse brains (Schmetsdorf et al. 2007). Under physiological 
conditions the expression of cell cycle related proteins may be associated with 
transcriptional or metabolic regulation (Tamaru et al. 1993; Miyajima et al. 1995; 
Schmetsdorf et al. 2005). However, in neurodegenerative disorders, such as Alzheimer’s 
disease, an unscheduled up-regulation of cell cycle-associated proteins has linked cell 
cycle reactivation to neuronal cell death (Nagy et al. 1997; McShea et al. 1997).  
 In order to address the role of Cdk1 in Purkinje cells in vivo, we crossed the 
Cdk1lox allele to a Purkinje-specific Cre recombinase (Tg.Pcp-2-Cre)(Barski et al. 2000).  
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Figure 10: Cdk1 is expressed independently of the cell cycle in Purkinje cells of the 
cerebellum. A) Immunohistochemistry (IHC) of Cdk1 and Ki67 of consecutive sections of 
Tissue Microarray (TMA) samples, scale bars 10000μm. B) Cdk1 and Ki67 IHC of consecutive 
sections of Purkinje Cells of the Cerebellum (scale bars 50μm), Colon (scale bars 100μm) and the 
Testis (scale bars 500μm). C) Representative RT-PCR analysis of laser microdissected Purkinje 
Cells, neighboring Cdk1-negative brain tissue and testis for Cdk1, PCP-2 (Purkinje cell protein 2) 
and B-actin. D) Representative microgrpahs of Cdk1 IHC on cerebellum sections from 
respective Cdk1lox; Pcp2-Cre (Purkinje-specific Cre) mice at 8 months of age. 
 
Recombinase activity is first observed around postnatal day 6 and fully established two to 
three weeks after birth in the majority of Purkinje cells and some retinal bipolar neurons. 
We maintained Cdk1lox/lox; Tg.Pcp-2-Cre+/T mice until 8-9 months of age (n=8) and 
observed no obvious physiological or motor function phenotype as compared to WT or 
heterozygous littermate controls. We confirmed the ablation of Cdk1 in Purkinje cells by 
IHC (Figure 10d). However, in order to fully identify the role of Cdk1 expression in the 
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Purkinje cells of the cerebral cortex further physiological and motor-function tests would 
need to be performed. Due to the scope of this project, this line of investigation was not 
pursued further. 
4.4.2  Role of Cdk1 in angiogenesis 
 Angiogenesis is the physiological process by which new blood vessels are formed 
from existing blood vessels and is required both in maintenance and repair of 
vasculature. In contrast to vasculogenesis, or de novo generation of blood vessels, 
angiogenesis creates new vessels from existing vasculature. There are two types of 
angiogenesis, sprouting angiogenesis and intussusceptive angiogenesis. Sprouting 
angiogenesis is characterized as having four phases: 1) Activation of endothelial cells 
which results in the alteration and partial degradation of the mother vessel’s basement 
membrane allowing for endothelial cell projection into the connective tissue; 2) Parallel 
migration of polarized endothelial cells and formation of the capillary bud; 3) Basement 
membrane formation along the growing capillary bud; 4) Coverage of growing capillary 
bud by proliferating pericytes resulting in the formation of the new vessel. 
Intussusceptive angiogenesis is the formation of new vessels by splitting an existing 
vessel in two and is carried out in four phases: 1) The two opposing capillary walls 
establish a zone of contact; 2) Reorganization of the endothelial cell junctions creates a 
perforation in the vessel bilayer allowing growth factors and cells to enter the lumen; 3) 
A pericyte and myofibroblast core/pillar is formed between the two new vessels at the 
zone of contact, these cells will begin laying the collagen fibers to provide the 
extracellular matrix for vessel formation; 4) Finally, as the core grows the two daughter 
vessels will form. Intussusceptive angiogenesis occurs without a significant increase in 
the number of endothelial cells, thus without the need for cellular proliferation. Whereas 
sprouting angiogenesis does indeed require proliferation. Sprouting angiogenesis, where 
proliferating endothelial cells contribute to the growth of the new vessel, is the primary 
mechanism involved in physiological angiogenesis.  
 Angiogenesis is a process that is essential for most tumor formation, thus 
significant efforts have focused on determining mechanisms to block angiogenesis. The 
majority of research has surrounded growth factors which induce the activation of 
endothelial cells, such as vascular endothelial growth factor receptor (VEGFR), and have 
resulted in the development of inhibitors that are currently being used in the clinic (e.g. 
Pazopanib and Regorafenib). A study performed in a mouse model for p185BCR-Abl+ 
B-acute lymphoid leukemia found that Cdk6 forms part of a transcription complex that 
Catherine Evangeline Symonds  Results 
 
77 
induces expression of the tumor suppressor p16INK4a and the pro-angiogenic factor 
VEGF-A (Kollmann et al. 2013). In tumors lacking functional expression of p16INK4a, 
Cdk6 was able to promote tumor formation by stimulating proliferation as well as 
angiogenesis (Kollmann et al. 2013). These findings provide a link between cell cycle 
progression and angiogenesis, however further studies will be needed to fully elucidate 
the role of cellular proliferation in angiogenesis.  
In order to assess the role of proliferation in angiogenesis directly, we targeted 
Cdk1 elimination in the endothelial compartment of mice and induced angiogenesis 
physiologically using a wound healing assay. We made use of the Tie-2 driven tamoxifen-
inducible Cre recombinase, Tie2-CreERT2 knockin mouse (Rodrigo Dieguez-Hurtado 
and Sagrario Ortega unpublished data). Tie-2 is an angiopoietin tyrosine kinase receptor 
expressed on endothelial cells from embryogenesis through adulthood and is responsible 
for binding angiopoietin and inducing angiogenesis (Dumont et al. 1994; Suri et al. 1996; 
Puri et al. 1995; Sato et al. 1995; Wong et al. 1997). We crossed these mice to the 
conditional Cdk1lox mice and the reporter Gt-Rosa26-lslLacZ mice. First we assessed Cre 
recombinase activity by performing X-gal staining on the peritonea and diaphragms of 
Cdk1lox heterozygous and homozygous mice fed a tamoxifen-containing diet for five 
months. These tissues were analyzed for their dense microvasculature and tissue 
transparency in imaging. In both the heterozygous and wild-type mice we observed 
normal branching and density of microvasculature as well as complete induction of Cre 
recombinase activity in all vessels (Figure 11a). Given that angiogenesis is required for 
normal vascular homeostasis, this data could suggest that Cdk1, or endothelial cell 
proliferation, is in fact dispensable for normal vascular homeostasis. However, the lacZ 
reporter allele is only indirect evidence of Cdk1lox cleavage and we were unable to 
properly assess for Cdk1lox cleavage in the entire endothelial compartment, thus we 
cannot rule out the possibility of ineffective Cdk1lox cleavage. 
A common and well-defined scenario where sprouting angiogenesis is actively 
induced is during the course of wound healing. A skin wound, when the epidermal and 
dermal layers are broken, induces an intricate biochemical cascade that will trigger the 
healing process. This process is initiated by hemostasis, or blood clotting, followed by 
inflammation, the growth of new tissue (proliferation) and remodeling of tissue 
(maturation). Angiogenesis specifically takes place during the proliferative stage to 
reconstruct the broken or lost vasculature in the wounded area and will initiate days after 
the injury lasting up to a couple months. In order to determine the role of Cdk1 in the 
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angiogenic response of vasculature during wound healing, we fed wild-type, 
heterozygous and homozygous Cdk1lox mice a Tamoxifen-containing diet ad libidum for 
a month prior to the assay.  
 
Figure 11: Role of Cdk1 in physiological angiogenesis. A) X-gal staining of diaphragm and 
peritonea of respective Cdk1lox; Tie2-CreERT2; Rosa26lslLacZ mice. B) Analysis of first wound 
healing experiment (4 mm wound size). C) Analysis of second wound healing experiment (6 mm 
wound size). D) Average of experiments 1 and 2. E) Representative images of wounds from 
experiment 1 at sacrifice (day 12 – d12) of Cdk1+/+ and Cdk1lox/lox mice with endogenous Tie2-
CreERT2 and having been fed a Tamoxifen-containing diet for 1 month prior to assay (lower 
right-hand inset is mouse ID).  
 
An initial experiment was performed utilizing a skin punch of 6 mm to induce 
circular wounds medially on the shaved back skins of 2 Cdk1+/+ and 4 Cdk1lox/lox mice.  
The wounds were measured daily and collected as samples at day 12 to analyze molecular 
markers of angiogenesis. We observed a reduction in the kinetics of wound healing in 
both the heterozygous and homozygous Cdk1lox mice. An initial lag was observed at day 
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3, with 31.1% closure in the wild-type mice and 19% and 15.9% closure in the 
heterozygous and homozygous Cdk1lox mice. The mice depleted of Cdk1 were only able 
to reduce wound size on average by 46.4%, the heterozygous control achieved 59.2% 
wound closure, whereas the wild-type control reached 66.6% wound closure (Figure 
11b,e).  
 
Figure 12: Ablation of Cdk1 in endothelial compartment delays wound healing. A) B-gal, 
CD31 and Cdk1 IHC of vasculature from consecutive tissue sections proximal to wound of 
respective mice. B) B-gal IHC of wound and neighboring skin of wild-type and homozygous 
Cdk1lox mice. Images were taken from samples in Experiment #1. (E: epidermis, D: Dermis, S: 
Scab, dotted line: division between wound/scab and epidermal and dermal regrowth). 
 
Given these findings, we performed a second experiment where two, 4 mm 
circular wounds were made bilateral to the dorsal medial plane on the shaved back skins 
of 2 Cdk1+/+ and 3 Cdk1lox/lox mice. We utilized smaller wounds in the second experiment 
so that we could induce two measurable wounds per mouse, maximize the data obtained 
and minimize variability per mouse. We also made four additional wounds, bilateral to 
the dorsal medial plane and inferior to the initial wounds, three and six days after the 
initial wounds so that we could obtain samples at earlier stages during the wound healing 
process. These additional wound measurements were not taken into consideration for 
the kinetics. When we look at the day 3 kinetics in the second experiment we observe a 
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stark delay in wound healing of the homozygous (5.3% closure) Cdk1lox mice as 
compared to the control wild-type (41.5% closure) mice (Figure 11c). However, overall 
at the time of sacrifice we only observed a 69.5% and 62.5% closure in wild-type and 
homozygous Cdk1lox mice respectively at day 9 (Figure 11c). When we averaged the 
percent wound closure between the experiments for the wild-type and homozygous 
Cdk1lox mice, we observe an overall delay in wound healing kinetics, suggesting that lack 
of Cdk1 results in a delayed or inefficient wound healing angiogenic response.  
 We performed immunohistochemical analysis of Cdk1, CD31 (an endothelial cell 
marker) and β-gal expression in the skin surrounding the wound and the neighboring 
tissue. We observed sufficient Cre recombinase activity to induce expression of the β-gal 
marker as well as deplete Cdk1 from the endothelial cells in the neighboring dermis of 
the wound (Figure 12a). We also observed that histopathologically the wild-type control 
animals displayed advanced wound healing, with significant regrowth of the epidermis 
and dermis below the wound, whereas in the homozygous Cdk1lox mice the scab is still 
present and skin regeneration has not occurred to the same extent (Figure 12b). These 
data taken together with the wound healing kinetics demonstrate that depletion of Cdk1 
leads to delayed or impaired wound healing, further suggesting proliferation to be a key 
aspect of sprouting angiogenesis. Further studies will be needed to fully elucidate the 
molecular mechanisms involving Cdk1 in wound-induced angiogenesis.  
 
4.4.3  Role of Cdk1 in tumor-driven angiogenesis 
 Given the initial findings we obtained with the wound healing assays and the 
importance of angiogenesis in tumor development and progression, we decided to target 
Cdk1 depletion in the endothelial compartment of mice with Tg.MMTV-PyMT driven 
mammary tumors. Breast tissue is highly vascularized and it has long been accepted that 
angiogenesis plays a pivotal role in breast neosplasms (Folkman 1971). Previous studies 
have demonstrated breast tumors to be highly vascularized with Tie2-positive endothelia 
(Peters et al. 1998). The transgenic mouse model Tg.MMTV-PyMT expresses the 
polyomavirus middle T antigen under the control of the murine mammary tumor virus 
promoter/enhancer (Guy et al. 1992). In this strain female carriers will develop palpable 
mammary tumors as early as 5 weeks of age (in FVB background) which are highly 
vascularized and can metastasize to the lung; while male carriers will also develop 
mammary tumors, albeit at a later age (Guy et al. 1992; Gao et al. 2008). We crossed 
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these mice to the Cdk1lox, Tie2-CreERT2; Gt-Rosa26-LSL-LacZ strain and maintained the 
Tie2-CreERT2 in homozygosity, the Gt-Rosa26-LSL-LacZ in either homozygosity or 
heterozygosity and the Tg.MMTV-PyMT in heterozygosity. Given that the resulting 
genetic background would result in varied survival outcomes, we performed a Kaplan 
Meier survival analysis on female carriers of the Tg.MMTV-PyMT transgene and 
determined median survival to be 20 weeks of age with detectable hyperplasias at 10 
weeks of age in our strain’s genetic background (Figure 13a,b). We confirmed vascularity 
of Tg.MMTV-PyMT tumors by staining 10 week hyperplasias and neighboring tissue for 
CD31 (Figure 13c), observing positively stained vasculature associated with both tissue 
types.  
We waited until mice developed palpable tumors and then fed Cdk1+/+, Cdk1+/lox, 
and Cdk1lox/lox animals a Tamoxifen-containing diet ad libidum. We confirmed Cre 
recombinase activity in the tumor vasculature by performing X-gal staining on tumor 
samples of animals fed a Tamoxifen-containing diet (Figure 13d). We then performed a 
Kaplan-Meier statistical analysis of survival on the sample cohorts and found that there 
was a increase in median survival of the Cdk1lox/lox animals (n=7) to 40.5 days post 
Tamoxifen diet, as compared with 25.5 and 20 days in the Cdk1+/lox (n=21) and Cdk1+/+ 
(n=6) cohorts respectively (Figure 13e). Although we observed an increase in median 
survival, the number of animals analyzed for the Cdk1lox/lox genotype was limited to 7, and 
6 in the Cdk1+/+ genotype, and the variation we observed was too significant to faithfully 
draw any conclusions. 
Given the inconclusiveness of our findings, we cannot rule out the potential for 
targeting proliferation in the endothelial compartment as a way to inhibit tumor-
associated angiogenesis. However, tumors are capable of bypassing the need for 
physiological angiogenesis, which could provide the tumor an evasion mechanism for a 
approach of this kind. Evidence has shown that certain types of tumors (melanomas and 
gliomas) are capable of generating their own vasculature in a process termed 
vasculogenic mimicry (Maniotis et al. 1999; El Hallani et al. 2010; Schnegg et al. 2015; 
Liu et al. 2013). In this process tumor cells will mimic endothelial cells and form tumor 
associated vasculature. While, vasculogenic mimicry has yet to be thoroughly investigated 
in all tumor types, it is clear that tumors have multiple mechanisms to overcome failed 
angiogenesis. Thus, targeting Cdk1 in the endothelial compartment as an endeavor to 
thwart endothelial proliferation may not be sufficient in bypassing the capability of the 
tumor to generate and recruit necessary vasculature.  
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Figure 13: Targeting proliferation in endothelial compartment to inhibit tumor-
associated angiogenesis. A) Kaplan-Meier survival curve in weeks of Tg.MMTV-PyMT in 
mixed genetic background (FVB/C57Bl/6J). “Tamoxifen Diet” refers to therapeutic treatment 
window. B) Representative image of 10 and 20 week PyMT mouse mammary hyperplasia and 
adenoma respectively. C) IHC of CD31 in 10-week hyperplasia and neighboring healthy 
mammary tissue. D) X-gal staining of 20 week tumor. E) Kaplan-Meier survival curve of all mice 
analyzed. F) Kaplan-Meier survival curve of mice analyzed removing outliers. G) Fold change in 
tumor burden during Tamoxifen-containing diet. 
 
4.5  Cell cycle function of Cdk1 
4.5.1  Cell cycle analysis in MEFs 
 We have so far observed the essential role of Cdk1 in early embryogenesis and 
adult homeostasis, particularly in proliferative tissues. Thus, to obtain a clear 
understanding of minute cell cycle changes upon elimination of Cdk1, we generated 
primary MEFs carrying the Cdk1 conditional allele in combination with the Tg.hUBC-
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CreERT2 transgene. We initially isolated wild-type, heterozygous and homozygous 
Cdk1lox genotypes and addressed the functionality of Cre recombinase activity in these 
cells by southern blot. To avoid the positive selection pressure of cells maintaining Cdk1 
under proliferative conditions, cells were synchronized and maintained in G0 by serum 
starvation with 0.1% FBS for 72, 96 and 120 hours in the presence of 4-
hydroxytamoxifen (4-OHT, a metabolite of Tamoxifen, was utilized in cell culture since 
Tamoxifen cannot be properly metabolized by the cells). We observed significant, but 
not complete cleavage of Cdk1lox alleles by southern blot analysis (Figure 14a).  
 
Figure 14: Cdk1-nul l  MEFs arrest with a 4n DNA content and do not enter into mitosis. 
A) Southern blot analysis of Cdk1lox cleavage after serum starvation for 72, 96 and 120 hours 
respectively in the presence of 4-OHT containing medium.  B) Cell cycle analysis by flow 
cytometry (DNA content by PI) and western blot analysis of protein expression from cell lysates 
at time of flow cytometry analysis (insets). C) Representative time-lapse images of serum starved 
(0.1% FBS for 96 hours) and stimulated (+10% FBS) Cdk1-/lox (no 4-OHT) vs. Cdk1-/Δ (+4-
OHT) MEFs expressing H2B-GFP. Top panels, for each condition, show brightfield images and 
bottom field shows H2B-GFP fluorescence expression. Time stamps in upper panels of Cdk1-
/lox cells represent time since entrance into mitosis (showing ten minute intervals), while Cdk1-
/Δ time stamps are the time since serum starvation release (showing 1 hour intervals) (hh:mm).  
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 Given this finding, we decided to include the Cdk1-null allele in conjunction with 
the Cdk1lox allele in an attempt to facilitate the elimination of the Cdk1lox allele. Indeed 
when we synchronized Cdk1-/lox; Tg.hUBC-CreERT2 cells in G0 by serum starvation for 
72 hours and then stimulated their release into the cell cycle (with 10% FBS), we 
observed efficient cleavage of the Cdk1lox allele by western blot analysis of protein 
expression up to 48 hours post-release (Figure 14b-insets). We then compared the cell 
cycle kinetics of the Cdk1-null cells with germline heterozygous (Cdk1+/-; Tg.hUBC-
CreERT2+/T) or induced heterozygous (Cdk1lox/-; Tg.hUBC-CreERT2+/T) control MEFs 
and observed that cells lacking Cdk1 were able to enter and progress through the S phase 
of the cell cycle arresting with a 4n DNA content (Figure 14b). Moreover, to ensure that 
cells were not entering mitosis, we performed time-lapse microscopy of synchronized 
cells expressing a histone H2B-GFP fluorescence marker to observe chromatin 
condensation. As compared to the heterozygous control cells, the cells lacking Cdk1 did 
not undergo chromatin condensation, nuclear envelope breakdown or mitotic entry 
(Figure 14c and supplemental videos). 
 
Figure 15: Cdk1-nul l  differentiated cell types undergo multiple rounds of 
endoreplication. A) Cell cycle analysis of Cdk1+/Δ and Cdk1-/Δ MEFs with endogenous 
Tg.hUBC-CreERT2 at day 8 of asynchronous culture in the presence of 4-OHT containing media. 
B) Western blot analysis of cell cycle proteins (Cdk1, Cdk2, Cyclin A, Cyclin B1 and B-Actin as a 
loading control) in Cdk1-/lox; Tg.hUBC-CreERT2+/T MEFs over time, post addition of 4-OHT to 
culture media (Days 0, 3 5, 7 and 9 respectively). C) Immunofluorescence of heterozygous and 
null Cdk1lox; Tg.hUBC-CreERT2 cells at day 8 post-addition of 4-OHT to culture media. D) Cell 
cycle analysis of keratinocytes from Cdk1lox/lox; Tg.hUBC-CreERT2+/T animals, 8 days post-
addition of 4-OHT to culture medium or in the absence of 4-OHT at respective time of culture.  
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To address the length of the cell cycle arrest we performed asynchronous 
depletion of Cdk1 and collected samples for flow cytometry analysis of cell cycle 
distribution 8 days post-addition of 4-OHT to the culture media. We observed that cells 
lacking Cdk1 underwent multiple rounds of endoreplication resulting in up to 16n ploidy 
(Figure 15a). Moreover, when we analyzed Cyclin B and A along with Cdk2 expression 
levels in these MEFs over time, we observed a gradual decrease of Cyclin B in cells 
lacking Cdk1 5-7 days post-addition of 4-OHT to culture media, whereas Cyclin A and 
Cdk2 protein levels remained mostly unchanged (Figure 15b). When we analyzed these 
cells by immunofluorescence staining of the DNA (DAPI) and actin (phalloidin) we 
observed cells to be larger both in cytoplasmic as well as nuclear size (Figure 15c). Taken 
together these results demonstrate that elimination of Cdk1 in MEFs results in cell cycle 
arrest at the G2-M transition and multiple rounds of endoreplication.  
4.5.2  Cell cycle analysis in Keratinocytes 
 MEFs are commonly utilized in the analysis of molecular interactions and 
biochemistry as they are well characterized. In order to confirm our findings in a 
secondary primary cell type, we extracted keratinocytes from the tail skin of young 
Cdk1lox; Tg.hUBC-CreERT2 mice. Cells were maintained in the presence of 4-OHT for 8 
days and analyzed by flow cytometry for cell cycle distribution. Indeed we observed that 
upon ablation of Cdk1, keratinocytes also underwent multiple rounds of endoreplication 
reaching a ploidy of up to 32n (Figure 15d). These results further demonstrate that Cdk1 
elimination results in G2-M cell cycle arrest and can induce multiple rounds of 
endoreplication in differentiated cell types. 
4.5.3  Molecular analysis of G2-M cell cycle arrest upon depletion of Cdk1 
Cdk1 has thoroughly been studied for the indispensable function it provides at 
the G2-M transition of the cell cycle. In all model systems only Cdk1 bound with Cyclin 
B1 has been capable of providing the substrate specificity as well as reach the kinetic 
activity necessary to surpass the restrictive threshold at the G2-M transition. Cdk1 
activity is balanced through inhibitory phosphorylation by Wee1 and Myt-1 kinases as 
well as positively by the Cdc25 family of phosphatases. These are in turn negatively and 
positively regulated by Cdk1 itself respectively, creating a bi-stable switch able to provide 
the specific activity necessary for the cell to enter into mitosis. However, balance at the 
G2-M transition is also provided by Greatwall/Mastl kinase, via the phosphorylation of 
Arpp19 and alpha-Endosulfine (ENSA). Arpp19 and ENSA inhibit the PP2A family of  
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Figure 16: Inhibition of PP2A partially rescues G2-M cell cycle arrest in absence of Cdk1. 
A) Representative images of fluorescence signals within the 4 groups (negative, low, mid, max) 
and mitotic signal for phosphorylated Histone H3 (pH3 – Green) and phosphorylated MPM-2 
(pMPM2 – Red). B) Intensity, frequency and quantification of pH3 in Cdk1lox MEFs with the 
respective treatments. C) Intensity, frequency and quantification of pMPM2 in Cdk1lox MEFs 
with the respective treatments. (OA: Okadaic Acid)  
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phosphatases (Mochida et al. 2010; Gharbi-Ayachi et al. 2010), which dephosphorylate 
the myriad of Cdk1 mitotic substrates necessary to enter into mitosis. Cdk1 itself 
activates Greatwall/Mastl, albeit indirectly, however the intricacies of this mechanism 
have yet to be fully elucidated (Domingo-Sananes et al. 2011). Thus at the G2-M 
transition of the cell cycle, there is a fine balance between mitotic kinase activity and 
inhibitory phosphatase activity. 
Utilizing the Cdk1lox; Tg.hUBC-CreERT2 cells, we set out to determine if cells 
can compensate for the lack of Cdk1 when mitotic inhibitory signals are diminished. To 
do this we made use of the high-throughput confocal microscope (Opera) and the 
previously tested experimental conditions for G2-M cell cycle arrest upon serum 
starvation and release in the absence of Cdk1. We utilized staining against 
phosphorylated histone H3 (pH3), which is phosphorylated on serine 10 during mitosis, 
as well as the monoclonal antibody recognizing phosphorylation of serine/threonine 
mitotic epitopes (pMPM-2) as readouts for mitotic entry. We performed the experiment 
by synchronizing cells by serum starvation and then stimulating re-entry into the cell 
cycle. At 36 hours post-release cells were treated with one of the following inhibitors: 1) 
Fostriecin, an antitumor antibiotic from Streptomyces pulveraceous, which shows inhibitory 
activity against protein phosphatase types 2A (PP2A) and 4 (PP4); 2) Tautomycetin, a 
selective inhibitor of protein phosphatase 1 (PP1) resulting in an inhibition of 
proliferation; 3) Okadaic Acid, a naturally occurring polyether toxin derived from marine 
dinoflagellates, Prorocentrium spp., which acts as a reversible, potent and selective inhibitor 
of PP2A and PP1. All cells and conditions were treated with Vincristine 12 hours post-
release, an anticancer drug that disrupts microtubules and can stably maintain a mitotic 
cell cycle arrest (Manchado et al. 2010), in order to capture all cells that entered into 
mitosis. Cells were then fixed and stained 48 hours post-release, processed by the Opera 
and analyzed using tailored scripts to detect nuclei and fluorescent intensity (as outlined 
in Materials and Methods and Figure 16a).  
Using this system we confirmed that MEFs lacking Cdk1 do not enter into 
mitosis as there was no significant associated pH3 or pMPM-2 fluorescence signal 
detected (Figure 16b,c – second row). Cells lacking Cdk1 and treated with Tautomycetin 
also showed no induction of pH3 or pMPM-2 (Figure 16b,c – third row). However, we 
did observe a significant induction of pH3 and pMPM-2 in Cdk1-null cells treated with 
either Fostriecin or Okadaic Acid (Figure 16b,c – 4th and 5th rows respectively). These 
results demonstrate that when the inhibitory mechanisms counteracting pro-mitotic 
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kinase activity are disrupted, specifically PP2A, cells lacking Cdk1 have the capacity to 
enter into mitosis. Given the strong requirement for cylin-associated kinase activity at the 
G2-M transition, we hypothesize that other Cdks are capable of compensating for the 
loss of Cdl1.  
 
4.6  Compensation for Cdk1 in v ivo  
 While Cdk1 can compensate for the loss of interphase Cdks, a Cdk that can 
compensate for the absence of Cdk1 has yet to be described. If indeed there is no 
specialized function for Cdk1, but rather the functions of Cdk1 at the G2-M transition 
are solely due to the accumulation of Cdk-associated kinase activity; we may suggest that 
the ability of interphase Cdks to compensate for Cdk1 could be achieved by reducing 
Cdk-associated inhibitory signals or decreasing the kinase threshold required for mitotic 
entry. Indeed the observation that depletion of PP2A-associated phosphatase activity in 
G2 will allow for mitotic entry in cells lacking Cdk1, is a clear demonstration that of the 
cyclin-associated G2-M kinase activity threshold being lowered to facilitate mitotic entry.  
Similar evidence generated with shRNA against Cdk1 in wild-type, p21-null and DKO 
MEFs for p21 and Cdk2, demonstrated the ability of p21-null MEFs to progress the cell 
cycle further into G2 or mitosis (as detected by pH3) when Cdk1 is depleted (Figure 
17a,b). This was dependent upon Cdk2, as the DKO MEFs were unable to enter into 
mitosis (Figure 17b,c). These findings further support the cylin-assocated kinase 
threshold model of the cell cycle, where in the absence of a potent Cdk-inhibitor, p21, 
Cdk2 was capable of partially compensating for Cdk1 in promoting the G2-M transition.  
Figure 17: Partial rescue of G2-M cell cycle arrest in cells depleted of Cdk1 by 
concomitant absence of p21 .  A) Western blot of Cdk1 and GAPDH (loading control) for 
respective genotypes and shRNA (NS: non-specific control, Cdk1). B) pH3 quantification by IF 
for MEFs with respective genotypes, with and without Cdk1 inhibition. MEFs were synchronized 
by serum starvation (0.1% FBS for 72 hours) and released by stimulation with 10% FBS for 24h. 
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Therefore, with the aim to confirm this data in vivo, we generated Cdk1; p21 
double knockout embryos and followed their development ex vivo to see if they could 
rescue the Cdk1-null lethality. Indeed we were able to obtain embryos that progressed 
past the stage of Cdk1-/- embryonic arrest (E1.5-3.5), embryos formed morulae and 
blastocysts but began to die before hatching (Figure 18a). In fact, all of the Cdk1-/-; p21-/- 
DKO embryos appeared to arrest and undergo cell death, being incapable of hatching 
from the zona pelucidae (Figure 18a).  
 
Figure 18: Early embryo Cdk1-nul l  proliferative arrest is partially rescued in absence of 
p21. A) Representative images (at E1.5, E4.5 and E6.5 respective to days post-coitum) of 
embryos extracted at E1.5 and grown in vitro with respective genotypes. Table outlines number of 
embryos presenting with each phenotype (hatching or developmental arrest and embryonic 
death). B) Micrographs of Hematoxylin and Eosin (H&E - left panel) and Cdk1 IHC (right three 
panels) of decidua from Cdk1; p21 crosses isolated at embryonic day 7.5 (E7.5 - left two panels) 
and E5.5 (right two panels). Last panel shows a Cdk1-negative staining zone in a decidua where 
no embryo was detected (outlined by dotted line) 
 
 To assess under more physiological conditions the observed rescue by p21-null in 
Cdk1-null embryonic proliferative arrest, we extracted p21-null decidua at E7.5 and E5.5 
and performed immunohistochemical analysis of Cdk1 expression. We extracted 32 
decidua at E7.5 and found 19 embryos that stained positive for Cdk1 (Table 3 and Figure 
18b). The remaining decidua did not have detectable embryos (Figure 18b – last panel on 
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right). At E5.5 we extracted 14 decidua and found 9 embryos that all stained positive for 
Cdk1 (Table 2 and Figure 18b). These data demonstrate that Cdk1-null; p21-null (double 
knockout DKO) embryos can indeed progress further in embryonic development when 
compared to the Cdk1-KO embryos and thus are capable of compensating for a lack of 
Cdk1 up until peri-implantation stage of development. While the rescue is only partial, 
this is the first evidence in vivo of the mammalian cell cycle progressing in the absence of 
Cdk1.  
 IHC + Cdk1 ND 
E5.5 9 5 
E7.5 19 13 
 
Table 2: Decidua genotypes by IHC from Cdk1; p21 crosses. Embryo genotypes as 
determined by IHC of Cdk1 in E5.5 and E7.5 decidua (ND: not detected). 
 
4.7  Role of Cdk1 in embryonic and induced pluripotent stem cells 
 The lethality we observed in Cdk1-/- embryos at E3.5 is intriguing because it is at 
the first stage of major differentiation where the inner cell mass (ICM) and the 
trophoectoderm lineages are formed. In fact in the presence of wild-type p21, Cdk1-/- 
embryos do not undergo proper compaction, arresting between the 8-16 cell stage. The 
ICM is the source of ES cells and as previously discussed maintains a distinct cell cycle 
profile from that found in MEFs or Keratinocytes. Given the distinct cell cycle and 
limited cell cycle regulatory mechanisms present in ES cells(White & Dalton 2005; V. C. 
Li et al. 2012), we decided to analyze the role of Cdk1 in ES and iPS cell cycles. 
 
 
 
 
 
 
Figure 19: Alkaline phosphatase 
activity of 4F reprogrammed MEFs. 
Representative alkaline phosphatase 
activity staining (orange) in 4F 
reprogrammed MEFs (4F – Yamanaka 4 
factors, Oct4, c-Myc, Klf4 and Sox2). 
Two independent clones shown for 
reprogrammed and control MEFs. 
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 Induced pluripotent stem cells (iPS) are generated by exogenously inducing Oct4, 
Sox2, c-Myc and Klf4 transcription factor activity in MEFs until the expression becomes 
endogenous and the MEFs reprogram into pluripotent stem cells capable of forming 
self-renewable colonies, differentiating into the three germ layers, forming teratomas and 
contributing to chimera formation (Takahashi & Yamanaka 2006). We generated iPS 
cells from the Cdk1lox; Tg.hUBC-CreERT2 MEFs and isolated ES cells from ICM 
outgrowths from E3.5 embryos of the Cdk1lox; Tg.hUBC-CreERT2 mouse strain. The 
clones we isolated were positive for alkaline-phosphatase activity (Figure 19) which has 
been shown to be upregulated in pluripotent ES and iPS cells. 
 
Figure 20: Cdk1 ablation in ES cells results in a transient G2-M cell cycle arrest, an 
upregulation of differentiation factors and apoptosis. A) Cell cycle (PI) and western blot 
analysis of ES cells. B) Western blot analysis of Caspase 3 activation upon depletion of Cdk1 by 
addition of 4-OHT to ES cell culture media for 48 hours. C) Time-lapse micrographs of Cdk1-/lox; 
Tg.hUBC-CreERT2+/T ES cells in the absence and presence of 4-OHT. Top panel shows 
brightfield images and bottom panels, expression of exogenous H2B-GFP. Time stamps 
represent time since entry into mitosis/apoptosis respectively (hh:mm). D) RNA expression 
levels of stem and differentiation markers upon elimination of Cdk1 in ES cells (+4-OHT ). 
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 In order to address the role of Cdk1 in the ES and iPS cell cycle we treated 
asynchronous Cdk1-/lox; Tg.hUBC-CreERT2+/T cells (and respective heterozygous controls) 
with 4-OHT over the course of 3 days. Given the rapid turnover of ES and iPS cells, we 
observed almost complete cleavage of Cdk1 by 48 hours post-treatment with 4-OHT 
(Figure 20a, b). When we analyzed cell cycle distribution by flow cytometry we observed 
that cells lacking Cdk1 arrested with a 4n DNA content (Figure 20a). Interestingly, 
almost the entire population arrested with a 4n DNA content in the iPS and ES cell 
clones lacking Cdk1, as compared to MEFs, where the majaroity of cells progressed on 
to endoreplicate. Moreover, the arrest we see in ES and iPS cells is temporal, with cells 
exiting the cell cycle and undergoing cell death (as observed by time-lapse microscopy) in 
a caspase-dependent manner (Figure 20b,c and supplemental videos). When we collected 
Cdk1+/Δ and Cdk1-/Δ samples after 48 hours of 4-OHT addition to culture media and 
performed quantitative RT-PCR, we found that expression of pluripotency genes was 
downregulated (Klf-4, Nanog, Oct3/4 and Sox2), along with an upregulation in early 
differentiation markers (Brachyury and Cdx2) upon ablation of Cdk1 (Figure 20d). 
Similar findings have been reported previously using siRNA against Cdk1 (Zhang et al. 
2011). Taken together these findings demonstrate that Cdk1 elimination is lethal in 
pluripotent iPS and ES cells and that either Cdk1 or the continued progression of the cell 
cycle is necessary to maintain pluripotency.  
 In order to further elucidate the differential phenotype we observed between the 
MEFs and the ES and iPS cells, we performed an experiment where we cultured iPS cell 
clones under various conditions: 1) ES cell medium + FBS ; 2) ES cell medium + KSR; 
3) ES cell medium + KSR (knockout serum replacement) + 2i (Gsk3B and Mek 
inhibitors). We utilized iPS clones as they are more sensitive to differentiation induced by 
culture media variations. KSR is more capable than FBS at maintaining iPS cell culture in 
a homogenous and pluripotent state. In addition, recent reports show that 2i culture 
media will further maintain cells in a “ground state” of pluripotency (Kanda et al. 2012; 
Marks et al. 2012). Therefore, the cells were grown under restrictive, highly pluripotent 
conditions (condition 1) or more permissive conditions for differentiation (condition 3). 
When we eliminated Cdk1 under these conditions we observed that cells maintained 
under pluripotent conditions would arrest transiently and undergo cell death, whereas the 
iPS clones grown in more permissive conditions would undergo endoreplication and 
generate cells with an 8n DNA content (Figure 21a). This suggests that the cell death 
phenotype we observed in the ES and iPS cell clones is due to a lethal effect of Cdk1 
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elimination in pluripotent cell types, which is also coherent with the in vivo data of early 
embryonic lethality. 
 
Figure 21: Apoptotic phenotype in ES cells is condition-dependent and not due to DNA 
DSBs. A) Cdk1+/lox and Cdk1-/lox ES cells with endogenous Tg.hUBC-CreERT2 allele were grown 
in the presence of 4-OHT in Standard ES cell media supplemented with FBS, KSR or KSR + 2i 
and analyzed for DNA content (PI) by flow cytometry at 1, 2 4 and 7 days post-addition of 4-
OHT to culture media. B) Western blot analysis of DDR regulatory proteins including Chk2, 
pChk2, Cdk1, yH2AX, pSmc-1, pKap-1 in ES cells upon ablation of Cdk1 by 4-OHT addition to 
media for 20, 30 and 40 hours (T20, T30 and T40 respectively), B-actin was used as the loading 
control. Positive controls of cells treated with HU (hydroxyurea) and irradiated (yIR) were 
included, along with a control of cells not treated with 4-OHT. C) Western blot analysis of 
yH2AX, Cdk1, pRPA, pChk1, and GAPDH as loading control.   
 
 In early Cdk1-null embryos we observed phosphorylated γH2AX (Figure 4), a 
molecular marker for DNA damage. Thus we hypothesized that Cdk1 elimination could 
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be resulting in an imbalance of Cdk-dependent DNA repair functions. Given that Cdks 
are induced in DNA repair, we assessed ES cell clones upon elimination of Cdk1 and did 
indeed observe an increase in phosphorylated γH2AX (a marker for DNA double strand 
breaks) by western blot (Figure 21b). However, when we assessed for activation of 
regulators of DNA double strand break (DSB) repair downstream of ATM (ataxia 
telangiectasia mutated), such as phosphorylated Chk2, Kap1 or Smc1, we found no 
activation of the pathway by western blot (Figure 21b). We also assessed for activation of 
replicative single strand break repair and observed no phosphorylation of Chk1, although 
we did see an increase in phosphorylated replication protein A (Rpa)(Figure 21c). 
Phosphorylated γH2AX on serine 139 can be associated with G2-M cell cycle arrest 
upon γ-IR (Tu et al. 2013) but can also be phosphorylated upon induction of caspase-
dependent apoptosis (Rogakou et al. 2000). From these results we can conclude that the 
observed phosphorylation of γH2AX is induced by the elimination of Cdk1, however 
this is independent of DNA DSBs.  
 
4.8  RNA Sequencing analysis of Cdk1-nul l  MEFs and ES cells  
 In order to address the Cdk1-null observed lethality in embryonic cells versus 
differentiated cell types, we set out to analyze the expression profiles of Cdk1-null ES 
cells as compared to Cdk1-null MEFs. Human ES cells express a constitutively active 
form of the pro-apoptotic protein Bax (Dumitru et al. 2012) so that they are poised to 
rapidly induce apoptosis and cell death. While this mechanism has not been detailed in 
mouse ES cells, it is intuitive that embryonic cells would employ a failsafe mechanism to 
prevent development under adverse conditions. In order to gain further insight into the 
molecular mechanism that induces cell death in ES cells upon elimination of Cdk1, we 
performed RNA sequencing of G2-M arrested Cdk1-null ES cells and G2-M arrested 
Cdk1-null MEFs and compared to respective Cdk1 heterozygous control cells. We 
utilized MEFs since they are still embryonic cells and they reliably arrest at the G2-M 
phase of the cell cycle in vitro. Two clones were sequenced for each condition from 1 μg 
of RNA with an RNA integrity number of 10 and a single read of 40 base pairs was 
performed on the Illumina Genome Analyzer IIx (GAIIx). An average of 7,094,448 high 
quality reads were obtained per sample yielding an average of 284 Mbases. An average of 
93.5% of bases had a quality greater than or equal to the Q30 as determined by the 
clusters passing filter (Table 3). Quality filtered sequence reads were aligned to the NCBI 
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m37 mouse assembly, April 2007, strain C57BL/6J. Similarities of expression data were 
compared and a principle component test was performed demonstrating that the MEF 
and ES cell samples were highly correlated and mapped together by cell type as was to be 
expected (Figure 22a and Table 4).  
 
Figure 22: Upon Cdk1 elimination in MEFs and ES cells the Cell Cycle is the major 
node of differentially regulated genes. A) Principal component analysis of RNA sequencing 
analysis (Red: Het-MEFs, Blue: KO-MEFs, Light Green: Het-ES, Dark Green: KO-ES). B) 
Venn diagram of Cdk1-null MEF and ES cell differentially expressed gene set overlaps. C) String 
v9.2 analysis of MEF DEGs. D) String v9.2 analysis of ES cell DEGs. Red circles highlight 
Cdk1/Cell Cycle gene node. 
 
We then performed expression analysis on the four populations: 1) Cdk1+/Δ; 
Tg.hUBC-CreERT2+/T ES cells (Het-ES); 2) Cdk1Δ/Δ; Tg.hUBC-CreERT2+/T ES cells (KO-
ES); 3) Cdk1+/Δ; Tg.hUBC-CreERT2+/T MEFs (Het-MEF); 4) Cdk1Δ/Δ; Tg.hUBC-
Catherine Evangeline Symonds  Results 
96 
CreERT2+/T MEFs (KO-MEF). We first identified differentially expressed gene sets 
when comparing Het-ES vs. Het-MEF, KO-ES vs. KO-MEF, Het-ES vs. KO-ES and 
Het-MEF vs. KO-MEF (Supplemental File 1) and then performed gene set enrichment 
analysis (GSEA). Maintaining a false discovery rate (FDR) of less than 0.05 (Figure 22b) 
we utilized the significant DEGs in the Het-ES vs. KO-ES and the Het-MEF vs. KO-
MEF conditions to identify known protein-protein interaction networks using the 
STRING database v9.1 (Franceschini et al. 2013). In the Het-ES vs. KO-ES analysis 
Cdk1 was a central node and we identified the GO biological processes of cell 
differentiation, cell cycle and cell death to be significantly enriched (Figure 22d). 
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Single Read 40 DBM300-1 10.0 ACAGTG 6 1 6,974,982 279 80.1 93.6 
    DBM38-7 10.0 CGATGT 6 1 8,119,027 325 81.0 93.5 
    DBM38-8 10.0 TGACCA 6 1 7,718,163 309 79.9 93.5 
    DBM425-3 10.0 GCCAAT 6 1 5,393,083 216 80.7 93.3 
    DBO692-13 10.0 CTTGTA 6 1 6,348,969 254 68.3 93.6 
    DBO692-4 10.0 CAGATC 6 1 6,879,134 275 70.6 93.6 
    DBO752-6 10.0 GTGAAA 6 1 8,146,092 326 71.9 93.7 
    DBO752-9 10.0 CCGTCC 6 1 7,176,137 287 69.6 93.3 
 
Table 3: RNA Sequencing Read Data (Q30). Run type, read length, sample ID, RNA 
Integrity Number, Barcode, Lane, Read, Number of high quality reads (Clusters PF), yield 
(Mbases), % of reads mapped confidently (% Align), % >= Q30 bases (PF). % Align (PF) is the 
percentage of filtered (Passing Filter) reads that were uniquely aligned to the reference. % 
>=Q30 bases (PF) is the yield of bases with Q30 or higher from clusters passing filter divided by 
total yield of clusters passing filter. 
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DBM300.1 1 0.93208 0.91054 0.84102 0.65316 0.68216 0.68347 0.66813 
DBM425.3 0.93208 1 0.93198 0.93169 0.71019 0.74521 0.74921 0.73140 
DBM38.7 0.91054 0.93198 1 0.91095 0.72106 0.73092 0.73733 0.73312 
DBM38.8 0.84102 0.93169 0.91095 1 0.71792 0.72416 0.72625 0.72499 
DBO692.13 0.65316 0.71019 0.7210 0.71792 1 0.94375 0.93616 0.97237 
DBO752.6 0.68216 0.74521 0.7309 0.72416 0.94375 1 0.98628 0.96934 
DBO692.4 0.68347 0.74921 0.73733 0.72625 0.93616 0.98628 1 0.97572 
DBO752.9 0.66813 0.73140 0.73312 0.72499 0.97237 0.96934 0.97572 1 
 
Table 4: PC analysis of RNA Sequencing Samples. Principal component analysis of Het-
MEFs (DBM38.7 & DBM38.8), KO-MEFs (DBM300.1 & DBM425.3), Het-ES (DBO692.4 & 
DBO752.9), and KO-ES (DBO692.13 & DBO752.6). The samples which have correlation values 
closest to 1.0 are the most similar. 
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 Similar to the ES cells in the Het-MEF vs. KO-MEF analysis the cell cycle was a 
primary node and we identified the GO biological processes of cell differentiation, cell 
division and regulation of cell death to be significantly enriched (Figure 22c). These 
findings were similar to those found in the GSEA analysis, which included cell cycle 
associated pathway enrichment. This data was expected and confirmed our previously 
discussed results however we have yet to glean any insight into possible molecular 
mechanisms that differ between ES cells and MEFs that would result in the differential 
phenotype we observe. 
Figure 23: Common genes upon elimination of Cdk1 in MEFs and ES cells. A) Venn 
diagram of all four data sets. B) String analysis of genes from overlapping (169) genes between 
MEFs and ES cells upon elimination of Cdk1. C) qRT-PCR of ES vs. MEFs to validate 
significant genes. 
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 With the aim of identifying significant regulators that differ between ES cells and 
MEFs we performed a VENN diagram analysis of the significant DEGs (Figure 23a). 
Comparing all four experimental conditions allowed us to identify differentially regulated 
genes specific to one or multiple experimental conditions. For example a gene 
upregulated in ES cells upon elimination of Cdk1 may also be upregulated in MEFs as 
compared to ES cells, suggesting that it could play a role in differentiation. Using the 
VENN diagram analysis we were able to generate gene lists specific to different 
conditions. We found that the cell cycle pathway and associated genes were linked to the 
majority of the conditions but specifically, in a list of 28 genes differentially regulated 
upon elimination of Cdk1 in both ES cells and MEFs, we identified Arpp19 to be 
upregulated upon elimination of Cdk1 (Table 5). Arpp19, is a PP2A inhibitor that aids in 
the regulation of the G2-M transition. Moreover, we associated a list of 169 genes found 
to be unique to ES cells and differentially regulated upon elimination of Cdk1. When we 
analyzed the list of 169 genes using the STRING database v9.1, we surprisingly found 
Cdk1 to be a central node in the model with cell cycle, cell differentiation and cell death 
interaction networks all significantly enriched (Figure 23b). 
 While assessing this data, Piotr Sicinski (Dana Farber Cancer Institute, Boston, 
USA) provided us a list of 84 genes known to be involved in apoptosis. We cross-
referenced these genes to our RNA sequencing data obtained fold-change values for 
these genes (Figure 24). We found a handful of these genes of interest as they were either 
significantly differentially expressed in ES cells or MEFs upon ablation of Cdk1. We then 
performed RT-PCR to validate the differential expression of these genes (Figure 23c). 
We found that Akt1, Casp2, Bcl2l1, Birc5, CideA and Mcl1 were all differentially 
regulated between the ES and MEFs. Of particular interest we found that Birc5 
(Survivin), an inhibitor of apoptosis is downregulated in ES cells while significantly 
upregulated in MEFs upon ablation of Cdk1. In a preliminary experiment where we 
transfected ES cells with wild-type Survivin, we find a rescue of the apoptotic phenotype 
and an increase in the number of Cdk1-null ES cells arrested in G2-M (Figure 25). Also 
of interest in this group of genes is CideA, a cell death activator that we found to be 
induced in ES cells and downregulated in MEFs upon ablation of Cdk1. Mcl1, a member 
of the Bcl-2 family of proteins, can be both an activator or inhibitor of apoptosis and we 
see that there is downregulation of Mcl1 in ES cells and upregulation in MEFs upon 
ablation of Cdk1. In contrast Bag3, Bak1 and p21 were all downregulated upon 
elimination of Cdk1 in both the ES cells and MEFs. Bag3 is a Bcl2-Associated  
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Gene ID Gene Function 
Hist1h2bc Alcoholism|Viral carcinogenesis|Systemic lupus erythematosus 
Slc9a3r2 Aldosterone-regulated sodium reabsorption 
Nars Aminoacyl-tRNA biosynthesis 
Ephx2 Arachidonic acid metabolism|Metabolic pathways|Peroxisome 
Ptpn11 Jak-STAT signaling pathway|Renal cell carcinoma|Chronic myeloid leukemia 
Plod2 Lysine degradation 
Ngfrap1 Neurotrophin signaling pathway 
Ncoa4 Pathways in cancer|Thyroid cancer 
Sorbs1 PPAR signaling pathway|Adherens junction|Insulin signaling pathway 
Sulf2 sulfatase 2 
Anxa6 Annexin A6, calcium signaling 
Arid4b AT rich interactive domain 4b (Rbp1-like), transcription factor (Rb) 
Psrc1 transcriptional target of p53 and p73, microtubule binding, cell cycle 
Schip1 PDGF signaling, estrogen signaling, Fos 
Gm14431 KRAB box and zinc finger C2H2 type domain containing protein 
Nusap1 microtubule binding, cell cycle, mitosis 
Mum1l1 cell division, growth and differentiation (putative chromatin binding site) 
Arpp19 G2-M transition, cell cycle, mitosis, protein phosphatase inhibitor activity 
Mtap7d1 MAP7 domain containing 1, Foxp3-interactor 
Epb4.1l1 tight-junctions and AMPA signaling 
Ppp1r18 protein phosphatase 1, regulatory subunit 18, interactor of Foxp3 
Fhl1 delta-notch signaling pathway, differentiation, negative reg. of cell cycle 
Cgnl1 cingulin-like 1, actin cytoskeleton, cell junction 
Cd24a CD24a antigen, hematopoietic cell lineage 
Txnip immune system (oxidative stress, apoptosis and cancer ) 
Dbnl debrin-like, Apoptosis 
St5 suppression of tumorigenicity 5, positive activator of Erk1 and Erk2 
 
Table 5:  Cell cycle genes significantly differentially regulated between ES and MEFs 
upon elimination of Cdk1. Gene IDs and their annotated functions
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Athanogene 3 protein that interacts with and inhibits Hsp70/Hsc70 chaperone activity 
promoting the release of its substrates and can be antiapoptotic. Bak1, Bcl2-
Antagonist/Killer 1, interacts with and inhibits the anti-apoptotic activity of Bcl2 and 
induces mitochondrial release of cytochrome c, thus inducing apoptosis. Of interest 
among these genes is p21, since we observed in vivo that the loss of p21 was capable 
partially rescuing early embryonic lethality of Cdk1-null embryos, it is unclear why p21 
RNA levels are downregulated upon ablation of Cdk1. These data provide an initial 
indication as to the molecular mechansisms differentiating ES cells and MEFs. 
 
Figure 24: Relative expression of apoptotic gene set in ES cells and MEFs upon ablation 
of Cdk1. Fold change values were obtained from differentially expressed data sets of Het-ES vs. 
KO-ES and HetMEF vs. KO-MEFs for each gene respectively.  
 
 Taken together the RNA sequencing data provides a functionally relevant data 
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set to address novel G2-M regulators, cell cycle arrest, pluripotency and cell death 
pathways. Moreover, our findings were consistent with what we observed in vitro and 
provide support to the experimental data we have obtained thus far. Further analysis of 
molecular pathways and regulators is ongoing to be able to elucidate the molecular 
mechanism responsible for inducing cell death in ES cells upon elimination of Cdk1.  
 
Figure 25: Rescue of ES cell apoptosis upon ablation of Cdk1 and exogenous expression 
of Survivin. Cdk1+/lox; Tg.hUBC-CreERT2+/T and Cdk1-/lox; Tg.hUBC-CreERT2+/T ES cell clones 
were transfected with wild-type Survivin and treated with 4-OHT for 48h. Cells were then 
analyzed by flow cytometry for cell cycle (DNA content) and Caspase 3 positivity (Casp3). Here 
we show a representation of cell cycle breakdown between G1 (2n) and G2 (>2n) and the relative 
Caspase 3 positive subset.  
 
4.9  Cdk1 elimination in hematopoietic stem cells 
 We have observed thus far that eliminating Cdk1 in vivo results in embryonic 
and adult mouse lethality, an arrest of proliferative tissues in the cell cycle at the G2-M 
transition and ongoing endoreplication, as well as transient cell cycle arrest followed by 
apoptosis in ES and iPS cells. In collaboration with Rebeca Sanchez and José Carlos 
Segovia (CIEMAT, Madrid, Spain), we set out to determine whether the cell death 
phenotype is specific to embryonic stem cells or can also be observed in adult stem cell 
compartments. We analyzed hematopoietic stem cells (HSC), which reside in the bone 
marrow of adult mammals and are a well characterized source of adult stem cells. Thus, 
we isolated the bone marrow from Cdk1lox; Tg.hUBC-CreERT2 mice and sorted out the 
LSK (Lin-, Sca1+ and cKit+) , the Sca1 and cKit double negatives, and the granulocyte 
and monocyte progenitors (GMP) populations. LSK cells comprise both the long-term 
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and short-term hematopoietic stem cell populations and are capable of self-renewal and 
giving rise to all hematopoietic cell lineages. The Sca1 and cKit double negative cells or 
hematopoietic precursor cell (HPC) is more mature and no longer capable of self-
renewal, however still maintains the ability to generate either lymphoid or myeloid 
lineages. The GMP population is lineage committed and can only generate monocytes or 
granulocytes.  
 
Figure 26: Elimination of Cdk1 in HSC populations results in G2-M cell cycle arrest and 
apoptosis. Analysis of HSC cell cycle and apoptosis upon ablation of Cdk1. A) G1, S and G2 
percentages in LSK, cKit and GMP cell populations after treatment with 4-OHT for five days 
(white bars are Cdk1 heterozygous cells and black bars are Cdk1-null cells). B) Percentage of 
apoptotic cells in LSK, cKit and GMP cell populations after 5 days of treatment with 4-OHT.  
 
 Cells were stimulated to proliferate and grown in vitro following standard HSC 
growth protocols to maintain stemness (see Materials and Methods) in the presence or 
absence of 4-OHT to induce endogenous Cre recombinase and cleavage of the Cdk1lox 
allele. Cells were then analyzed by flow cytometry at day 3 post-addition of 4-OHT for 
DNA content (cell cycle profile) and 7AAD (7-amino-actinomycin D) viability stain. In 
all cells depleted of Cdk1 we observed a statistically significant induction of G2-M (4n 
DNA content) cell cycle arrest (Figure 26a). In the LSK and the HPC cell populations, 
we observed a significant decrease in the percentage of cells in G1 (with a 2n DNA 
content)(Figure 26a). Since our analysis of the cell cycle was performed 5 days after 
addition of Tamoxifen, the decrease in number of cells found in G1 could be attributed 
to a greater number of cells entering the cell cycle but not continuing to cycle, either due 
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to a cell cycle arrest or cell death. Indeed, we observed a significant increase in apoptosis 
in the LSK and HPC cell populations, while the GMP population was viable and able to 
maintain the cell cycle arrest (Figure 26b). These data are congruent with our findings in 
embryonic stem cells and further demonstrate that Cdk1 is essential for maintaining both 
adult and embryonic stem cell viability.  
 
 
4.10  Therapeutic potential of targeting Cdk1  
4.10.1  Teratomas 
 Teratomas are tumors with tissue components deriving from more than one 
germ layer. They can occur physiologically or can be generated by injecting ES cell lines 
into Nude mice. In order to address the feasibility of targeting Cdk1 elimination in stem 
cells of a tumor compartment, we generated teratomas from the Cdk1lox; Tg.hUBC-
CreERT2 ES cell lines. Once tumors were palpable we fed mice a Tamoxifen-containing 
diet ad libidum for 5 days. Tumor samples were then collected and processed by 
immunohistochemistry. We observed teratoma formation with contribution from all 
three germ layers from the ES cell lines utilized (Figure 27a). We then stained for yH2AX 
in the teratomas by immunofluorescence and observed an induction of yH2AX positive 
staining in teratomas depleted of Cdk1 (Figure 27b). While this data is preliminary, it 
suggests that therapeutic targeting of Cdk1 can induce apoptosis of tumor-associated 
stem cells. Ongoing 
experiments are currently being 
conducted to address this 
further.  
 
 
 
 
 
Figure 27: Cdk1 elimination in 
teratomas induces phosphorylation 
of yH2AX. A) Generation of all three 
germ layers in Cdk1-/lox; Tg.hUBC-
CreERT2+/T ES cell derived teratomas. 
B) Phosporylated yH2AX positive 
staining in Cdk1+/- and Cdk1-null 
teratomas. 
 
Catherine Evangeline Symonds   Results 
104 
4.10.2  Mammary Tumor Cancer Stem Cells 
 Cdk1 inhibitors have been thoroughly tested in the clinic, however their toxic 
systemic effects outweigh their efficacy. Taken together, our findings show that Cdk1 
depletion results in a cell cycle arrest in lineage committed and differentiated cell types, 
and a transient cell cycle arrest followed by rapid apoptosis in stem cells. We 
hypothesized that temporal inhibition of Cdk1 in a tumor environment will induce 
apoptosis of the cancer stem cells and prime the tumoral cells for standard therapy. 
Recent findings have described a method for the isolation of mouse mammary tumor 
stem cells by FACS (Ma et al. 2012). Using the Tg.MMTV-PyMT mouse mammary 
tumor model they isolated the Lin-CD44lowCD24+CD29+CD49f+Sca-1low surface 
marker expressing population and identified these cells to be able to differentiate in vitro, 
form clonal populations in vitro, and initiate tumor formation when transplanted in vivo 
with 1 x 103 being the limiting number of cells necessary to induce tumor formation (Ma 
et al. 2012). Thus, using our Cdk1lox; Tg.MMTV-PyMT mice, we have isolated tumoral 
cell lines. When we infected asynchronouos cell lines with Ad-Cre we observed cells 
undergoing multiple rounds of endoreplication upon elimination of Cdk1 (Figure 28a). 
When we analyze the same cell lines by FACS analysis for the previously defined stem 
cell marker profile and apoptosis, we observe an induction of apoptosis in the cancer 
stem cell pool (Figure 28b). This data suggests that while differentiated tumoral cells will 
arrest in the cell cycle and undergo endoreplication upon elimination of Cdk1, transiently 
targeting Cdk1 in a tumoral population can eliminate cancer stem cells. This data is only 
preliminary but taken together with our previous findings both in vitro and in vivo we 
believe that targeting Cdk1 temporally in tumor cell populations, would act to eliminate 
cancer stem cells while priming the tumoral cell population for further treatment via 
irradiation or chemotherapy.  
Figure 28: Cdk1 elimination 
in tumor cell populations 
can induce cell cycle arrest, 
endoreplication and 
apoptosis. A) Cell cycle 
analysis of Tg.MMTV-PyMT 
tumoral cell lines infected with 
Ad-GFP or Ad-Cre-GFP and 
analyzed 3 and 7 days post 
infection. B) Western blot 
analysis of tumor cell 
populations for Cdk1. C) 
Induction of apoptosis 
(AnnexinV +) in CSC 
population by FACS analysis. 
  
 
 
 
 
 
5. Discussion 
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5.1  Cdk1 is essential in mouse embryogenesis and viability 
 The mammalian cell cycle is regulated by multiple Cdks and Cyclins, including 
Cdks 1, 2, 4 and 6 and Cyclins A, B, D and E. Over the past two decades genetic studies 
have provided insight into the connection between these cell cycle regulators and 
mammalian development, homeostasis and viability. Through these studies the 
interphase Cdks were found to be dispensable for life, albeit each Cdk was found to have 
cell-specific functions including: pancreatic β-cell proliferation (Cdk4), hematopoietic 
regulation (Cdk6) and essential functions in meiosis (Cdk2) (Rane et al. 1999; Ortega et 
al. 2003; Malumbres et al. 2004; Berthet et al. 2003; Tsutsui et al. 1999). Given that the 
Cdk provides the kinase activity of the Cdk-Cyclin heterodimeric cell cycle regulatory 
unit and the cyclin provides substrate specificity, these initial findings led to the 
understanding that the interphase Cdks were capable of compensating for eachother in 
maintaining essential cell cycle progression and homeostasis. Indeed when compound 
knockout models were generated, more severe phenotypes were observed. Cdk2 and 
Cdk4 DKO mice completed embryonic development but died shortly after birth, 
whereas Cdk4 and Cdk6 DKO mice died late in embryogenesis (Barrière et al. 2007; 
Malumbres et al. 2004). Lastly, a TKO mouse was generated lacking all interphase Cdks: 
Cdk2, Cdk4, Cdk6 as well as Cdk3 (due to an endogenous mutation). These mice were 
able to undergo embryogenesis until midgestation (E13.5-15.5) when they began to die 
and Cdk1 was found capable of providing all essential cell cycle associated kinase activity 
necessary (Santamaría et al. 2007). These final studies confirmed that the interphase Cdks 
are dispensable for the essential mammalian mitotic cell cycle and that Cdk1 is capable of 
compensating for their loss.  
 When similar studies were performed with the Cyclins the phenotypes were 
generally similar but some important distinctions were unveiled. Cyclin D1, D2 and D3 
combined knockout resulted in lethality at E16.5 with hematopoietic defects (Kozar et al. 
2004). Cyclin E1 and E2 individual knockouts were viable but combined knockout 
resulted in lethality at E11.5 (Geng et al. 2003; Parisi et al. 2003). However, this 
phenotype was due to an inability of trophoblast giant cells to increase in ploidy resulting 
in abnormal placental development. The lethality of Cyclin E KO embryos was able to 
be rescued by tetraploid complementation (Eggan et al. 2001; Tanaka et al. 1997) 
prolonging life to E15.5-18.5 (Geng et al. 2003; Parisi et al. 2003). Cyclin A1 knockouts 
were viable but the males were infertile, while Cyclin A2 knockout mice were lethal at 
E5.5 (Liu et al. 1998; Murphy et al. 1997). Cyclin B2 knockouts were viable with no 
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obvious defects, whereas elimination of Cyclin B1 resulted in early embryonic lethality, 
prior to E10 (Brandeis et al. 1998).  
 When we compare with the E13.4-15.5 lethality observed in the Cdk TKO 
model, elimination of all Cyclin D was less lethal allowing embryos to develop up to 
E16.5, while the loss of all Cyclin E resulted in lethality at E11.5, two days earlier than 
the Cdk TKO model. This disparity can be explained by the respective roles of Cyclin D 
and E in G1 and S phase. The tetraploid complementation rescue of Cyclin E KOs 
clearly demonstrates the essential role of Cyclin E in development of the extraembryonic 
placenta, while highlighting the ability of the remaining Cyclins to compensate for 
embryonic development until E15.5-18.5, when KO embryos die due to cardiovascular 
abnormalities, the same as Cyclin D KOs (Kozar et al. 2004; Geng et al. 2003; Parisi et 
al. 2003). Thus, when we do not account for the placental defects of Cyclin E KOs, both 
Cyclin D and Cyclin E KO mice display less lethality than their corresponding Cdk KOs. 
This may be explained by the ability of Cyclin A to compensate for the loss of Cyclins D 
and E in early embryonic development. "
 In contrast, when we examine the lethality of Cyclin A2 KO mice, the phenotype 
is starkly different from that of its corresponding Cdk. Cdk2 is the primary Cdk known 
to associate with Cyclin A, and yet, while Cyclin A2 KO mice die at E5.5, Cdk2 KO mice 
show no obvious phenotype, aside from male infertility (Ortega et al. 2003). This 
dichotomy was a surprise to the research community at the time and demonstrates that 
Cyclin A2 is essential for mammalian cell cycle progression and embryonic development 
whereas Cdk2 is dispensable.  
 Another disparity that Cdk2 KO mice give prominence to is the trophoblast 
giant cell phenotype of Cyclin E KO mice. Cdk2 also associates with Cyclin E and the 
ability of Cdk2 KO mice to develop without the need for tetraploid complementation 
demonstrates that the role of Cyclin E in trophoblast giant cells is specific to Cyclin E as 
this defect is not even present in the TKO Cdk model, where Cdk1 can compensate for 
the loss Cdk2 binding with Cyclin E and Cyclin A2. Trophoblast stem cells differentiate 
into trophoblast giant cells and undergo rapid endocycles up to 1000n DNA content and 
result in placentation (Cross 2005). The mechanism by which endocycles occur is 
through the inhibition of Cdk1 and ability of Cdk2-Cyclin E complexes to initiate DNA 
synthesis. The Cdk2-Cyclin E complexes form a transitory ternary complex with the 
CKIs p21Cip1, p27Kip1 and p57Kip1, whose expression fluctuate allowing for Cdk1 and Cdk2 
inhibition for proper endocycle progression. Indeed it is the fluctuation of p57Kip1 
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specifically that regulates the Cdk activity associated with trophoblast giant cell 
endocycles (Ullah et al. 2008; Zhang et al. 1998). However, not all cyclin-Cdk complexes 
have the same sensitivity towards CKIs and the role of Cyclin E in directing ternary 
complex formation must be critical to trophoblast giant cell endoreplication (Parisi et al. 
2003). In MEFs lacking Cdk2, there was no detected Cyclin E-associated kinase activity 
(Ortega et al. 2003), however, Cdk1 was found to form complexes with Cyclin E in 
whole embryo lysates of Cdk2-null embryos (Santamaría et al. 2007). Thus in Cyclin E 
KO trophoblast stem cells, Cdk1/2-Cyclin A complexes form, which are unable to 
inhibit CKI activity or form the ternary complexes necessary to induce endoreplication 
and differentiation, whereas in Cdk2 KO trophoblast stem cells Cyclin E is still present 
and capable of driving endoreplication.  
 Finally, when we consider the Cyclin B1 knockout, while the analysis of 
embryonic lethality was not fully elucidated, it was clear that Cyclin B1 nullizygous 
embryos were not present at E10 and therefore must have died before reaching that 
stage of development (Brandeis et al. 1998). Further studies into the role of Cyclin B1 in 
early embryogenesis and cell cycle regulation is merited. Cyclin A2 and B1 are expressed 
primarily during S and G2 phases of the cell cycle. Both bind and interact with Cdk1, 
while Cyclin A2 can also bind Cdk2. Given that Cdk1 was able to compensate for the 
lack of interphase Cdks in the TKO model, it stands to logic that the loss of its partner 
Cyclins would result in a similar phenotype as that observed when Cdk1 was eliminated. 
Indeed the gene trap disruption of Cdk1 resulted in early embryonic lethality (Santamaría 
et al. 2007) and our findings as well as those published by Diril and colleagues (Diril et al. 
2012) corroborate these results with Cdk1-null embryos dying before implantation. In 
fact the inability for Cdk1-null embryos to develop into blastocysts and in vitro complete 
initial cell divisions clearly demonstrates that elimination of the mitotic kinase is essential 
for cell cycle progression. Whereas in the case of Cyclin A2, embryos can progress up to 
later stages of development, past implantation (Murphy et al. 1997). 
 While expression of the zygote genome occurs as early as the two cell stage, early 
embryogenesis is know to be supported, if not driven by the presence of maternal 
mRNAs. These maternal mRNAs are present in the oocytes and maintain their levels 
until peri-implation (Bachvarova & De Leon 1980). Thus the disparity we see in 
developmental potential of Cdk1-null embryos in vitro vs. in vivo may be due to the 
stability of the maternal mRNAs under the stresses of in vitro culture. In fact in the Cyclin 
A2 nullizygous embryos, Cyclin A2 expression was detected in early morula-blastocyst 
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stage embryos by immunofluorescence, which could only be from the translation of 
maternal mRNAs (Murphy et al. 1997). Moreover, it has been demonstrated that ES cells 
lacking both Cyclin A1 and Cyclin A2 are not viable (Kalaszczynska et al. 2009). These 
findings are similar to those we present here where ES cells depleted of Cdk1 are unable 
to proliferate and die via apoptosis. Given that ES cells represent the cells that form the 
embryo proper and in utero maternal mRNA can drive development up until peri-
implantation, these findings when considered together demonstrate that Cyclin A2 and 
Cdk1 are essential for early embryonic cell cycles and viability. We can also postulate that 
the early embryonic cell cycles may be more dependent on Cyclin A2, as the maternal 
mRNA can maintain embryo development further than in the case of Cdk1-null embryos, 
however embryonic stem cells require both Cyclin A2 and Cdk1.  
 
5.2  Threshold model of cell cycle progression 
Initial belief in the cell cycle field was that higher organisms had developed 
multiple, functionally-specific Cdk homologues from the single yeast Cdk in order to 
provide the required layers of complexity appropriate and each playing a pivitol role in 
regulating proper cell cycle progression. Indeed, the finding that Cdk2 was dispensable 
for mouse development and homeostasis (Ortega et al. 2003) was not expected from the 
research community, and partially disproved the idea that greater organismal complexity 
required a higher level of molecular regulation. This idea grew ever weaker, as Cdks 4 
and 6 were also found to be dispensable to the cell cycle (Rane et al. 1999; Malumbres et 
al. 2004). Combined genetic ablation of interphase Cdks (Barrière et al. 2007; Malumbres 
et al. 2004) further proved that higher organisms did not require an additional layer of 
regulation. Finally, when all mammalian interphase Cdks (2, 3, 4 and 6) were eliminated 
and embryonic development progressed (Santamaría et al. 2007), the added complexity 
of essential mammalian cell cycle regulatory mechanisms was definitively called into 
question. How could a complex mammalian cell cycle progress with a single Cdk? What 
is the specific purpose of the interphase Cdks in essential mammalian cell cycle 
progression? 
During these years, a study in yeast demonstrated the ability to manipulate the 
cell into specific phases of the cell cycle based on the amount of Cdk-associated kinase 
activity alone (Coudreuse & Nurse 2010). By generating a yeast strain mutant for mitotic 
cyclin homologues cig1, cig2 and puc1 and expressing a cyclin B homologue cdc13 fused 
with a linker to a temperature- and analogue-sensitive cdc2 mutant, the authors were able 
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to interrogate the autonomous function of cdc13-cdc2 to drive the cell cycle and if this 
progression could be mediated by distinct thresholds of cdc2 activity. Indeed, the 
authors were able to artificially modulate the activity of the cdc13-cdc2 molecule and 
progress the cell through S and M phases of the cell cycle (Coudreuse & Nurse 2010). 
Moreover, the authors establish that the different phases of the mitotic cell cycle operate 
independently from each other and can be defined by specific Cdk activity thresholds 
(Coudreuse & Nurse 2010). These findings when taken together with those from the 
triple interphase Cdk knockout model strongly demonstrate that the cell cycle is a basic 
function of cellular physiology and that the mechanisms that regulate the essential cell 
cycle are shared across species, in particular the Cdk-associated kinase activity threshold 
model of cell cycle regulation. 
Herein we have presented the generation of a conditional knockout mouse 
model for Cdk1. We have demonstrated that elimination of Cdk1 in adult tissue 
homeostasis is lethal and that Cdk1 is essential for early embryonic development. During 
the course of this research a similar model was published by Diril and collegues, where 
they observed early embryonic lethality at E3.5 and full recovery from partial 
hepatectomy via endoreplication and cell expansion, rather than proliferative recovery 
(Diril et al. 2012). Moreover, in vitro data demonstrated that cells lacking Cdk1 would 
arrest with a 4n DNA content (at the G2-M transition) and undergo multiple rounds of 
endoreplication (Diril et al. 2012). These data confirm and support the findings that we 
present here, demonstrating that Cdk1 elimination is lethal for mouse development and 
adult homeostasis.  
When we consider this data in light of the Cdk-associated kinase activity 
threshold model of cell cycle regulation, it is curious as to why another one of the many 
interphase Cdks would not compensate for the lack of Cdk1. The threshold model is 
based on steadily increasing Cdk-associated kinase activity throughout interphase, 
followed by a significant peak of Cdk1-associated kinase activity at the G2-M transition 
and later a depletion of all Cdk activity during mitosis. The Cdk-associated kinase activity 
is constantly regulated by a system of bistable switches, through phosphatases that 
dephosphorylate Cdk substrates, kinases that inhibit Cdk activity, and Cdk-inhibitors 
such as p21 (Domingo-Sananes et al. 2011). Given that the expression and activation of 
Cdk1 is specific to the G2-M transition of the cell cycle and its binding with Cyclin B, we 
hypothesized that the inherent regulatory mechanisms inhibiting interphase Cdks to 
prevent unscheduled mitotic entry may act in concert with a lack of Cdk1 to inhibit 
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interphase Cdks more aggressively. We tested this hypothesis both in vivo with Cdk1; p21 
DKO mice and in vitro with phosphatase inhibitors. In vivo we observed a clear and 
substantial rescue of early embryonic Cdk1-null proliferative arrest and lethality in 
embryos also lacking p21. Albeit the rescue was not functionally viable past implantation 
(E5.5), the absence of Cdk1 was compensated for in the maintenance of the essential 
embryonic cell cycle. In vitro, utilizing Cdk1-null MEFs and a high-throughput screening 
mechanism for controlled mitotic entry, we observed that phosphatase inhibitors 
(specifically against PP2A) were capable of advancing Cdk1-null MEFs into mitosis.  
Taken together our data support the threshold model of cell cycle regulation, 
where a single Cdk is capable of maintaining the essential cell cycle. Competitive 
regulatory mechanisms that are in place to prevent unscheduled cellular division maintain 
interphase Cdks at bay in the absence of Cdk1. However, upon elimination or depletion 
of these factors, other Cdks are capable of compensating for the absence of Cdk1. 
Further research will be needed to determine the Cdk responsible for rescue of the Cdk1-
null phenotype, however, given expression and activity patterns, we believe that Cdk2 is 
responsible for this observed compensation. We have generated TKO mice for Cdk1; 
Cdk2; p21 and are currently in the process of assessing this both in vivo and in vitro.  
 
5.3  Tissue specific functions of Cdk1  
Previous genetic studies have identified tissue-specific cell cycle-independent 
functions of cell cycle proteins, including the interphase Cdks. Namely, Cdk2 in 
prophase I of the meiotic cell cycle (Ortega et al. 2003), Cdk4 in β-islet pancreatic cells 
(Rane et al. 1999) and Cdk6 in hematopoiesis (Malumbres et al. 2004). In order to 
address the second aim of this thesis, we investigated the role of Cdk1 in both Purkinje 
cells of the cerebellum as well as the endothelial compartment during angiogenesis.  
We decided to assess the role of Cdk1 in the Purkinje cells of the cerebellum due 
to our observation that Cdk1 was expressed in these cells independently of Ki67. 
Analysis was unable to either confirm expression of Cdk1 by RT-PCR or identify 
obvious motor function defects in mice depleted of Cdk1 in the Purkinje cells alone. 
Further investigation would be needed to fully address the potential role for Cdk1 
expression in these cells.  
Given the importance of angiogenesis in tumor growth and dissemination, there 
are many studies investigating the potential for inhibiting angiogenesis to thwart tumor 
growth. Sprouting angiogenesis, the primary form of angiogenesis requires heavily on the 
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induction of proliferation in the endothelial cell compartment. Therefore, we sought to 
address the role of proliferation in physiological angiogenesis (wound healing) as well as 
pathological angiogenesis (Tg.MMTV-PyMT). In both cases we saw minimal effects upon 
eliminating Cdk1 in the endothelial compartment during angiogenesis. In the wound 
healing assay, we observed a significant delay in initial wound closure kinetics as well as a 
delayed healing process. During wound healing the initial response is inflammation and 
debriding of the exposed area. This is quickly followed by an induction of angiogenesis 
that will form new vessels in the damaged tissue allowing tissue perfusion and aiding in 
the healing process. Given that we observed a delay in wound healing in mice lacking 
Cdk1 in the endothelial vasculature, we can propose that the delay was due to an inability 
for proper induction of angiogenesis. There are two primary types of angiogenesis, 
sprouting (proliferative) and intussusceptive (branching). The former requires 
proliferation of endothelial cells which grow out of the mother vessel to form a new 
vessel. The latter is a division and reorganization of the existing vessel architecture in 
order to provide vasculature to the area in need. It is possible that the delay we observed 
was due to the time necessary in order to activate intussusceptive angiogenesis, however, 
further studies would be necessary to fully explore this theory. 
We next utilized the Tg.MMTV-PyMT mammary tumor model in conjunction 
with the endothelial-specific tamoxifen-inducible Cre recombinase to study how 
targeting endothelial cell proliferation can affect tumor growth. The Tg.MMTV-PyMT 
tumor model develops highly vascularized tumors. In our analysis, we observed a 
minimal increase in overall survival, thus we cannot conclude that targeting Cdk1 in 
vascular angiogenesis is a viable therapeutic option. However, given the inherent 
variability of tumor growth within the model further analysis would be needed. Indeed 
control animals that did not develop tumors but were fed a Tamoxifen-containing diet ad 
libidum to assess endothelial homeostasis upon depletion of Cdk1, presented with no 
obvious phenotypic defects. Physiological angiogenesis is required in normal tissue 
homeostasis and can be induced during muscle activity. Therefore, while a more 
comprehensive analysis would need to be performed to fully address the role of Cdk1 in 
physiological angiogenesis, our data suggest that endothelial proliferation is not a 
standard requirement for homeostatic angiogenesis. Moreover, we cannot rule out the 
potential for other mechanisms of angiogenesis, such as vasculogenic mimicry, which has 
been documented in several tumor types, and intussusceptive angiogenesis. Our data 
present preliminary evidence that inhibiting proliferation in the endothelial compartment 
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may in fact delay angiogenesis, however further investigation is required. 
 
5.4  Cell cycle function of Cdk1 
 As has been previously reported (Diril et al. 2012), when we eliminated Cdk1 in 
MEFs we observed an arrest of cells with a 4n DNA content (at the G2-M transition), 
followed by multiple rounds of endoreplication. These cells would arrest indefinitely 
without entering into mitosis reaching up to 16n and 32n ploidy. We confirmed this data 
in primary keratinocytes as well. Thus, differentiated cells lacking Cdk1 can progress 
through interphase without any cell cycle defects, but cannot independently enter into 
mitosis. Interestingly, when we observe cell cycle proteins, Cyclin B1 levels remain 
constant and then slightly decline, even in the absesnce of Cdk1, suggesting that another 
Cdk may initially be stabilizing Cyclin B1 and preventing its degradation. Overall the cell 
cycle effects of eliminating Cdk1 in MEFs were to be expected as Cdk1 has been studied 
thoroughly using shRNA, small molecule inhibitors and genetics (Diril et al. 2012). 
 When we analyzed the effect of eliminating Cdk1 in other cell types, such as 
keratinocytes and Tg.MMTV-PyMT tumoral cell lines, we observed similar results to the 
MEFs. Ablation of Cdk1 in these cell types will result in an arrest at the G2-M phase 
transition, followed by endoreplication. As was previously discussed, the ability of cells 
to undergo endoreplication upon elimination of Cdk1 is not surprising as this is a 
requirement in cells, such as trophoblast giant cells, that naturally undergo 
endoreplication (Ullah et al. 2008; Zhang et al. 1998). However, what remains unclear is 
if this is a phenotype observed in cells that naturally have a predisposition to 
endoreplicate or whether the elimination of Cdk1 in all proliferating cell types will result 
in endoreplication. Given that cells of the Cdk1-null early embryo were unable to sustain 
viability, eventually dying, we decided to look at early embryonic cell cycles.  
 The role of Cdk1 in early embryonic development was interesting since the 
embryonic cell cycle is quite distinct being biphasic between S and M phases, with little 
regulation and believed to be driven by constitutively high levels of Cyclins and Cdks 
(White & Dalton 2005). When we assessed the role of Cdk1 in the embryonic stem cell 
cycle, similar to the MEFs, we observed a cell cycle arrest at the G2-M transition. 
However, the arrest was transient followed by phosphorylation of γH2AX and induction 
of caspase-dependent apoptosis. This is similar to previous results using the Cdk1 
inhibitor RO3306, where ES cells treated with the inhibitor underwent a transient G2-M 
arrest followed by cell death (Ullah et al. 2008). We further analyzed the apoptotic 
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phenotype and determined it to be independent of DDR. We cannot rule out that 
elimination of Cdk1 results in DNA damage, as we still observe a strong induction of 
γH2AX. Phosphorylated γH2AX can also be associated to apoptosis directly (Rogakou 
et al. 2000). Moreover, the phenotype in ES and iPS cells is similar to what is observed in 
vivo. Previous evidence has shown, that early embryos are capable of maintaining a cell 
cycle arrest ex vivo, as is the case in the Cdc20-null embryos (Manchado et al. 2010), 
whereas the Cdk1-null embryos undergo apoptosis and cannot maintain a stable cell cycle 
arrest.  
 In order to elucidate the molecular mechanisms behind ES cell death and MEFs 
ability to arrest and undergo endoreplicaiton, we performed RNA sequencing of ES and 
MEFs in the presence or absence of Cdk1. In line with expectations, we observed Cdk1 
and cell cycle pathways to be differentially expressed in both the MEFs and the ES cells. 
We were able to identify Arpp19 to be significantly upregulated upon ablation of Cdk1. 
This could be expected as Arpp19 served to inhibit PP2A phosphatase activity against 
Cdk1 substrates, since there is no Cdk1 activity the cell has no requirement for PP2A 
activity. We also observed an induction of apoptotic and cell death pathways in Cdk1-null 
ES cell populations. When we further analyzed specific gene sets, we found Survivin to 
be downregulated in ES cells but conversely upregulated in MEFs. Survivin is a member 
of the chromosome passenger complex, can activate the SAC and is phosphorylated by 
Cdk1-Cyclin B1 (Tsukahara et al. 2010). Aside from the cell cycle functions of Survivin, 
it is also involved in apoptosis and phosphorylation by Cdk1 on threonine 34 has been 
shown to inhibit its mitotic activity and enhance its anti-apoptotic activity (Barrett et al. 
2009). Given that Cdk1 is known to phosphorylate Survivin we believe that the 
differential expression we observe in MEFs and ES cells may partially explain the 
difference in response to Cdk1 elimination. In fact a recent study has linked high 
expression levels of Survivin in human ES cells to pluripotency (Mull et al. 2014). 
Moreover, in esophageal cancers and hepatocellular carcinomas Oct4 was shown to 
induce expression of Survivin, promoting cancer cell proliferation and correlating with 
poor prognosis (C. Li et al. 2012; Cao et al. 2013). We are currently investigating this 
further in order to delineate the connection between Survivin and Cdk1 in ES cell 
viability and cell cycle regulation. 
 Aside from the understanding the difference between the observed phenotype in 
stem and differentiated cells upon elimination of Cdk1, the RNA sequencing data that 
we have obtained can also be utilized in order to gain a better understanding of the 
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regulatory mechanisms in place during the G2-M transition in all cell types. We have 
generated a list of genes that are significantly differentially regulated in both the ES cells 
and the MEFs upon elimination of Cdk1. We have curated this list to obtain a more 
finite number of genes of interest. Moreover, given the comparison between ES cells and 
MEFs, our data also provide an inherent analysis of pluripotency. With the VENN 
diagram analysis we have been able to sort out the genes that are differentially regulated 
due to cell cycle changes (upon elimination of Cdk1) and generate a list of genes that are 
differentially regulated between ES cells and MEFs under all circumstances. One caveat 
with our data is that proliferation has been associated with pluripotency While our 
analysis of the RNA sequencing data is not complete, the continued analysis will surely 
provide a valued asset to the stem cell and cell cycle fields as well as further insight into 
the regulatory mechanisms controlling the G2-M cell cycle transition and cell fate 
decisions during proliferation. 
 Lastly, in order to determine the role of Cdk1 ablation in other stem cell 
compartments we analyzed HSC populations as well as teratomas from the previously 
mentioned ES cell clones. We found similar data to that found in the ES cells. 
Interestingly, the LSK and c-Kit+ HSC populations both resulted in an increase in 
apoptosis as compared to the GMP population. In the teratomas, we were able to 
identify an increase in phosphorylated yH2AX upon ablation of Cdk1. Taken together 
these data demonstrate that elimination of Cdk1 in a stem cell compartment in vivo will 
result in apoptosis, whereas differentiated cells will arrest and undergo endoreplication.  
 
5.4  Therapeutic potential of targeting Cdk1 
 Aside from the previously discussed potential therapeutic approach in vascular 
endothelia, given the differential phenotype observed between stem and differentiated 
cell types we wanted to determine if targeting the cancer stem cell population could be 
therapeutically advantageous. Indeed, we observed an increase in apoptosis in the CSCs 
from Tg.MMTV-PyMT tumors lacking Cdk1. Moreover, the remaining cell population 
undergoes cell cycle arrest and endoreplication. These findings are preliminary evidence 
demonstrating a therapeutic potential for already existing Cdk1-inhibitors (RO-3306).  
 Indeed, therapeutic targeting of Cdk1 would need to be thoroughly investigated 
as initial studies demonstrated significant toxic complications due to therapy, as would be 
expected given the results we have presented here. However, the advancement of tissue 
and cell-specific drug delivery methods are advancing and may soon become a reality in 
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the clinic. If one could direct the Cdk1-inhibitor to a specific cell and tissue type to 
eliminate the CSC population, the remainder of the tumor could be targeted with 
chemotherapy, radiation therapy or surgery with less risk for recurrence. Systemic 
delivery of Cdk1 inhibitors would need to be on a strict dosing schedule to avoid toxic 
complications. However, if targeting Cdk1 in the CSC population, while arresting the 
remainder of the tumoral cells at the G2-M transition would be viable, one could quite 
effectively target complete tumor elimination. 
 
  
 
 
 
 
 
6. Conclusions 
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The conclusions obtained from this work were the following: 
 
1. Cdk1-null embryos present with a proliferative arrest, followed by lethality at 8-16 
cell stage of development, demonstrating the essential role for Cdk1 in early 
embryonic cell cycles and development.  
2. The Tg.hUBC-CreERT2 tamoxifen-inducible Cre recombinase is more efficient 
and expressed in a more homogenous and ubiquitous manner than the RERT. 
3. Cdk1 is essential for adult mouse homeostasis. Adult mice lacking Cdk1 cannot 
thrive, proliferative tissue compartments arrest and undergo atrophy, resulting in 
malnourishment, weight-loss and death. 
4. Loss of p21 is capable of rescuing Cdk1-null early embryonic lethality up to a later 
developmental stage.  
5.  Differentiated mitotic cells lacking Cdk1 arrest with a 4n DNA content at the 
G2-M transition, undergo multiple rounds of endoreplication but are incapable 
of traversing mitosis.  
6. Inhibition of PP2A phosphatase activity is capable of rescuing Cdk1-null cell 
cycle arrest and induce progression of cell cycle into late G2 or early mitosis. 
7. Cdk1 is dispensable for endothelial homeostasis, while depletion of Cdk1 in the 
endothelial vasculature diminishes physiological angiogenesis potential but does 
not completely block angiogenesis. 
8. Elimination of Cdk1 in a stem cell compartment will induce caspase-dependent 
apoptosis and phosphorylation of yH2AX.  
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Las conclusions más relevantes de esta tesis son las siguientes: 
 
1. Los embriones nulos de Cdk1 se presentan con una parada proliferativa, seguida 
por letalidad al estado de desarollo de 8-16 celulas,  demostrando el papel 
esencial de Cdk1 en los ciclos celulares embrionarios tempranos y en el 
desarrollo.  
2. El Tg.hUBC-CreERT2 Cre recombinasa inducible por Tamoxifen es más eficiente 
y expresada de manera más omogenio y ubiquo que el RERT. 
3. Cdk1 es esencial para la homeostasis del ratón adulto. Ratones adultos carentes 
de Cdk1 no pueden desarrollarse con salud, los tejidos proliferativos se paran y 
sufren atrofia, resultando en malnutrición, pérdida de peso y muerte.  
4. La pérdida de p21 es capaz de rescatar la letalidad embrionaria temprana debida a 
la falta de Cdk1 hasta un estadio posterior del desarrollo.  
5. Las células mitóticas diferenciadas carentes de Cdk1 se paran con un contenido 
de ADN 4n en la transición G2-M, sufren múltiples rondas de endoreplicación 
pero son incapaces de atravesar la mitosis.  
6. La inhibición de la actividad fosfatasa de PP2A es capaz de rescatar parcialmente 
la detención del ciclo celular en células nulas de Cdk1 e inducir la entrada en 
mitosis.  
7. Cdk1 es dispensable por la homeostasis vascular, mientras su eliminación en la 
vasculatura endotelial disminuye el potencial angiogénico fisiológico pero no 
bloquea su desarrollo.  
8. La eliminación de Cdk1 en compartimentos de células madre induce apoptosis 
dependiente de caspasa y fosforilación de yH2AX. 
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Supplemental Figure 1a: Comparison of RERT  and Tg.hUBC-CreERT2  inducible Cre 
mice. Kidney, heart and lung samples from Rosa26lslsLacZ, Tg.hUBC-CreERT2; Rosa26lslLacZ; 
RERT, or Rosa26lslLacZ controls at 2, 4 and 8 weeks of Tamoxifen-containing diet ad libidum. 
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Supplemental Figure 1b: Comparison of RERT  and Tg.hUBC-CreERT2  inducible Cre 
mice. Pancreas, spleen and thymus samples from Rosa26lslsLacZ, Tg.hUBC-CreERT2; 
Rosa26lslLacZ; RERT, or Rosa26lslLacZ controls at 2, 4 and 8 weeks of Tamoxifen-containing diet 
ad libidum. 
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Supplemental Figure 1c: Comparison of RERT  and Tg.hUBC-CreERT2  inducible Cre 
mice. Colon, intestine and stomach samples from Rosa26lslsLacZ, Tg.hUBC-CreERT2; 
Rosa26lslLacZ; RERT, or Rosa26lslLacZ controls at 2, 4 and 8 weeks of Tamoxifen-containing diet 
ad libidum. 
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CDK2 regulates nuclear envelope protein dynamics and telomere
attachment in mouse meiotic prophase
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ABSTRACT
In most organisms, telomeres attach to the nuclear envelope at the
onset of meiosis to promote the crucial processes of pairing,
recombination and synapsis during prophase I. This attachment
of meiotic telomeres is mediated by the specific distribution of several
nuclear envelope components that interact with the attachment
plates of the synaptonemal complex. We have determined by
immunofluorescence and electron microscopy that the ablation
of the kinase CDK2 alters the nuclear envelope in mouse
spermatocytes, and that the proteins SUN1, KASH5 (also known
as CCDC155) and lamin C2 show an abnormal cap-like distribution
facing the centrosome. Strikingly, some telomeres are not attached to
the nuclear envelope but remain at the nuclear interior where they are
associated with SUN1 and with nuclear-envelope-detached vesicles.
We also demonstrate that mouse testis CDK2 phosphorylates SUN1
in vitro. We propose that during mammalian prophase I the kinase
CDK2 is a key factor governing the structure of the nuclear envelope
and the telomere-led chromosome movements essential for homolog
pairing.
KEY WORDS: Meiosis, CDK2, SUN1, Telomere, Nuclear envelope
INTRODUCTION
Meiosis represents a specialized type of cell division characterized
by the existence of a single round of DNA replication, followed
by two rounds of chromosome segregation. In most sexually
reproducing organisms, homologous chromosomes must correctly
achieve the processes of pairing, recombination and synapsis
during the meiotic prophase I in order to prompt the further
generation of haploid cells. The tethering of telomeres to the
nuclear envelope is considered a prerequisite that facilitates and
mediates the initiation and accomplishment of these processes
(Koszul and Kleckner, 2009; Kracklauer et al., 2013; Scherthan,
2007; Zickler and Kleckner, 1998). The attachment of telomeres to
the nucleoplasmic face of the inner nuclear membrane (INM) of
the nuclear envelope occurs at the leptotene stage of meiotic
prophase I. These anchoring sites represent nuclear envelope
bridges linking the cytoskeleton and the nucleoskeleton that mediate
the chromosomal movements during prophase I stages (Koszul and
Kleckner, 2009; Kracklauer et al., 2013). In animals and fungi,
telomeres move on the inner surface of the nuclear envelope and
become clustered at a certain nuclear region, adjacent to the
centrosome, creating a bouquet-like arrangement of chromosomes
during zygotene. Afterwards, telomeres disperse along the nuclear
envelope during the pachytene and diplotene stages until their
detachment at the transition between diakinesis and prometaphase I.
As shown in recent years, the proper tethering of telomeres to
the nuclear envelope is not only mediated by telomeric DNA and
the attachment plates of the axial elements and lateral elements of
the synaptonemal complex, but by their interactions with other
protein components (Alsheimer, 2009). In this regard, the
evolutionarily conserved SUN-domain-containing proteins
present at the INM are required to tether the telomeres to the
nuclear envelope through their interaction with adaptor proteins
that mediate their association to the telomeres at the attachment
plates (Alsheimer, 2009; Hiraoka and Dernburg, 2009; Koszul
and Kleckner, 2009). Moreover, SUN domain proteins interact at
the perinuclear space of the nuclear envelope with KASH domain
proteins, located at the outer nuclear membrane, to form the so-
called LINC complexes that connect the nucleoskeleton and the
cytoskeleton (Starr and Fridolfsson, 2010). Thus, SUN domain
proteins provide a link to nucleoskeleton structures, such as the
nuclear lamina, whereas KASH domain proteins connect to the
microtubule or actin-based cytoskeleton. Consistent with this
arrangement, it has been recently reported that in mouse meiosis
KASH5 associates with SUN1 and SUN2, and with cytoplasmic
dynein (Horn et al., 2013; Link et al., 2014; Morimoto et al., 2012).
Interestingly, it has also been recently demonstrated that different
serine/threonine protein kinases phosphorylate the nucleoplasmic
domain of SUN1 at the meiotic nuclear envelope in the nematode
Caenorhabditis elegans, and that these modifications are required
for telomere movement and attachment to the centrosome (Labella
et al., 2011; Penkner et al., 2009; Sato et al., 2009).
Cyclin-dependent kinases (CDKs) are a group of serine/
threonine protein kinases, highly conserved from yeast to
humans, which participate in the regulation and progression of
the cell cycle and the subsequent cell division. In recent years,
however, it has become evident that CDKs demonstrate a high
level of functional redundancy. In this context, the only CDK that
seems to be essential for the cell cycle is CDK1, the so-called
‘mitotic kinase’, whose deletion causes cell cycle arrest
(Santamarı´a et al., 2007). In contrast, it has been reported that
the previously considered master regulator of cell cycle
progression in mammals, namely CDK2, is dispensable for
mitotic cell cycle progression and division (Berthet et al., 2003;
Ortega et al., 2003; Tetsu and McCormick, 2003). However, a
possible role of CDK2 in meiosis arose from the finding that it
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locates at telomeres and at late recombination nodules throughout
meiotic prophase I (Ashley et al., 2001). Indeed, the essential role
of CDK2 in gametogenesis was demonstrated from the evidence
that Cdk22/2 mice were infertile, with complete penetrance
(Berthet et al., 2003; Ortega et al., 2003). Accordingly, in
Cdk22/2 male mice, meiosis arrests in prophase I, triggering the
apoptotic pathway in the spermatocytes, which results in the
absence of further meiotic stages (Berthet et al., 2003; Ortega
et al., 2003). In a previous study, we reported that in male mouse
meiosis CDK2 was required for recombination, proper homolog
pairing and synapsis, and sex-body formation (Viera et al., 2009).
Moreover, we described that in Cdk22/2 mutant spermatocytes
some telomeres did not attach accurately to the nuclear envelope
during prophase I stages, and suggested that this could lead to
extensive non-homologous synapsis (Viera et al., 2009).
In the present study, we have performed a detailed analysis of
possible modifications in the structure and composition of the
nuclear envelope in Cdk22/2 spermatocytes. For this purpose, we
have investigated the organization of the nuclear envelope as well
as the presence, distribution and dynamics of representative nuclear
envelope protein components by using immunofluorescence and
electron microscopy. Furthermore, we have tested whether mouse
testis CDK2 is able to phosphorylate SUN1 in vitro. According to
our results, we propose and discuss the putative participation of
CDK2 in maintaining the structure and dynamics of the nuclear
envelope, as well as its role in driving the attachment of meiotic
telomeres to the nuclear envelope and in chromosome movement
and bouquet formation, in male mouse meiosis.
RESULTS
Cdk22/2 spermatocytes display an anomalous distribution
of SUN1
We have previously described that in the most advanced meiotic
prophase I stage found in Cdk22/2 male mice, i.e. in pachytene-
like spermatocytes, some telomeres seemed to be in the nuclear
interior and thus were not attached to the nuclear envelope (Viera
et al., 2009). Given that it has been proposed that SUN domain
proteins present at the INM are involved in the anchoring of
telomeres to the nuclear envelope in meiocytes from several
species (Alsheimer, 2009; Hiraoka and Dernburg, 2009; Koszul
and Kleckner, 2009; Kracklauer et al., 2013), we compared the
pattern of distribution of SUN1 in wild-type and Cdk22/2
spermatocytes. To this end, we made a double-immunolabeling
of SUN1 and SYCP3, a structural protein component of the axial
and lateral elements of the synaptonemal complex, to define
meiotic staging during prophase I. We used the squashing
technique because it preserves the nuclear volume and
chromosome condensation, and positioning inside spermatocyte
nuclei (Page et al., 1998; Parra et al., 2002). In wild-type leptotene
spermatocytes, SUN1 appeared as small spots at the nuclear
envelope (Fig. 1A,B), whereas at zygotene most SUN1 spots were
present at the ends of axial and lateral elements giving a bouquet-
like arrangement (Fig. 1C,D). In pachytene spermatocytes, all
SUN1 signals appeared at the ends of synaptonemal complexes, the
attachment plates, associated with the nuclear envelope
(Fig. 1E,F). Strikingly, in all prophase I Cdk22/2 spermatocytes
SUN1 was mainly observed as a polarized cap-shaped continuous
labeling at the nuclear envelope (Fig. 1G–L). Given that it is
known that SUN1 participates in the attachment of the centrosome
to the nucleus (Tzur et al., 2006), we studied whether the
polarization of SUN1 in mutant spermatocytes was related to the
distribution of the centrosome. To address this, we performed a
double-immunolabeling of SYCP3 and pericentrin, a component of
the pericentriolar material present at the centrosome, and also of
pericentrin and SUN1. Our results showed that the centrosome was
always located near the nuclei as an unaltered ‘cloud’ from
leptotene up to pachytene both in wild-type and mutant
spermatocytes (supplementary material Fig. S1A–J). Interestingly,
the SUN1 cap present in all mutant spermatocytes was always
facing the centrosome (Fig. 1M,N; supplementary material Fig.
S1K–N). These results suggest that in the absence of CDK2 the
protein SUN1 is still able to become mostly polarized at the INM
near the centrosome, as occurs when it associates to telomeres
during the bouquet-like arrangement in wild-type zygotene nuclei.
However, SUN1 is unable to redistribute along the nuclear envelope
in pachytene-like mutant spermatocytes, as occurs in wild-type
pachytene spermatocytes when it associates to the attachment plates.
Surprisingly, in addition to the remarkable anomalous and
persisting polarization of SUN1 at the nuclear periphery, it also
appeared as small foci at the nuclear interior in all prophase I
stages in Cdk22/2 individuals (Fig. 1G–L). Therefore, we next
analyzed the possible spatial relationship between internal SUN1
foci and internal telomeres. A triple-immunolabeling of SUN1,
TRF1, a telomeric protein, and SYCP3 demonstrated that all
internal SUN1 foci were associated with internal TRF1 signals
(Fig. 1O,P). However, some internal TRF1 signals actually did not
colocalize with SUN1 (Fig. 1O,P). This association of SUN1 with
internal telomeres denoted an internal localization of the
transmembrane protein SUN1, which is remarkable and without
precedent in the literature. Given that several SUN1 foci could be
detected in a given Cdk22/2 spermatocyte, we scored the number
of internal SUN1 foci in ten squashed nuclei of each prophase I
stage, in two different Cdk22/2 individuals, after the
immunolabeling of SUN1 and SYCP3. Our results demonstrated
the presence of one up to four internal SUN1 signals in each
analyzed spermatocyte (Fig. 2A). In this sense, 50% of leptotene
spermatocytes presented a single SUN1 internal signal, whereas
the percentages of spermatocytes with two or three internal SUN1
foci were 30% and 15%, respectively. Remarkably, only 5% of
leptotene spermatocytes presented four SUN1 foci at their nuclear
interior. By contrast, only 20% of zygotene and pachytene-like
spermatocytes displayed only one internal SUN1 signal, whereas
four foci were present in other 20% of spermatocytes. These
observations prompted us to analyze the organization of the nuclear
periphery in wild-type and Cdk22/2 spermatocytes by electron
microscopy. In wild-type pachytene spermatocytes, telomeres
were attached to the nuclear envelope through the attachment
plates, disk-shaped electron-dense plates at the ends of the lateral
elements of the synaptonemal complex (Esponda and Gime´nez-
Martin, 1972; Liebe et al., 2004) (Fig. 3A). At the attachment sites,
both nuclear envelope membranes were thicker and associated with
fibrils that bridge the perinuclear space. These fibrils were in
apparent continuity with cytoplasmic fibrils that associated with
the outer nuclear membrane (Fig. 3A). According to current
models, the fibrils in the perinuclear space correspond, at least in
part, to SUN proteins, whereas the cytoplasmic fibrils might
represent KASH domain proteins (Schmitt et al., 2007). In mutant
pachytene-like spermatocytes, we found normally attached
telomeres (Fig. 3B). However, other telomeres in the same
nucleus did not attach to the INM through attachment plates, but
the ends of the lateral elements contacted laterally with the INM
(Fig. 3C). In other cases, the ends of the lateral elements contacted
with one or two membrane vesicles of ,200 nm in diameter, that
were apparently detaching from the INM (Fig. 3D,E,G).
RESEARCH ARTICLE Journal of Cell Science (2015) 128, 88–99 doi:10.1242/jcs.154922
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Interestingly, we also found that the ends of lateral elements or
synaptonemal complexes in internal nuclear regions were attached
to vesicles that were obviously separated from the nuclear envelope
(Fig. 3F,H,I). To our knowledge this is the first description of
telomere-associated vesicles in the nuclear interior of meiotic cells.
Taking into account our results, we wondered whether CDK2
could participate in the anchoring of the attachment plates of the
synaptonemal complex to the nuclear envelope, taking into
account that CDK2 has been cytologically detected at telomeres
in mouse prophase I spermatocytes (Ashley et al., 2001). For this
purpose, we analyzed by electron microscopy the telomeric
location of CDK2 in wild-type pachytene spermatocytes. We
found that CDK2 labeling was positioned over the attachment
plates that were associated with the INM (Fig. 4A). Given that in
C. elegans meiocytes SUN1 is phosphorylated by serine/
threonine protein kinases (Labella et al., 2011; Penkner et al.,
2009; Sato et al., 2009), we subsequently tested whether SUN1
might be a substrate for CDK2 phosphorylation in mouse. In
order to directly test this possibility we performed an in vitro
kinase assay using the N-terminal domain (amino acids 1–243) of
SUN1 as a substrate. Interestingly, CDK2 immunoprecipitated
from wild-type testis extracts could efficiently phosphorylate
recombinant SUN1 (Fig. 4B). Thus, at least in vitro, SUN1 is a
substrate for mouse testis CDK2 phosphorylation.
Taken together, our results suggest that CDK2-mediated
phosphorylation of SUN1 is involved in its accurate distribution
Fig. 1. SUN1 distribution at the nuclear envelope is disturbed in Cdk22/2 spermatocytes. (A–L) Double-immunolabeling of SUN1 (green) and SYCP3
(red) on squashed wild-type (A–F) and Cdk22/2 (G–L) prophase I spermatocytes. The first and third columns correspond to the z-projection of all the focal
planes throughout a wild-type and Cdk22/2 spermatocyte nucleus, respectively. The second and fourth columns present the partial z-projections of 15 focal
planes throughout the equatorial region of the same spermatocytes. (A,B) Wild-type (WT) leptotene nucleus. SUN1 appears as spots uniformly distributed at the
nuclear periphery. (C,D) WT zygotene nucleus. Most SUN1 spots are polarized at the nuclear envelope reflecting a bouquet-like telomere arrangement.
(E,F) WT pachytene nucleus. SUN1 is observed at the synaptonemal complex ends at the nuclear periphery. (G–L) Cdk22/2 prophase I nuclei. From leptotene
on SUN1 is always found as a continuous and polarized cap-like labeling at the nuclear envelope . Note that SUN1 also appears as small foci (arrows) in the
nuclear interior. (M,N) Double-immunolabeling of SUN1 (green) and pericentrin (yellow) on a zygotene Cdk22/2 spermatocyte. The SUN1 cap faces the
pericentrin-labeled centrosome. Note one internal SUN1 spot (arrow). (O,P) Triple-immunolabeling of SUN1 (green), TRF1 (purple) and SYCP3 (red) on a
zygotene Cdk22/2 spermatocyte. Both images are partial z-projections of 15 focal planes throughout the equatorial region. Two internal SUN1 foci (white arrows)
are near telomeric TRF1 signals, and three internal telomeric signals (yellow arrowheads) do not colocalize with SUN1 spots. Scale bar: 5 mm.
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and association to the attachment plates found at the ends of axial
and lateral elements during prophase I. Thus, in the absence of
CDK2 some telomeres are tethered to the nuclear envelope in
early prophase I stages, but some of them can detach from the
nuclear envelope peeling off vesicles derived from the INM,
accounting for the presence of SUN1 at internal telomeres (see
below).
KASH5 distribution is disrupted in Cdk22/2 spermatocytes
In mouse spermatocytes, SUN1 interacts with KASH5 to form
LINC complexes associated to the telomeres (Horn et al., 2013;
Morimoto et al., 2012). Thus, in wild-type pachytene
spermatocytes both SUN1 and KASH5 signals localized at the
ends of synaptonemal complexes attached to the nuclear envelope
(Fig. 5A–D). Given that the accurate localization of KASH5
during meiosis is disturbed in the absence of SUN1 (Horn et al.,
2013; Morimoto et al., 2012), and that we found a cap-shaped
polarization of SUN1 in Cdk22/2 spermatocytes, we then
analyzed the relative distribution of SUN1 and KASH5 in
Cdk22/2 individuals. Cdk22/2 spermatocytes, from leptotene up
to the pachytene-like stage, displayed a polarized SUN1 labeling
at the nuclear envelope (Fig. 5E,I,M), which was also observed
for KASH5 (Fig. 5F,J,N). Indeed, both proteins mostly
colocalized at the cap-shaped arrangement (Fig. 5G,K,O).
Nevertheless, whereas SUN1 was additionally detected as
discrete dots positioned at the nuclear interior, KASH5 was not
detectable inside the nuclei (Fig. 5H,L,P). Our observations
indicate that CDK2 drives the proper distribution of SUN1 at
telomeres in mouse spermatocytes, and that the polarization of
SUN1 at the nuclear envelope, in the absence of CDK2,
determines the altered distribution of its interacting protein
KASH5.
Cdk22/2 spermatocytes show a disturbed distribution of
nuclear envelope components
Given that we had observed that SUN1, as an INM protein, was
polarized at the nuclear envelope in Cdk22/2 spermatocytes, we
then explored whether the structure of the nuclear lamina was
similarly impaired. To verify this, we performed double-
immunolabeling experiments of SYCP3 with LAP2, another
INM integral protein, or lamin C2, a meiosis-specific isoform of
lamin A that appears at the docking sites for meiotic telomeres in
the nuclear envelope (Alsheimer and Benavente, 1996; Alsheimer
et al., 1999). In wild-type prophase I spermatocytes, LAP2 always
appeared to be homogeneously distributed at the nuclear envelope
(supplementary material Fig. S2A–F), whereas in Cdk22/2
prophase I spermatocytes we never observed LAP2 labeling at
the nuclear envelope (supplementary material Fig. S2G–L).
Nevertheless, in Cdk22/2 individuals, LAP2 was able to locate
to the nuclear envelope in testicular somatic cells (supplementary
material Fig. S2M–P), which are frequently found in squashed
preparations of seminiferous tubules. Lamin C2 showed a rather
homogeneous distribution at the nuclear envelope of wild-type
spermatocytes during leptotene and zygotene (Fig. 6A–D), but it
Fig. 2. Percentages of internal
SUN1 foci and telomeres.
(A) Percentages of internal SUN1 foci
in Cdk22/2 spermatocytes . The
presence of internal SUN1 signals
within a nucleus was scored in 20
squashed spermatocytes for each
prophase I stage in Cdk22/2
individuals. The graphic
representation corresponds to the
percentage of nuclei showing one
(blue), two (green), three (yellow) or
four (red) internal SUN1 foci.
(B) Percentages of non-attached
telomeres in wild-type and Cdk22/2
spermatocytes. The position of
telomeres within a nucleus was
scored in 20 squashed
spermatocytes for each prophase I
stage in wild-type (WT) and Cdk22/2
individuals. The graphic
representation corresponds with the
percentage of telomeres found at the
nuclear periphery (blue) or at the
nuclear interior (yellow).
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showed a patchy distribution in pachytene (Fig. 6E,F; see also
Alsheimer et al., 1999). Surprisingly, in all Cdk22/2 prophase I
spermatocytes lamin C2 appeared to be polarized showing a cap-
shaped labeling at the nuclear envelope (Fig. 6G–L). Given that
this labeling is similar to that found for SUN1 in mutant
spermatocytes, we co-detected lamin C2 and SUN1 to assess
whether these proteins colocalized at the nuclear envelope cap.
Our observations demonstrated that indeed both proteins
colocalized at the aberrant nuclear envelope cap in mutant
spermatocytes (Fig. 6M–P). Interestingly, some lamin C2 foci
were detected at the nuclear interior, however, these foci never
colocalized with internal SUN1 foci (Fig. 6N–P). These results
demonstrate that, in the absence of CDK2, the distribution of
SUN1 at the INM and the structure of the nuclear lamina are
severely disturbed, with a complete lack of LAP2.
Taking into account the drastic alterations in the distribution of
the nuclear envelope proteins SUN1, KASH5, LAP2 and lamin
C2 in Cdk22/2 spermatocytes, we also explored whether the
distribution of nuclear pore complexes (NPCs) was also affected.
For this purpose we performed a double-immunolabeling of
SYCP3 and RanGAP1, a Ran GTPase-activating protein that
localizes at the cytoplasmic filaments of NPCs (Mahajan et al.,
1997), in both wild-type and Cdk22/2 prophase I spermatocytes.
We observed that RanGAP1 was distributed as discontinuous
patches along the nuclear envelope in wild-type prophase I
spermatocytes. Accordingly, the projections of equatorial focal
planes revealed a discontinuous ring surrounding the nuclei of
these spermatocytes (supplementary material Fig. S3A–F).
Likewise, a homogeneous patchy distribution of NPCs was
observed in Cdk22/2 prophase I spermatocytes (supplementary
material Fig. S3G–L). Thus, the absence of CDK2 does not affect
the distribution of NPCs.
Telomere tethering to the nuclear envelope is altered in
Cdk22/2 spermatocytes
The abnormal cap-shaped distribution of several nuclear envelope
components in Cdk22/2 spermatocytes prompted us to
investigate telomere dynamics at the nuclear envelope in these
individuals. For this purpose, we determined the distribution and
behavior of telomeres in both wild-type and Cdk22/2
spermatocytes during early prophase I stages by a double-
immunolabeling of the telomeric protein TRF1 and SYCP3
(Fig. 7). In wild-type spermatocytes, telomeric TRF1 signals
were discernible at the ends of the developing axial elements, as
revealed by the anti-SYCP3 antibody during leptotene (Fig. 7A).
The z-projections of all focal planes throughout these nuclei
showed a homogeneous nuclear distribution of telomeres.
Progressively, most telomere signals were polarized at a
discrete nuclear region during zygotene denoting a bouquet-like
arrangement (Fig. 7C). In pachytene spermatocytes, telomeres
redistributed along the nuclear envelope and the bouquet-like
arrangement was disorganized (Fig. 7E). InCdk22/2 spermatocytes,
TRF1 signals appeared to be dispersed at the nuclear envelope and
they never presented a polarized distribution (Fig. 7G,I,K), and
thus a bouquet-like arrangement was never observed in zygotene
nuclei (Fig. 7I). This observation corroborates our previous
proposal that in Cdk22/2 spermatocytes the presence of
telomeres that did not attach to the nuclear envelope might
Fig. 3. Internal telomeres are associated with membrane
vesicles in Cdk22/2 spermatocytes. (A–I) Electron
micrographs showing telomere attachments in wild-type (+/+)
pachytene nuclei (A) and in pachytene-like (2/2) mutant
nuclei (B–I). (A) End of a synaptonemal complex attached to
the nuclear envelope (NE) showing the central element (CE),
the two lateral elements (red arrows) and their association to
the INM through the attachment plates (AP). Thin fibrils
attaching to the cytoplasmic side of the nuclear envelope are
indicated (black arrows). (B–I) In mutant spermatocytes some
telomere regions appear rather normal (B) whereas in other
cases one of the lateral elements (red arrows) interacts
laterally with the INM (C). Some other telomere regions
appear to be associated with one or two membrane vesicles
(blue arrows) either associated to the INM (D,E,G) or lying at
the nuclear interior (F,H,I). Scale bars: 200 nm (A–C);
500 nm (D–I).
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prompt the absence of bouquet formation, which ultimately leads
to the extensive non-homologous pairing found (Viera et al.,
2009).
Taking into account our previous observation of internal
telomeres in Cdk22/2 spermatocytes (Viera et al., 2009) and the
presence of SUN1 signals at internal telomeres associated with
membrane vesicles, we next investigated the origin of the failures
in telomere attachment to the nuclear envelope. To determine
whether the internal telomeres found in Cdk22/2 pachytene-like
spermatocytes arise by either their detachment from the nuclear
envelope, tearing SUN1-containing membrane vesicles, or by
their inability to attach to the nuclear envelope during preceding
meiotic stages, we analyzed early prophase I stages in wild-type
and Cdk22/2 spermatocytes. To address this, we estimated the
location of telomeres (either peripheral or internal) in ten nuclei
of each prophase I stage in two different individuals for each
genotype (wild-type and Cdk22/2) after the immunostaining of
TRF1 and SYCP3. The analyses of partial projections
corresponding to the equatorial regions of wild-type prophase I
spermatocytes demonstrated that 1.59% of the TRF1 telomere
signals were present at the nuclear interior in leptotene nuclei
(Fig. 7A,B; Fig. 2B). These internal telomeric signals were no
longer observed in wild-type zygotene and pachytene nuclei
(Fig. 7C–F; Fig. 2B). By contrast, in Cdk22/2 spermatocytes a
high percentage of internal telomeric signals were always
observed in leptotene (36.72%), zygotene (48.48%) and
pachytene-like (50.52%) spermatocyte nuclei, respectively
(Fig. 7G–L; Fig. 2B).
We also wondered whether the internal TRF1 signals that we
observed in Cdk22/2 spermatocytes corresponded to proximal
telomeres (located at the chromosome centromeric end) or distal
telomeres (located at the non-centromeric end), given that mouse
chromosomes are telocentric. To examine this, we performed
both a double-immunolabeling of centromeres and SYCP3
(Fig. 8), and a triple detection of telomeres, centromeres, and
SYCP3 (supplementary material Fig. S4). Our results showed
that in wild-type spermatocytes the centromeres were located at
the nuclear periphery from leptotene up to pachytene (Fig. 8A–
F; supplementary material Fig. S4A–D). However, in Cdk22/2
spermatocytes the centromere signals were found, not only at the
nuclear periphery, but also at the nuclear interior in all prophase
I stages (Fig. 8G–L; supplementary material Fig. S4E–P). The
simultaneous labeling of centromeres and telomeres showed that
in mutant spermatocytes both the proximal telomeres, with TRF1
and ACA signals, and the distal telomeres, only with TRF1
signals, were likewise present at the nuclear interior at all
prophase I stages (supplementary material Fig. S4E–P). Taken
together, our results indicate that in the absence of CDK2 some
telomeres, independently of their proximal or distal
chromosomal position, are unable to attach to the nuclear
envelope during leptotene and remain at the nuclear interior in
later prophase I stages, and a bouquet-like arrangement is not
reached. Moreover, the presence of intranuclear telomeres
associated with nuclear-envelope-derived membrane vesicles
(Fig. 3D–I) and with SUN1 (Fig. 1P) indicates that some
attached telomeres have detached from the nuclear envelope in
the course of meiotic prophase I.
DISCUSSION
CDK2 regulates SUN1 distribution at the meiotic
nuclear envelope
SUN1 is a member of the SUN domain protein family that is
known to participate in the attachment of meiotic telomeres to the
INM of the nuclear envelope (Alsheimer, 2009; Hiraoka and
Dernburg, 2009; Koszul and Kleckner, 2009; Kracklauer et al.,
2013). In wild-type mice, SUN1 is enriched at discrete nuclear
envelope docking sites that physically connect the telomeres of
meiotic chromosomes to the nuclear envelope (Ding et al., 2007).
By contrast, we found that in the Cdk22/2 background most
SUN1 arranges into a cap-like structure polarized at the nuclear
envelope region facing the centrosome. This result therefore
indicates that CDK2 is not essential for the association of SUN1
to the INM. Interestingly, we have additionally observed that the
SUN1 cap at the nuclear envelope is detected in all prophase I
stages in these mutant spermatocytes. This finding suggests that
SUN1 is able to load to the INM, but that it cannot disperse to
discrete regions in the absence of CDK2. Accordingly, we
suggest that during mammalian meiosis CDK2 regulates the
lateral diffusion of SUN1 along the nuclear envelope. Our data
demonstrate at the ultrastructural level that CDK2 locates at the
attachment plates of the synaptonemal complex, where SUN1
participates in telomere anchoring to the nuclear envelope (Ding
et al., 2007), and that mouse testis CDK2 phosphorylates SUN1
in vitro. Thus, the cytological and biochemical data together
indicate that the phosphorylation of the nucleoplasmic domain of
Fig. 4. CDK2 locates at the attachment plates and phosphorylates
SUN1 in vitro. (A) Immunogold EM examination of CDK2 in wild-type (+/+)
mouse pachytene spermatocytes. CDK2 locates at the attachment plates
(AP) of the lateral elements (red arrows) that are connected with the INM of
the nuclear envelope (NE). Scale bar: 200 nm. (B) In vitro kinase assay.
Kinase activity associated with CDK2 immunoprecipitates obtained from 8-
week-old wild-type testis extracts. Recombinant SUN1 (amino acids 1–243)
together with the canonical CDK substrate pRb (amino acids 773–928) were
used in parallel. Results from two independent experiments are shown. M,
mock immunoprecipitate.
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SUN1 by CDK2 could be an important step in regulating SUN1
distribution along the nuclear envelope in spermatocytes.
Interestingly, two recent studies have reported that the kinases
CHK-2 and PLK-2, by phosphorylating the nucleoplasmic
domain of SUN-1 during C. elegans meiosis, do not regulate
telomere attachment, but the telomere movement along the
nuclear envelope and homolog pairing (Labella et al., 2011;
Penkner et al., 2009; Sato et al., 2009). Similarly, in mouse
meiosis CDK2 could be responsible for phosphorylating SUN1 to
direct the lateral diffusion of these LINC complexes and then
move telomeres along the nuclear envelope. Accordingly, in
Cdk22/2 individuals the KASH domain protein that interacts with
SUN1 to form meiotic LINC complexes, namely KASH5,
presents an altered distribution, which is coincident with SUN1
at the nuclear envelope. Thus, our data indicate that CDK2 is
dispensable for the interaction of SUN1 and KASH5 at LINC
complexes, and support recent reports stating that in male mouse
meiosis the localization of KASH5 is to some extent dependent
on SUN1 (Horn et al., 2013; Link et al., 2014; Morimoto et al.,
2012). Indeed, it has been demonstrated that in mouse meiosis
SUN1–KASH5 complexes are necessary to promote chromosome
pairing, and the proper progression of prophase I, by generating a
nucleocytoplasmic bridge connecting telomeres to microtubules
(Horn et al., 2013; Link et al., 2014; Morimoto et al., 2012).
Consequently, the defective distribution of LINC complexes
along the nuclear envelope of Cdk22/2 spermatocytes results in a
lack of telomere and chromosome movements, which would
promote failures in homologue pairing, accounting for the
defective synapsis previously reported in these individuals
(Viera et al., 2009). Therefore, we propose that CDK2 is
needed to transfer the microtubule-dependent cytoplasmic
forces to move telomeres along the meiotic nuclear envelope.
CDK2 regulates the structure of the prophase I
nuclear envelope
Our results show that in the absence of CDK2 the lamin-
associated protein LAP2 is not detected at the nuclear envelope
during prophase I. By contrast, in Cdk22/2 mutants LAP2 is still
detected at the nuclear envelope of somatic testicular cells, as in
rat testis (Schmitt et al., 2007). These results thus suggest that
CDK2 might be involved in the regulatory mechanism that allows
the association of LAP2 to the INM during meiosis.
Fig. 5. SUN1 and KASH
distribution in Cdk22/2
spermatocytes. Triple-
immunolabeling of SUN1 (green),
KASH5 (blue) and SYCP3 (red) on
pachytene wild-type (WT) (A–D) and
prophase I Cdk22/2 (E–P) squashed
spermatocytes. The first three
columns correspond to the z-
projection of all the focal planes
throughout a nucleus. The fourth
column presents the partial z-
projections of 15 focal planes
throughout the equatorial region of
the same nuclei. (A–D) WT
pachytene nucleus. SUN1 and
KASH5 are positioned at discrete
sites of the nuclear envelope,
coincident with the attachment plates
of the synaptonemal complex, and
thus they are detected at the nuclear
periphery. (E–P) Cdk22/2 prophase I
spermatocytes. In all prophase I
stages, SUN1 and KASH5 are
invariably distributed as a continuous
and polarized cap-like arrangement
at the nuclear envelope. Although
SUN1 also appears as small foci
(arrows) at the nuclear interior,
KASH5 is not detectable at these
foci. Scale bar: 5 mm.
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Consequently, it should be addressed in further investigations
whether CDK2 participates in the regulation of the phosphorylation
pathway of LAP2 during mammalian meiosis.
We have also found that in Cdk22/2 spermatocytes the
distribution of lamin C2 at the nuclear envelope is disturbed.
Indeed, lamin C2 unusually shows a cap-like distribution facing
the centrosome. Given that in mammals the meiotic A-type lamin,
lamin C2, is exclusively expressed during prophase I (Alsheimer
and Benavente, 1996; Furukawa et al., 1994; Smith and
Benavente, 1992), it can be assumed that CDK2 is involved in
the assembly of the meiosis-specific nuclear lamina. In the
Cdk22/2 background, the distribution of lamin C2 at the nuclear
envelope during meiosis is surprisingly coincident with that
observed for SUN1. SUN1 and its paralog SUN2 are present at
the INM of the nuclear envelope in both somatic and germ cells,
and they are able to interact with A-type lamins directly through
their nucleoplasmic domain (Alsheimer, 2009; Gerace and Huber,
2012; Tzur et al., 2006). During mouse meiosis, SUN1, SUN2
and lamin C2 appear to be enriched at the attachment sites of
telomeres to the nuclear envelope (Alsheimer et al., 1999;
Alsheimer et al., 2000; Ding et al., 2007; Schmitt et al., 2007).
Hypothetically, two possible pathways can determine the altered
distribution of SUN1 and lamin C2 in Cdk22/2 spermatocytes.
One possibility is that CDK2 regulates the localization of SUN1
and lamin C2 in an independent manner, and that its ablation
alters the distribution of both proteins individually. Alternatively,
CDK2 might participate in a pathway that regulates only one of
these proteins, either SUN1 or lamin C2, one of which determines
the dynamics of the other. In this sense, it has been recently
demonstrated, in somatic cells, that the interaction of SUN1 with
lamin A is disrupted after the phosphorylation of SUN1 by CDK1
or PLK1 (Patel et al., 2014). However, previous reports have
demonstrated that mutant mice lacking SUN1 do not present an
altered organization of the lamin-B-based nuclear lamina during
meiosis (Ding et al., 2007), and conversely, the absence of lamin
C2 does not promote a modification of SUN1 or SUN2
distribution at telomeres (Link et al., 2013; Schmitt et al.,
2007). Indeed, despite the fact that it has been demonstrated that
in somatic cells SUN1 presents an extremely strong interaction
with A-type lamins, SUN1 localization at the nuclear envelope is
independent of lamin A (Crisp et al., 2006). Moreover, in Cdk22/2
spermatocytes all the internal SUN1 foci were associated with
internal telomeres, whereas the internal lamin C2 signals were
never located at internal telomeres or close to internal SUN1 foci.
Taking into account our data, and previous results, it can be
assumed that the localization of SUN1 and lamin C2 at meiotic
telomere attachment sites is independent from each other.
However, we suggest that CDK2-mediated phosphorylation
Fig. 6. Lamin C2 distribution is
disturbed in Cdk22/2
spermatocytes. (A–L) Double-
immunolabeling of lamin C2 (green)
and SYCP3 (red) on squashed wild-
type (WT) (A–F) and Cdk22/2
(G–L) prophase I spermatocytes. The
images correspond to the partial z-
projections of 15 focal planes
throughout the equatorial region of
each spermatocyte. (A–F) WT
prophase I nuclei. Lamin C2 is
uniformly distributed at the nuclear
envelope. (G–L) Cdk22/2 prophase I
nuclei. Lamin C2 appears to be
polarized, showing a cap-shaped
labeling at the nuclear envelope.
(M–P) Equatorial z-projection of a
squashed Cdk22/2 zygotene nucleus
double-immunolabelled for lamin C2
(green) and SUN1 (purple) and
chromatin counterstaining with DAPI
(blue). Lamin C2 and SUN1
colocalize showing a cap-like
distribution at the nuclear envelope.
Some internal lamin C2 spots (white
arrows) are observed but they do not
colocalize with SUN1 internal focus
(yellow arrowhead). Scale bar: 5 mm.
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Fig. 7. Telomeres do not attach
accurately to the nuclear envelope
in Cdk22/2 spermatocytes. Double-
immunolabeling of TRF1 (green) and
SYCP3 (red) on squashed wild-type
(WT) (A–F) and Cdk22/2
(G–L) prophase I spermatocytes. The
first and third columns correspond to
z-projections of all focal planes
throughout a nucleus. The second
and fourth columns show the partial
z-projections of 15 focal planes
throughout the equatorial region of
the same nuclei. (A,B) WT leptotene
nucleus. Some telomeric TRF1
signals (arrows) are evident at the
nuclear interior. (C–F) WT zygotene
and pachytene nuclei. No internal
TRF1 signals are observed. Note the
bouquet-like arrangement of most
telomeres associated to the nuclear
envelope in the zygotene nucleus,
and the telomere signals at the
synaptonemal complex ends in
pachytene. (G–L) Cdk22/2 prophase
I nuclei. Internal TRF1 signals
(arrows) are evident in all prophase I
nuclei. The bouquet-like arrangement
of telomeres is not observed in
zygotene nuclei. Scale bar: 5 mm.
Fig. 8. Centromere distribution is disturbed in Cdk22/2 spermatocytes. Double-immunolabeling of centromeres (ACA, blue) and SYCP3 (red) on squashed
wild-type (WT) (A–F) and Cdk22/2 (G–L) prophase I spermatocytes. The first and third columns correspond to the z-projection of all the focal planes
throughout a WT and Cdk22/2 spermatocyte, respectively. The second and fourth columns present the partial z-projections of 15 focal planes throughout the
equatorial region of the same nuclei. (A–F) WT leptotene, zygotene and pachytene nuclei. Centromere signals at one of the ends of axial and lateral elements
are located at the nuclear periphery from leptotene up to pachytene. Note the bouquet-like arrangement of centromeres, indirectly labeling the proximal
chromosome ends, in the zygotene nucleus. (G–L) Cdk22/ prophase I nuclei. Some centromere signals (arrows), representing proximal telomere ends, lie at the
nuclear interior from leptotene up to the pachytene-like stage. Scale bar: 5 mm.
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might specifically promote the positioning of lamin C2 at the
nuclear envelope, and/or its redistribution to the telomere-docking
sites, as occurs for SUN1. The bulk of our results therefore
demonstrate that the ablation of CDK2 causes a severe disruption
in the structure of the meiotic nuclear envelope in mouse
spermatocytes. Thus, we propose CDK2 as an essential kinase,
the first one described in mammals, which regulates the assembly
and dynamics of the nuclear envelope during meiotic prophase I.
CDK2 mediates meiotic telomere attachment and dynamics
Meiotic telomere attachment to the nuclear envelope and their
further clustering at a discrete region, which ensures the bouquet-
like arrangement of chromosomes, represents a shared feature
among a variety of species to facilitate the proper achievement of
homology search, recombination and synapsis (Koszul and
Kleckner, 2009; Scherthan, 2007; Zickler and Kleckner, 1998).
In this sense, our data indicate that the absence of CDK2 inhibits
the formation of the bouquet-like arrangement in spermatocytes,
which could account for the defects in the processes of homolog
pairing, recombination and synapsis previously reported (Viera
et al., 2009). Surprisingly, in fifth and sixth generation
telomerase-deficient mice (Terc2/2), in which telomeric DNA
repeats shortened down to below detection levels (Franco et al.,
2002), and in shelterin protein Rap1-knockout mice (Scherthan
et al., 2011), telomeres are still able to properly attach to the
nuclear envelope. In striking contrast, in mice defective for
SUN1, telomeres are frequently found at the nuclear interior
during prophase I, revealing the importance of non-telomeric
proteins for meiotic telomere attachment (Ding et al., 2007; Link
et al., 2014). Given that CDK2 locates at late recombination nodules
and at telomeres during mouse prophase I (Ashley et al., 2001;
Viera et al., 2009), it has been proposed that CDK2 participates in
the organization of the Holliday junction intermediates and
telomeric DNA t-loops, which share structural similarities
(Ashley et al., 2001). Indeed, in Cdk22/2 spermatocytes late
recombination nodules were never found (Viera et al., 2009), but
defects in the tethering of meiotic telomeres to the nuclear
envelope, ring chromosomes and chromosome end-to-end fusions
have been reported, indicating a putative participation of CDK2 in
telomere capping (Viera et al., 2009). In the present study, we
demonstrate by electron microscopy the presence of CDK2 at the
attachment plates of the synaptonemal complex, suggesting a
possible participation of CDK2 in meiotic telomere attachment.
Moreover, we found that in Cdk22/2 spermatocytes a high
percentage of telomeres were lying at the nuclear interior in
leptotene (37.72%), and that this percentage was increased in
zygotene and pachytene-like spermatocytes (48.48% and 50.52%,
respectively). Thus, we speculate that at least two non-mutually
exclusive events might lead to the appearance of internal telomeres
in the absence of CDK2. The first one implies that some telomeres
are unable to attach to the nuclear envelope during leptotene, and
therefore remain in the nucleoplasm in further prophase I stages, as
described in knockout mouse models for Smc1b2/2 and Sun12/2
mice (Adelfalk et al., 2009; Ding et al., 2007). An alternative, and
more fascinating possibility, consists in the detachment of
telomeres that were initially attached to the nuclear envelope,
accounting for the increase in the rate of non-attached telomeres in
zygotene and pachytene-like nuclei. It is widely accepted that
several chromosome functions can be governed by mechanical
stresses transmitted along the chromosome axes (Kleckner et al.,
2004). In this regard, physical tensions generated by the ongoing
heterologous synapsis in Cdk22/2 spermatocytes might spread
along chromosomes up to the telomeres, forcing their detachment
from the nuclear envelope. This possibility is strongly supported by
the presence of SUN1 and membrane vesicles, probably peeled off
the INM of the nuclear envelope, at the internal telomeres found in
Cdk22/2 spermatocytes. Indeed, the fact that the number of
internal SUN1 foci increased during prophase I progression, as
synapsis proceeds, also reinforces this proposal. In this context, it
has been shown that SUN1 persists at the axial and lateral elements
ends on spread spermatocytes after a harsh preparative technique
that disrupts the nuclear envelope (Adelfalk et al., 2009; Ding
et al., 2007; Morimoto et al., 2012). Accordingly, SUN1 at
detached telomeres in Cdk22/2 spermatocytes could bring with
them vesicles derived from the nuclear envelope. Based on our
data, we propose that either or both events would finally disrupt
chromosome movements, and the formation of a bouquet-like
arrangement, and explain the meiotic defects previously found in
Cdk22/2 spermatocytes (Viera et al., 2009). However, a detailed
analysis of meiotic telomere attachment to the nuclear envelope in
other mouse models displaying non-homologous synapsis would
clarify whether this is a particular phenotype of the Cdk22/2
background, or by contrast if it represents a general consequence of
non-homologous synapsis.
In summary, our results point to CDK2 as a key factor
governing the assembly, structure and dynamics of the meiotic
nuclear envelope in mice. Moreover, CDK2 is essential for the
accurate attachment of meiotic telomeres to the nuclear envelope
and chromosome movements in prophase I.
MATERIALS AND METHODS
Ethics statement
Animals were kept under SPF barrier conditions at the CNIO animal
facility. Animals were handled according to relevant regulatory standards
and experiments were approved by the Universidad Auto´noma de Madrid
Ethics Committee.
Immunofluorescence microscopy
Adult male C57BL/6 mice (wild-type) and adult Cdk22/2 mice (Ortega
et al., 2003) were used for this study. Testes were removed, detunicated
and seminiferous tubules then processed for squashing as previously
described (Page et al., 1998; Parra et al., 2002). After fixation, the
squashed spermatocyte preparations were rinsed three times for 5 min in
PBS, and incubated overnight at 4 C˚ with the corresponding primary
antibodies diluted in PBS. To detect SYCP3, we employed either a mouse
monoclonal antibody (Abcam, ab-12452) or a rabbit polyclonal serum A1
(a gift from Christa Heyting, Wageningen University, Wageningen, The
Netherlands) at a 1:100 dilution. To detect SUN1, we used an affinity-
purified guinea pig polyclonal antibody raised against a peptide
corresponding to amino acids 428–722 of mouse SUN1 (Adelfalk
et al., 2009) at a 1:30 dilution. The centrosome was revealed by using a
rabbit polyclonal anti-pericentrin antibody generated against the residues
100–600 of mouse pericentrin 1 (Abcam, ab-4448) at a 1:10 dilution.
TRF1 was detected with a rabbit polyclonal serum (Alpha Diagnostic
International, TRF 12-S), raised against mouse TRF1, at a 1:50 dilution.
KASH5 was detected with a rabbit polyclonal antibody generated against
the amino acid residues 242–688 of mouse KASH5 (Link et al., 2014),
following previous reports (Morimoto et al., 2012), at a 1:30 dilution.
The mouse monoclonal 13d4 antibody (Alsheimer et al., 1998) was used
to reveal LAP-2 at a 1:10 dilution. To detect lamin C2 we employed
either a rabbit polyclonal antibody raised against the amino acids 231–
340 of human lamin A (Santa Cruz Biotechnology, sc-20681) that also
recognizes lamin C2 in mouse spermatocytes (Jahn et al., 2010) or an
affinity-purified rabbit polyclonal antibody generated against mouse A-
type lamins (Jahn et al., 2010) at a 1:10 dilution. Centromeres were
revealed with a human anti-centromere antibody (ACA) (Antibodies
Incorporated, 15-235) at a 1:50 dilution. A goat anti-RanGAP1 antibody
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(Pichler et al., 2002) was employed to detect RanGAP1 (a gift from
Frauke Melchior, Zentrum fu¨r Molekulare Biologie der Universita¨t
Heidelberg, Heidelberg, Germany) at a 1:10 dilution.
Following three washes in PBS, the slides were incubated for 30 min
at room temperature with secondary antibodies diluted in PBS. The
appropriated combinations of the following secondary antibodies were
employed for simultaneous double- or triple-immunolabeling: a
fluorescein isothiocyanate (FITC)-conjugated donkey anti-mouse IgG
antibody (Jackson) at a 1:150 dilution, a Texas-Red-conjugated donkey
anti-mouse ML IgG antibody (Jackson) at a 1:150 dilution, a FITC-
conjugated donkey anti-rabbit ML IgG antibody (Jackson) at a 1:150
dilution, a Texas-Red-conjugated donkey anti-rabbit ML IgG antibody
(Jackson) at a 1:150 dilution, a FITC-conjugated goat anti-human IgG
antibody (Jackson) at a 1:150 dilution, a FITC-conjugated donkey anti-
guinea-pig ML IgG antibody (Jackson) at a 1:150 dilution, a Texas-Red-
conjugated donkey anti-guinea-pig ML IgG antibody (Jackson) at a 1:150
dilution, and a FITC-conjugated donkey anti-goat ML IgG antibody
(Jackson) at a 1:40 dilution. Subsequently, slides were rinsed in PBS,
and, in double-immunolabeling experiments, counterstained for 3 min
with 5 mg/ml DAPI. After a final rinse in PBS, the slides were mounted
in Vectashield (Vector Laboratories) and sealed with nail varnish.
Observations were performed using an Olympus BX61 microscope
equipped with a motorized z-axis and epifluorescence optics. Image
stacks comprising 65 focal planes across the entire spermatocyte nuclei
were captured with an Olympus DP71 digital camera controlled by the
analySIS software (Soft Imaging System). The complete image stacks
were used to analyze the relative distribution of the proteins at a given
entire nucleus and for estimating the percentages that are presented at the
results section. For a better presentation of the results in the figures,
stacks were subsequently processed for obtaining complete z-projections
(65 focal planes) or partial z-projections (15 focal planes along the
equator of the nucleus) using the public domain software ImageJ
(National Institutes of Health). Final images were processed with Adobe
Photoshop 7.0 software.
Transmission electron microscopy and immunogold
electron microscopy
Electron microscopy was performed according to standard procedures
(Schramm et al., 2011). Testes of wild-type and Cdk22/2 mice were fixed
for 2 h at 4 C˚ in 2.5% glutaraldehyde in 50 mM cacodylate buffer. Then,
samples were washed in cacodylate buffer and postfixed in 1% osmium
tetroxide for 1 h at 4 C˚. After rinsing several times in water, samples
were dehydrated in an ethanol series and embedded in Epon. Ultrathin
sections were stained with uranyl acetate and lead citrate. Observations
were performed in a Zeiss EM-10 transmission electron microscope
operated at 80 kV. For immunoelectron microscopy we proceeded as
previously described (Schramm et al., 2011). Briefly, 10-mm mouse testis
cryosections were fixed with acetone for 10 min at 220 C˚ and air dried.
Incubation with a rabbit anti-CDK2 antibody (Abcam, ab-7954), at a 1:50
dilution in PBS, was carried out in a humidified chamber for 4 h at room
temperature. After two rinses in PBS, sections were fixed for 10 min in
2% formaldehyde and blocked with 50 mM NH4Cl. A goat anti-rabbit
secondary antibody conjugated to 6-nm-gold particles (Dianova) was
incubated overnight at 4 C˚ and samples were washed subsequently in
PBS. Samples were fixed for 30 min in 2.5% glutaraldehyde and post-
fixed in 2% osmium tetroxide. After rinsing three times with H2O,
samples were dehydrated in an ethanol series and embedded in Epon.
Ultrathin sections were stained with uranyl acetate and lead citrate
according to standard procedures.
In vitro kinase assay
For the in vitro kinase assay, we proceeded as previously reported
(Martı´n et al., 2005). Briefly, testis lysates were prepared with the
Precellys 24 tissue homogenizer (Bertin technologies) in
immunoprecipitation buffer (0.5% Nonidet p-40; 50 mM Tris-HCl
pH 7.5; 50 mM NaCl) supplemented with the protease inhibitor
cocktail (Roche). Lysates were clarified by centrifugation and 500 mg
were incubated overnight at 4 C˚ with 2 mg of a rabbit anti-CDK2
antibody (Santa Cruz Biotechnology, sc-163) followed by precipitation
with protein-A–sepharose beads for 2 h. Immunoprecipitates were
washed three times with 1 ml of immunoprecipitation buffer and three
times with kinase buffer (50 mM Hepes pH 7.5; 50 mM urea; 10 mM
MgCl2; 5 mM MnCl2; 1 mM DTT). The beads were suspended in 30 ml
of kinase buffer containing 1 mg substrate; either His-tagged Sun1 (amino
acids 1–243) or retinoblastoma protein (pRb) (amino acids 773–928,
Upstate, 12-439); 30 mM ATP and 10 mCi of [c-32P] ATP (Perkin Elmer,
6000Ci/mmol). After incubation for 30 min at 30 C˚ with occasional
mixing the samples were boiled with SDS/PAGE sample buffer and
separated by electrophoresis. Phosphorylated proteins were visualized
with a phosphoimager (Storm 820; Molecular Dynamics) after overnight
exposure.
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Figure S1 
 
 
Fig. S1. Centrosome distribution in wild-type and Cdk2-/- spermatocytes. (A-J) Double-
immunolabeling of pericentrin (green) and SYCP3 (red) and chromatin counterstaining with 
DAPI (blue) on squashed wild-type (A-F) and Cdk2-/- (G-J) prophase I spermatocytes. The 
images correspond to the partial Z-projections of 15 focal planes throughout the equatorial 
region of each spermatocyte. (A-F) WT prophase I nuclei. The centrosome (pericentrin 
staining) appears as a cloud near the nucleus. (G-J) Cdk2-/- leptotene and zygotene nuclei. 
The centrosome appears as a cloud near the nucleus. (K, L) Double-immunolabeling of 
pericentrin (green) and SUN1 (red) and chromatin counterstaining with DAPI (blue) on a 
squashed Cdk2-/- pachytene-like spermatocyte. The SUN1 cap-like labeling at the NE is 
always found facing the centrosome. Note internal SUN1 signals (arrows). Scale bar: 5 μm. 
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Figure S2 
 
 
Fig. S2. LAP2 does not assemble at the NE in Cdk2-/- spermatocytes. Double-
immunolabeling of LAP2 (green) and SYCP3 (red) and chromatin counterstaining with DAPI 
(blue) on squashed wild-type (A-F) and Cdk2-/- (G-P) prophase I spermatocytes. Images are 
partial Z-projections of 15 focal planes throughout the equatorial region of each 
spermatocyte. (A-F) WT prophase I nuclei. LAP2 appears uniformly distributed at the NE. (G-
L) Cdk2-/- prophase I nuclei. LAP2 is not detected at the NE. (M-P) Cdk2-/- testicular somatic 
cell (top) and prophase I spermatocyte (bottom). LAP2 locates at the NE in a somatic cell, 
but it is absent at the NE of the spermatocyte. Scale bar: 5 μm. 
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Figure S3 
 
 
 
Fig. S3. The distribution of nuclear pore complexes is not modified in Cdk2-/- 
spermatocytes. Double-immunolabeling of RanGAP1 (green) and SYCP3 (red) and 
chromatin counterstaining with DAPI (blue) on squashed wild-type (A-F) and Cdk2-/- (G-L) 
prophase I spermatocytes. Images are partial Z-projections of 15 focal planes throughout the 
equatorial region of each spermatocyte. RanGAP1 appears as small spots at the NE both in 
WT and Cdk2-/- prophase I spermatocytes. Scale bar: 5 μm. 
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Figure S4 
 
 
 
 
Fig. S4. Telomere and centromere distribution in Cdk2-/- spermatocytes. Triple-
immunolabeling of telomeres (TRF1, green), centromeres (ACA, blue) and SYCP3 (red) on 
pachytene wild-type (A-D) and prophase I Cdk2-/- (E-P) squashed spermatocytes. The first 
three columns correspond to the Z-projection of all the focal planes throughout a nucleus. 
The fourth column presents the partial Z-projections of 15 focal planes throughout the 
equatorial region of the same nuclei. (A-D) WT pachytene nucleus. All the proximal 
telomeres (white arrows), with telomere and centromere signals, and the distal telomeres 
(green arrows), with only telomere signals, are located at the nuclear periphery. (E-P) Cdk2-
/- prophase I nuclei. Both proximal telomeres (white arrows) and distal telomeres (green 
arrows) can be found at the nuclear interior in all prophase I stages. Scale bar: 5 μm. 
Journal of Cell Science | Supplementary Material
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SUMMARY
Polyploidization is a natural process that frequently
accompanies differentiation; its deregulation is
linked to genomic instability and cancer. Despite its
relevance, why cells select different polyploidization
mechanisms is unknown. Here we report a system-
atic genetic analysis of endomitosis, a process
in which megakaryocytes become polyploid by
entering mitosis but aborting anaphase. Whereas
ablation of the APC/C cofactor Cdc20 results in
mitotic arrest and severe thrombocytopenia, lack of
the kinases Aurora-B, Cdk1, or Cdk2 does not affect
megakaryocyte polyploidization or platelet levels.
Ablation of Cdk1 forces a switch to endocycles
without mitosis, whereas polyploidization in the
absence of Cdk1 and Cdk2 occurs in the presence
of aberrant re-replication events. Importantly, abla-
tion of these kinases rescues the defects in Cdc20
null megakaryocytes. These findings suggest that
endomitosis can be functionally replaced by alterna-
tive polyploidization mechanisms in vivo and provide
the cellular basis for therapeutic approaches aimed
to discriminate mitotic and polyploid cells.
INTRODUCTION
Variation in ploidy is commonly found in multiple organisms and
polyploid cells are an essential part of the developmental pro-
gram in many different species (Edgar et al., 2014). In most
cases, developmentally programmed polyploidy is an irrevers-
ible process linked to terminal cell differentiation and the acqui-
sition of new functional capabilities. In addition, polyploidy has
been proposed to buffer the genome against genetic damage
(Pandit et al., 2013). Somatic polyploidy can be achieved through
multiple modifications of the basic cell division cycle. These spe-
cial cycles include endocycles, originally described as a process
in which rounds of DNA replication occur while mitosis is
completely bypassed (successive DNA synthesis and gap
phases), or endomitosis, an atypical cell cycle in which cells un-
dergo an aberrant mitosis in the absence of segregation of the
previously duplicated genomes. The term ‘‘endoreplication’’ is
often used either to refer to endocycles or more widely to include
diverse polyploidizationmechanisms andwill not be used here to
avoid confusion. Both endocycles and endomitosis lead to uni-
form and integral duplication of the genome in mammals (Sher
et al., 2013). Other processes, such as re-replication, lead to
nonuniform increased ploidy, as a consequence of alteration in
the regulatory modules that impose a single round of DNA repli-
cation per cell cycle, and normally lead to cell death (Arias and
Walter, 2007).
Polyploidization is an essential part of the programmed
developmental process required for the formation of placental
trophoblast giant cells, which use endocycles to achieve chro-
matin-values (C-value, a multiple of the DNA content of the
unreplicated haploid chromosome complement) of >1,000.
Similarly, bone marrow megakaryocytes can reach up to
128C in humans or 64C in the mouse through endomitotic
cell cycles. Whereas endocycling is characterized by low
expression of mitotic genes, and low cyclin-dependent kinase
(Cdk) activity, mitotic genes are normally expressed during
endomitosis in megakaryocytes (Edgar and Orr-Weaver,
2001; Sher et al., 2013). Megakaryocytes are the largest (50–
100 mm) cells in the bone marrow and they produce platelets
by fractionation of the cytoplasm after a terminal differentiation
process in which the cytoplasmic volume increases in parallel
with ploidy (Thon and Italiano, 2012). Polyploidization in mega-
karyocytes occurs in the presence of an aberrant mitosis in
which cells do not undergo cleavage furrow formation after
the 4N stage, and they skip late anaphase and cytokinesis,
suggesting that segregation of chromosomes is not necessary
for megakaryocyte maturation and platelet formation (Geddis
et al., 2007; Kaushansky, 2008; Lordier et al., 2008; Ravid
et al., 2002; Wen et al., 2009). The increase in cell volume likely
helps to generate a large amount of mRNA and protein neces-
sary to be packaged into platelets (Zimmet and Ravid, 2000).
To what extent ploidy and platelet formation are linked is not
well established (Machlus and Italiano, 2013), and why poly-
ploidy in these cells is specifically achieved through abortive
mitosis is presently unclear.
The variation in polyploidization mechanisms raises the ques-
tion of whether these unconventional cycles have functional links
with the differentiation of specific cell types or they simply repre-
sent alternative processes to increase ploidy. In addition, inhibi-
tion ofmultiplemitotic kinases such as Aurora A or Aurora B does
not impair polyploidization in cultured megakaryocytes (Lordier
et al., 2010; Wen et al., 2012), an observation that, while opening
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new therapeutic opportunities in cancer (Krause and Crispino,
2013), illustrates our limited understanding on how polyploiza-
tion is modulated. We have analyzed in this work new mouse
strains lacking selected key proteins involved in mitotic entry
(Cdks; Figure 1A), mitotic progression (Aurora B), or mitotic
exit (the anaphase-promoting complex [APC/C] cofactor
Cdc20) during megakaryocyte maturation in vivo. Our results
confirm that Aurora B, a kinase essential for proper attachment
of microtubules to kinetochores (Nezi and Musacchio, 2009), is
not required for megakaryocyte maturation (Lordier et al.,
2010). However, genetic ablation of Cdc20 results in mitotic
arrest and severe thrombocytopenia indicating that endomitosis
is the major megakaryocyte polyploidization mechanism in vivo.
Importantly, genetic ablation of Cdk1, an enzyme essential for
mitosis, prevents endomitosis but does not impair platelet for-
mation, as a consequence of reprogramming from endomitosis
to endocycles that alternate DNA synthesis and gap phases.
Similarly, concomitant ablation of Cdk1 andCdk2 results in aber-
rant re-replication without dramatically affecting platelet levels.
Furthermore, the loss of Cdk1 or the concomitant ablation of
both Cdk1 and Cdk2 can significantly rescue proplatelet forma-
tion and platelet levels in Cdc20 null mice. These results suggest
that reprogramming from endomitosis to other unconventional
cell cycles in vivo is compatible with megakaryocyte function,
even in the presence of re-replication, a dangerous process in
which DNA is unevenly replicated.
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Figure 1. Aurora-B Is Dispensable for
Megakaryopoiesis and Platelet Formation
(A) Schematic representation of the role of
the molecules discussed in this work during
endomitosis.
(B) Bone marrow sections from 12-week-old mice
were stained with hematoxylin and eosin (H&E)
or treated for immunohistochemical staining of
Von Willebrand factor (VWF). Scale bars represent
50 mm (insets, 20 mm).
(C) Pf4-Cre; Aurkb(D/D) mice show normal mega-
karyocyte number (MKs per 403 microscopic
field) and VWF staining (relative VWF signal per
cell). At least 300 megakaryocytes from three
different animals per genotype were counted.
Data are mean ± SEM (ns; not significant; p > 0.05;
Student’s t test).
(D) Ploidy distribution (after DAPI staining) of
CD41+ bone marrow cells.
(E) Blood platelet levels from 8- to 12-week-old
Aurkb(D/D) and control mice (ns; not significant;
p > 0.05; Student’s t test).
(F) Schematic representation of mitotic progres-
sion in the absence of Aurora B.
See also Figure S1.
RESULTS
Aurora B Is Dispensable for
Megakaryocyte Development
To understand the requirements for
specific mitotic regulators during mega-
karyocyte development, we made use
of transgenic mice expressing Cre re-
combinase under the platelet factor 4 (Pf4) promoter (Tiedt
et al., 2007). In this model, Cre is expressed in megakaryocyte
progenitors and mature megakaryocytes with preference for
polyploid (R8C) cells (Figure S1 available online).
Aurora B is a mitotic kinase whose ablation results in a
normal mitotic entry but a premature exit from mitosis without
being able to segregate chromosomes, resulting in tetraploidy
(Ferna´ndez-Miranda et al., 2011; Trakala et al., 2013). Specific
genetic ablation of the murine Aurkb gene in megakaryocytes
(Figure S1) resulted in normal survival and no overt defects
during development or adulthood of Pf4-Cre; Aurkb(D/D)
(from now on Aurkb(D/D)) mice. These mutant mice displayed
fully mature megakaryocytes in the bone marrow as indicated
by Von Willebrand factor (VWF) staining (Figure 1B). The
absolute number of megakaryocytes and the level of VWF
staining per cell was not altered (Figure 1C), and we found
no significant differences in the ploidy distribution of cells
positive for the megakaryocytic marker CD41 (Figure 1D).
In Aurkb(D/D) mice, hematopoietic progenitors displayed
normal differentiation kinetics toward CD41+ cells when stimu-
lated with thrombopoietin (TPO), and mature megakaryocytes
were able to shed platelets (Figure S1). Accordingly, we found
no differences in blood platelet levels in Aurkb(D/D) mice
(Figure 1E), indicating a complete maturation, terminal differen-
tiation and full functionality of these mutant megakaryocytes
(Figure 1F).
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APC/C-Cdc20 Is Essential for Endomitotic Exit in
Megakaryocytes
The APC/C-Cdc20 complex is an E3-ubiquitin ligase whose
activity is essential for exiting the mitotic cycle by triggering
the degradation of the Cdk1 activator cyclin B1 (Peters, 2006).
Thus, Cdc20 ablation does not have any effect in interphase or
mitotic entry but cells are trapped in mitosis in the absence of
APC/C-Cdc20 activity (Manchado et al., 2010). Specific genetic
ablation of Cdc20 in megakaryocytes (Figure S2) resulted in a
dramatic phenotype characterized by lack of mature cells and
a significant increase in progenitors and small megakaryocytes
in the bone marrow (Figure 2A) and the spleen (Figure S2), a
phenotype commonly induced by lack of circulating platelets.
Cdc20(D/D) megakaryocytes were characterized by reduced
VWF staining (Figures 2A and 2B) and abundant mitotic figures
in the presence of phosphorylated histone H3, suggesting
mitotic arrest of mid-size megakaryocytes in the absence of
Cdc20 (Figure 2A). In addition, the 16C and 32C populations
were almost absent whereas 4–8C megakaryocytes were more
abundant (Figures 2A and 2C), likely as a consequence of the
terminal accumulation of mitotic 8C cells as a result of Cdc20
ablation in 2–4C cells. Accordingly, Cdc20(D/D) mutant mice
presented severe thrombocytopenia (108.4 ± 70.8 3 109 plate-
lets/l versus 781.6 ± 171.0 [mean ± SD] in control mice; p <
0.001; Student’s t test; Figure 2D), thus confirming a critical
role for Cdc20 in megakaryocyte function.
We next analyzed the cellular effect of megakaryocyte-
specific ablation of Cdc20 using bone marrow progenitors stim-
ulated in vitro with TPO. Three days after stimulation, mutant
megakaryocytes were smaller than control cells, presented
condensed DNA, and were positive for mitotic markers suggest-
ing mitotic arrest in vitro (Figure 2E). We then transduced these
megakaryocytes with lentiviral vectors expressing histone H2B
fused to the green fluorescent protein (H2B-GFP). As depicted
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Figure 2. Cdc20 Is Essential forMegakaryo-
cyte Maturation and Platelet Production
(A) Hematoxylin and eosin (H&E) and immunohis-
tochemical staining for Von Willebrand factor
(VWF) and phosphorylation of histone H3 (pH3) in
12-week-old mice. Scale bars represent 50 mm
(insets, 20 mm). The abundance of megakaryo-
cytes (mean ± SEM megakaryocyte per 403
microscopy field) and the percentage of mitotic
cells (mean ± SEM) are indicated in the histo-
grams. n = 250 cells from threemice per genotype.
(B) Quantification of VWF signal in Cdc20 null and
control megakaryocytes. n = 250 cells from three
mice per genotype.
(C) Ploidy distribution of bone marrow CD41+ cells
after DAPI staining.
(D) Blood platelet levels from 8- to 12-week-old
Cdc20(D/D) and control.
(E) Bone marrow cells were stimulated with TPO
for 3 days. Micrographs represent bright-field
and Giemsa staining, and immunofluorescence
(IF) for Aurora B (red; DAPI is in blue). Scale bars
represent 50 mm or 20 mm (IF).
(F) Cell fate of Cdc20-deficient megakaryocytes.
Every row represents a single cell and purple
frames depict endomitosis. Time 0 is set to mitotic
entry (DNA condensation). Interphase is shown in
pale brown and mitosis in black. Cell death is
represented by a red circle. Only a control cell (top)
is shown as an example.
(G) Duration of mitosis (DOM) in minutes estimated
by the analysis of individual cells by time-lapse
microscopy. In Cdc20(D/D) megakaryocytes, the
DOM is considered from DNA condensation until
cells die in mitosis.
(H) Representative time-lapse images of bone
marrow-derived megakaryocytes stably express-
ing histone H2B-GFP (green). Red in Cdc20(D/D)
megakaryocytes corresponds to Katushka fluo-
rescent protein (KFP), which is expressed in a
Cre-dependent manner.
(I) Scheme representing the essential role of
Cdc20 for endomitotic exit in megakaryocytes.
The Student’s t test was used for statistics in (A),
(B), (D), and (G). ***p < 0.001.
See also Figure S2.
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in Figures 2F–2H, controlCdc20(lox/lox) megakaryocytes under-
went typical endomitotic cycles in which cells displayed
condensed DNA for approximately 1–2 hr and exited mitosis in
the absence of chromosome segregation. Similar assays were
performed in Pf4-Cre; Cdc20(D/D); LSL-KFP megakaryocytes
in which the activity of Cre resulted in Cdc20 ablation and the
expression of Katushka fluorescent proteins (KFP) as a result
of the excision of a LoxP-STOP-loxP cassette (Figure S1). These
Cdc20(D/D) megakaryocytes displayed normal entry into
endomitosis but arrested with condensed chromosomes at
10–24 hr until cell death (Figures 2G and 2H). Althoughwe cannot
discard another unknown function for Cdc20 in platelet forma-
tion, these data are indicative of the essential relevance of
Cdc20 during endomitotic exit, resulting in lack of platelets
due tomitotic arrest in low-intermediate ploidy Cdc20 null mega-
karyocytes (Figure 2I).
Cdk1 Is Essential for Endomitosis but Dispensable
for Megakaryopoiesis
By definition, endomitotic cells do enter into mitosis and exit
without segregation, whereas endoreplicating cells completely
skip mitosis, frequently as a consequence of Cdk1 inhibition
(Zielke et al., 2013). We therefore eliminated Cdk1 activity in
megakaryocytes to prevent mitotic entry. The resulting Pf4-
Cre; Cdk1(D/D) mice did not display major defects in megakar-
yocyte number, morphology, or VWF staining in adult mice
(Figure 3A). Similarly, the ratio of highly polyploid (16C–32C)
megakaryocytes was partially reduced (Figure 3B), although
the number of platelets in peripheral blood was similar to that
of control littermates (Figure 3C). Whereas Aurora B and
Cdc20 protein levels are controlled by cell cycle-regulated
ubiquitin-dependent proteolysis (Peters, 2006), Cdk1 is more
stable raising the possibility that its depletion was not efficient
in this system. However, we confirmed that Cdk1 protein levels
were significantly reduced in mature (>4C) bone marrow
Cdk1(D/D) megakaryocytes (Figure 3D). After incubation of
bone marrow progenitors with TPO in vitro, Cdk1(D/D) mega-
karyocytes also accumulated normal levels of ploidy (Figure 3E)
and displayed a normal morphology whereas, as a control,
Cdc20(D/D) megakaryocytes presented smaller nuclei with
condensed DNA (Figure 3F). Similar depletion in Cdk1 protein
levels was obtained in this assay (Figure 3G). Therefore,
the lack of an obvious phenotype in platelet production was
not likely due to inefficient ablation of Cdk1 in these genetic
models.
To understand the cellular basis of these observations, we
monitored polyplodization in Cdk1(D/D) megakaryocyte precur-
sors by time-lapse microscopy. Bone marrow progenitors were
transduced with lentiviral vectors expressing lamin-CFP to stain
nuclear envelope, and H2B-GFP to label chromatin. In addition,
we used a vector expressing geminin-mCherry, a DNA replica-
tion regulator induced in S phase and degraded in an APC/C-
dependent manner during mitotic or endomitotic exit (Sakaue-
Sawano et al., 2008, 2013). Using these markers, together with
the quantification of nuclear and cellular volumes, endocycles
can be readily monitored in wild-type megakaryocytes
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Figure 3. Normal Megakaryocyte Function
in the Absence of Cdk1
(A) Bone marrow sections from Cdk1(lox/lox) and
Cdk1(D/D) mice stained with hematoxylin and
eosin (H&E) or after immunodetection of Von Wil-
lebrand factor (VWF) or phosphorylation of histone
H3 (pH3). Scale bars represent 50 mm (insets
20 mm). VWF signal per cell is quantified in the
histogram.
(B) Ploidy distribution of bone marrow CD41+ cells
after DAPI staining. A representative image out of
three separate experiments is shown.
(C) Blood platelet levels in Cdk1(lox/lox) and
Cdk1(D/D) mice.
(D) Immunodetection of Cdk1 in freshly isolated
megakaryocytes (CD41+ cells) from bone marrow.
Megakaryocytes were stained with Hoechst and
CD41+ cells were sorted according the DNA
content into two populations (2C–4C) and (>4C).
Vinculin was used as a loading control.
(E) DNA content of CD41+ bone marrow derived
>4C megakaryocytes at days 2 and 4 during pol-
yploidization upon TPO stimulation.
(F) Giemsa staining of the indicated megakaryo-
cytes 4 days after TPO stimulation in vitro. Scale
bars represent 50 mm.
(G) Immunodetection of Cdk1 in bone marrow-
derived >4C megakaryocytes after stimulation
ex vivo with TPO for 3 days. Vinculin is used as a
loading control. In (A) and (C), ns, not significant
(Student’s t test).
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(Figure S3). Control megakaryocytes were recorded for several
days and the behavior of individual cells is depicted in Figure 4A.
Most control megakaryocytes were characterized by abortive
mitosis (condensed chromosomes and pan-cellular geminin
signal), degradation of geminin (gemininlow phase), followed
in most cases by re-expression of geminin (gemininhigh), and
a new endomitotic phase (Figures 4A–4C). The histone signal
(Figure S3) and nuclear volume (Figure 4C) similarly increased
!2-fold during the gemininhigh phase, suggesting DNA replica-
tion in each of these endocycles. Cell volumes also increased
during this process without clearly correlating with any particular
phase (Figure 4C).
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Figure 4. Lack of Cdk1Results in Endorepli-
cative Polyploidization
(A) Cell fate of control bone marrow-derived
megakaryocytes during approximately 5 days in
the presence of TPO. Individual cells, stably ex-
pressing H2B-GFP (green) and Geminin-mCherry
(red), were recorded with time-lapse microscopy.
The red frame stands for S–G2 phases (gem-
ininhigh), whereas green frames represent G1
(gemininlow). Endomitosis is illustrated as a black
box surrounded by a purple frame.
(B) Representative immunofluorescences of an
individual control cell during endomitosis.
(C) Quantification of geminin fluorescent intensity,
nuclear volume, and cell volume in individual
control cells. Each line represents an individual cell
and purple frames depict endomitosis. Black ar-
rows indicate the 2-fold increase in nuclear and
cellular volume between two gemininhigh phases.
(D) Cell fate (similar to A) of individual cells derived
from Cdk1(D/D) bone marrow-derived megakar-
yocytes. In most cells, geminin is degraded in the
absence of mitosis. Red circles indicate cell death.
(E) Representative images of an individual
Cdk1(D/D) megakaryocyte in which geminin is
degraded in the absence of nuclear envelope
breakdown or mitosis.
(F) Quantification of the temporal profiles of gem-
inin fluorescent intensity, nuclear volume and cell
volume in Cdk1(D/D) megakaryocytes. Each line
represents an individual cell. Black arrows high-
light the 2-fold increase of nuclear and cellular
volume between two gemininhigh phases even in
the absence of endomitosis.
(G) Schematic representation of endocycles lack-
ing mitotic phases in the absence of Cdk1.
See also Figures S3 and S4.
In most Cdk1(D/D) megakaryocytes,
however, geminin was degraded in the
absence of endomitosis (Figures 4D–4F).
In these cells, geminin displayed an
exclusive nuclear localization in agree-
ment with the maintenance of the nuclear
envelope (as detected by lamin signal;
Figure S4) and the lack of chromosome
condensation (as monitored by histone
signal; Figures 4E and S4). Yet, geminin
was degraded and cells underwent
additional cycles characterized by the
oscillation in geminin levels in the absence of mitosis. Interest-
ingly, histone H2B-GFP signal (Figure S4) and nuclear volume
(Figure 4F) increased !2-fold in each of these endocycles, sug-
gesting the presence of DNA replication throughout the geminin-
high phase. Due to the difficulties in directly monitoring Cdk1
ablation in these individual cells, we also used the LSL-KFP allele
as a surrogate marker for Cre activity. Approximately 70% of
Pf4-Cre; Cdk1(D/D); LSL-KFP cells positive for the Katushka
signal (an indication of Cre activity in polyploid cells; see Fig-
ure S1) underwent cycles in which geminin was degraded
in the absence of endomitosis (S-G-S cycles), whereas all
control Pf4-Cre; Cdk1(+/+); LSL-KFP cells underwent typical
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endomitotic cycles (Figure S4). The fact that the increase in
ploidy was similar in wild-type and Cdk1(D/D) cells (Figures 4C
and 4F) indicates that megakaryocytes are able to polyploidize
using endocycling as an alternative route to endomitosis in the
absence of Cdk1 (Figure 4G).
Cdk2 Prevents Re-replication in the Absence of Cdk1
We next used Cdk2-deficient mice to test the contribution of
this kinase that is highly related to Cdk1 (Malumbres et al.,
2009), but whose relevance to somatic cell cycles is not clear
due to the lack of mitotic phenotypes in Cdk2-deficient mice
(Malumbres and Barbacid, 2009; Ortega et al., 2003). In the
absence of Cdk2 (Figure S5), megakaryocytes displayed normal
morphology (Figure 5A) and platelet number (943.3 ± 137.6 3
109 platelets/L versus 852.3 ± 134.4 in wild-type littermates;
p > 0.05, Student’s t test). Similarly, lack of Cdk2 did not dramat-
ically alter megakaryocyte maturation (Figure 5A) or platelet
numbers in a Cdk1(D/D) background (739 ± 56.6 3 109 plate-
lets/L in Cdk1(D/D); Cdk2(!/!) versus 863.4 3 ± 179.6 in
Cdk1(D/D); Cdk2(+/+) littermates; p > 0.05, Student’s t test).
Unexpectedly, genetic ablation of Cdk2 in a Cdk1 null back-
ground resulted in pan-nuclear phosphorylation of H2AX
(gH2AX) in megakaryocytes. Whereas gH2AX is usually found
in a light, scattered pattern during normal DNA replication,
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Figure 5. Lack of Cdk1 and Cdk2 Does Not Prevent Megakaryocyte Function despite Abnormal DNA Replication
(A) Representative bone marrow sections after staining with hematoxylin and eosin (H&E) or immunohistochemical staining for Von Willebrand factor (VWF) and
phosphorylation of H2AX (gH2AX). Scale bars represent 50 mm (insets 20 mm). The quantification of the VWF signal per megakaryocyte is plotted for the indicated
genotypes (ns, not significant; Student’s t test).
(B) Quantification of megakaryocytes negative for gH2AX (empty box) or displaying a spotted pattern (gray boxes) or strong pan-nuclear staining (filled boxed) of
gH2AX in the indicated genotypes.
(C) Ploidy distribution inside the bone marrow CD41+ population after DAPI staining. Plots are representative of three different experiments. The discrete peaks
corresponding to different DNA content are indicated (2C–32C). The bracket indicates the diffuse pattern of high ploidy (>8C) Cdk1(D/D); Cdk2(!/!) mega-
karyocytes.
(D) Time-lapse microscopy ofCdk1(D/D);Cdk2(!/!) bonemarrow-derived megakaryocytes after stimulation with TPO. Cells stably expressed histone H2B-GFP
(red), lamin-CFP (blue), and geminin-mCherry (red). The cell increased nuclear size while maintaining its lobule organization.
(E) Cell fate of multiple individual Cdk1(D/D); Cdk2(!/!) megakaryocytes. Red and green boxes represent S–G2 (gemininhigh) or G1 (gemininlow) phases.
Endomitosis is illustrated as a black box surrounded by a purple frame and red circles represent cell death.
(F) Quantification of the temporal profiles of geminin fluorescence intensity and nuclear volume in Cdk1(D/D); Cdk2(!/!) megakaryocytes.
(G) Plot representing fold increase in nuclear volume versus gemininhigh phase length in individual megakaryocytes with the indicated genotypes.
(H) A model suggesting that absence of Cdk1 and Cdk2 leads to increased ploidy by re-replication in megakaryocytes.
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strong pan-nuclear staining is indicative of a response to DNA
damage. Wild-type megakaryocytes or cells deficient in Cdk1
or Cdk2 displayed a scattered pattern in !25% of the cells.
However, Cdk1(D/D); Cdk2("/") megakaryocytes displayed an
additional 52% of cells with strong pan-nuclear gH2AX staining,
suggesting abnormal replication events (Figures 5A and 5B).
These data correlated with abnormal ploidy in Cdk1(D/D);
Cdk2("/") megakaryocytes in which the sharp peaks represent-
ing the 8C, 16C, and 32C populations were substituted with a
continuous distribution of high ploidy cells, a phenotype
frequently attributed to re-replication (Figure 5C).
Cdk1(D/D); Cdk2("/") megakaryocytes also presented gemi-
ninlow and gemininhigh phases without evidences for mitosis in
most cases (Figures 5D and 5E). Interestingly, the duration of
many gemininhigh phases was longer when compared to wild-
type or Cdk1(D/D) cells (Figures 5D–5G), and the increase in
nuclear volume per gemininhigh phase in Cdk1(D/D); Cdk2("/")
megakaryocytes was higher than 2-fold, and correlated (R2 =
0.887) with the length of the individual gemininhigh phases (Fig-
ure 5G). The fact that the increase in nuclear size was higher
than expected and did not correspond to discrete genome dou-
blings is consistent with a phenomenon known as re-replication
in which the original DNA is copied more than once within each
S phase (Figure 5H).
Cdk1 and Cdk2 Ablation Rescues Platelet Defects
in the Absence of Cdc20
Because inactivation of Cdk1 or Cdk1 plus Cdk2may trigger pol-
yploidization in the absence of endomitosis, we hypothesized
that lack of Cdks could rescue the mitotic-specific defects
observed in Cdc20 null megakaryocytes by reprogramming the
polyploidization process thus bypassing the mitotic arrest. We
therefore generated Pf4-Cre; Cdc20(D/D); Cdk1(D/D) or Pf4-
Cre; Cdc20(D/D); Cdk1(D/D); Cdk2("/") mutant mice. Whereas
genetic ablation of Cdc20 was characterized by the presence
of small megakaryocytes frequently arrested in mitosis, simulta-
neous ablation of Cdk1 allowed the accumulation of big mega-
karyocytes with increased VWF signal (Figures 6A and 6B) and
ploidy (Figure 6C), suggesting a partial rescue in the maturation
of these cells. Strikingly, concomitant ablation of Cdk1 and Cdk2
in a Cdc20 background led to an improved rescue in the matura-
tion of megakaryocytes (Figures 6A and 6B). The rescue in ploidy
was also improved because these triple mutant mice displayed
clear 16C and 32C peaks in the presence of a significant number
of cells with intermediate ploidy content (Figure 6C). These triple
mutants displayed clear polyploid peaks what were not as
evident in re-replicative Cdk1(D/D); Cdk2("/") megakaryocytes
(Figure 5C). As detected by flow cytometry studies, !17% of
triple mutant cells were positive for the mitotic marker phos-
pho-histone H3, an observation that likely reflects a partial
mitotic arrest imposed by lack of Cdc20 in low-ploidy cells that
may still express Cdk1 or Cdk2 (Figure S5). Yet, the percentage
of cells with intermediate levels of ploidy (different from an
exact multiple of the normal diploid number) was increased in
Cdc20(D/D); Cdk1(D/D); Cdk2("/") triple mutants to levels close
to those observed in Cdk1(D/D); Cdk2("/") double mutants
(Figure S5). Overall, the percentage of mitotic megakaryo-
cytes was significantly reduced in Cdc20(D/D); Cdk1(D/D) and
Cdc20(D/D); Cdk1(D/D); Cdk2("/") mutant mice (Figure 6D),
suggesting that Cdk1 null or Cdk1;Cdk2 null megakaryocytes
were able either to exit from the mitotic arrest imposed by lack
of Cdc20, or to polyploidize and form platelets in a endomi-
totic-independent manner. Time-lapse microscopy analysis
indicated that no megakaryocyte was able to exit from the
mitotic arrest imposed by Cdc20 ablation as a viable cell (Fig-
ure S5). However, about half of viable cells were able to start pol-
yploidization cycles in the absence of mitosis suggesting that
maturation of these cells was mediated by alternative polyploid-
ization mechanisms. The reprogramming was also suggested by
careful examination of nuclear morphology in vivo. Whereas
wild-type (or Cdk2 null) megakaryocytes displayed typical com-
plex nuclei characterized by the presence of multiple lobules (as
a result of abortive chromosome segregation), Cdk1(D/D) or
Cdk1(D/D); Cdk2("/") megakaryocytes (either in a wild-type or
Cdc20 null background) were frequently mono- or binucleated
(Figure 6E), supporting the hypothesis of a polyploidization
mechanism different from endomitosis in vivo.
The presence of pan-nuclear staining of gH2AX inCdc20(D/D);
Cdk1(D/D); Cdk2("/") also indicated replicative defects in triple
mutant mice that were not present in Cdc20(D/D); Cdk1(D/D)
megakaryocytes (Figure 6A). We therefore tested whether these
defects could be due to re-replication in the absence of both
Cdk1 and Cdk2 by using an adaptation of DNA fiber spreading
assays (Neelsen et al., 2013) to monitor re-replication on single
DNA molecules from megakaryocytes. Cells were sequentially
incubated with CldU and IdU, a technique commonly used to
distinguish moving forks, origin firing and termination events. In
this protocol, the overlap in these signals on the same replication
track is indicative of re-replication events caused by two or more
rounds of activation of the same replication origin. As shown in
Figure 7A, the levels of re-replication were below 5% in wild-
typemegakaryocytes aswell as in Cdk1- or Cdk2-singlemutants
in agreement with previous data in other control cultures
(Dorn et al., 2009; Neelsen et al., 2013). However, about 15%–
17% of labeled DNA replication tracks from both Cdk1(D/D);
Cdk2("/") and Cdc20(D/D); Cdk1(D/D); Cdk2("/") megakaryo-
cytes corresponded to re-replication events, indicating a poten-
tial loss of control over origin licensing in the absence of these
two kinases.
Alternative Polyploidy Cycles Can Drive Proplatelet
and Platelet Formation
To understand whether megakaryocytes were functional in the
presence of alternative polyploidization mechanisms, we next
performed proplatelet formation assays ex vivo. Five days after
TPO-induced differentiation of bone marrow progenitors,
24% ± 2% (mean ± SEM) of wild-type endomitotic megakaryo-
cytes were able to form proplatelets (Figure 7B). Cdk1(D/D)
megakaryocytes displayed a similar percentage of proplatelet-
bearing cells (21% ± 2%; Figures 7B and 7C). As a negative con-
trol, only 0.9%± 0.5% ofCdc20(D/D) megakaryocytes were able
to form proplatelets. Importantly, concomitant ablation of Cdk1
in a Cdc20 null background led to a significant rescue of propla-
telet formation (7.0% ± 0.4%) and this was further improved
in Cdc20(D/D); Cdk1(D/D); Cdk2("/") triple mutant cultures
(16% ± 3.5%; Figures 7B and 7C).
In agreement with these data, genetic ablation of Cdk1 was
able to significantly rescue thrombocytopenia in Cdc20 null
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mice. The mean number of circulating platelets increased from
114 ± 79 3 109 platelets/L in Cdc20(D/D) animals to 376 ±
18 3 109 platelets/L in Cdc20(D/D); Cdk1(D/D) double-mutant
mice (Figure 7D). Interestingly, concomitant ablation of one
or two alleles of Cdk2 further improved this rescue (598 ± 42 3
109 platelets/L in Cdc20(D/D); Cdk1(D/D); Cdk2(!/!) triple
mutants). Altogether, these results indicate that alternative
polyploidization mechanisms can result in functional megakar-
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Figure 6. Reprogramming Polyploidization
Rescue Defects in Cdc20-Deficient Mega-
karyocytes
(A) Representative bone marrow sections from the
indicated animals after staining with hematoxylin
and eosin (H&E) or immunohistochemical staining
for Von Willebrand factor (VWF), phospho-histone
H3 (pH3), or phosphorylated H2AX (gH2AX).
(B) Distribution of VWF signal per megakaryocyte.
Each dot represents an individual cell. n = 400 cells
and three mice per genotype. Student’s t test,
***p < 0.001.
(C) Ploidy distribution inside the bone marrow
CD41+ population after DAPI staining. The plot is
representative from three separate experiments.
Triple mutant bone marrows contain some poly-
ploid mitotic cells, in agreement with a partial
mitotic arrest imposed by Cdc20 loss, and a sig-
nificant percentage of cells with intermediate
levels of ploidy (Figure S5).
(D) Quantification of the mitotic index in mega-
karyocytes of the indicated genotypes. A repre-
sentative image or interphasic and mitotic mega-
karyocytes is shown.
(E) Quantification of interphasic nuclear shape
in megakaryocytes of the indicated genotypes.
Cdc20 null megakaryocytes are not included
because these cells are arrested in mitosis. At
least 350 cells from three different animals were
analyzed per genotype in (D) and (E). Data are
mean ± SEM; ***p < 0.001; Student’s t test.
See also Figure S5.
yocytes in vivo even in the presence of
re-replication events (Figure 7E).
DISCUSSION
Polyploidization provides an evolution-
arily conserved mechanism for postmi-
totic cell growth in unicellular and multi-
cellular organisms (Edgar et al., 2014;
Pandit et al., 2013). The increase in ploidy
can be achieved by variants of the cell
cycle that have been analyzed in detail
in Drosophila and Arabidopsis due to the
availability of multiple genetic models
(Edgar et al., 2014). In the mouse, poly-
ploidization has been mostly studied in
trophoblast giant cells and hepatocytes,
two cell types that undergo endocycling
or acytokinetic mitosis. In trophoblast
giant cells, mitosis is prevented by inhibi-
tion of Cdk1 activity by multiple mechanisms such as induction
of the p57Kip2 Cdk inhibitor, or by enhanced APC/C-Cdh1 activity
that results in the ubiquitin-dependent degradation of mitotic
cyclins (Garcı´a-Higuera et al., 2008; Ullah et al., 2008; Zielke
et al., 2013).
Early assays in stimulated megakaryocytes in vitro concluded
that polyploidization in these cells is achieved by endomitotic
cycles in which cells skip the later stages of mitosis and
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cytokinesis (reviewed in Ravid et al., 2002). Recent data using
time-lapse microscopy indicates different dynamics in furrow
formation between low- and high-ploidy megakaryocytes
(Lordier et al., 2008; Papadantonakis et al., 2008). The resulting
cells usually display a single polylobulated nucleus as a conse-
quence of chromosome decondensation and nuclear envelope
re-formation after aborted anaphase. The fact that more than
80% of mature megakaryocytes arrest in mitosis in the absence
of Cdc20 (Figure 2) supports the notion that endomitosis is the
major polyploidization mechanism for megakaryocytes in vivo.
The requirements for other mitotic regulators are unclear and
separate observations in the past suggested contradictory
data on the relevance of the expression of several mitotic regu-
lators such as Cdk-cyclin complexes or mitotic regulators during
endomitosis (Vitrat et al., 1998; Zhang et al., 1996). Recent data
indicate that mature megakaryocytes do not display a major
defect in the expression of the mitotic machinery (Sher et al.,
2013), although differences in specific RhoA exchange factors
or non-muscle myosins may explain defects in furrow formation
in high-ploidy megakaryocytes (Gao et al., 2012; Lordier et al.,
2008, 2012). Aurora B, an enzyme essential for error correction
during microtubule-kinetochore attachment, is dispensable for
megakaryocytes in vivo (Figure 1), in agreement with previous
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Figure 7. Functional Polyploidization in the
Absence of Cdk1 or Cdk1 and Cdk2
(A) Representative pictures of two independent
DNA fiber stretch assays in bone marrow-derived
megakaryocytes on day 4 after TPO stimulation. In
re-replicated tracks, the green (IdU) and red (CldU)
signals overlap resulting in a yellow signal. Fiber
integrity was monitored with an anti-ssDNA anti-
body (white). The percentage of re-replicated
tracks in the indicated genotypes is indicated. For
each sample at least 500 measurements were
performed. Data represent mean ± SEM.
(B) Pro-platelet (PPT; arrows) formation in bone
marrow-derived megakaryocytes analyzed 5 days
after TPO stimulation. Bottom: samples were
stained for a-tubulin (green) and DNA (DAPI; blue).
(C) The percentage of PPT-forming megakaryo-
cytes was estimated by counting cells exhibiting 1
or more cytoplasmic protrusions with areas of
platelet swellings as it is indicated by black arrows
in (B). At least 300 cells were analyzed per group.
Data represent mean ± SEM.
(D) Blood platelet levels in 8- to 14-week-old mice
with the indicated genotypes. Each dot represents
an individual animal. In (A), (C), and (D), Student’s
t test; ns, not significant. *p < 0.5; **p < 0.01;
***p < 0.001.
(E) A model indicating the mechanisms for poly-
ploidization in wild-type megakaryocytes (G1-S-
G2-endoM) or megakaryocytes deficient in Cdk1
(G-S-G) or Cdk1; Cdk2 double mutants (re-repli-
cation in S phase).
data showing that chemical inhibition
of this kinase does not prevent polyploid-
ization and maturation of these cells
(Lordier et al., 2010; Wen et al., 2012).
Thus, whereas most mitotic genes are
expressed in megakaryocytes, some of them may be dispens-
able due to the lack of ordered separation of chromosomes
during mitotic exit.
Here, we have found that genetic ablation of Cdk1 results in
bypass ofmitosis inmegakaryocytes (Figures 3 and 4), a process
that has also been observed in some cell lines (Hochegger et al.,
2007) or in hepatocytes (Diril et al., 2012), a cell type known to
undergo endocycling upon different stress conditions (Gupta,
2000). Importantly, Cdk1-deficient megakaryocytes not only
can increase ploidy using endocycles, but also generate normal
levels of proplatelets in vitro and platelets in vivo (Figures 3, 4,
and 7).
Unconventional cell cycles such as endomitosis or endo-
cycles maintain a mechanism to enable the oscillation in Cdk
and APC/C activity, thus ensuring the periodic relicensing of
DNA for replication. Loss of this control leads to re-replication
(also known as over-replication), a process in which some ori-
gins can be relicensed and refired before the whole genome
has been duplicated once, resulting in genome compositions
that differ from multiples of the normal ploidy (Arias and Walter,
2007). Apart from its physiological role in the amplification of
specific genes during the development of the Drosophila ovary
(Calvi et al., 1998; Claycomb et al., 2004), re-replication is
Developmental Cell 32, 155–167, January 26, 2015 ª2015 Elsevier Inc. 163
considered an aberrant process that does not appear to occur
as part of any developmental program in mammals. Pioneering
experiments by Nurse and colleagues showed that Cdks play a
dual role in triggering replication initiation and limiting DNA
replication to a single round per cell cycle by inhibiting relicens-
ing of origins within a single S phase (Broek et al., 1991; Dah-
mann et al., 1995). In mammals, both Cdk1 and Cdk2 can pre-
vent the function of the replication complex by phosphorylating
multiple regulators such as Cdt1, Cdc6, Orc1, or MCM pro-
teins, or by preventing polymerase activity (reviewed in Zhu,
2004). Depletion of Cdk1 and/or Cdk2 has been linked to re-
replication phenomena in cell lines although in many cases
these data are confusing given the use of different nomencla-
ture or the lack of direct techniques, such as DNA fiber analysis
to monitor these changes. Whereas Cdk1 is essential for the
mammalian cell cycle (Diril et al., 2012; Santamarı´a et al.,
2007), Cdk2 ablation in somatic cells does not result in major
defects in the mitotic cell cycle, likely as a consequence of
compensation by other Cdks (Berthet et al., 2003; Ortega
et al., 2003). Interestingly, concomitant ablation of these two
Cdks in megakaryocytes results in re-replication events, a phe-
nomenon that cannot be easily repaired and leads to DNA
breaks and apoptosis in other cell types (Arias and Walter,
2007; Neelsen et al., 2013). In Drosophila, polyploidy occurs
in the absence of DNA-damage induced apoptosis (Hassel
et al., 2014; Mehrotra et al., 2008). Similarly, megakaryocytes
seem to be tolerant to the aberrant ploidy resulting from re-
replication, probably as a consequence of the upregulation of
prosurvival proteins to progress safely through proplatelet for-
mation and platelet shedding (Josefsson et al., 2011). Thus,
Cdk1;Cdk2-deficient megakaryocytes provide a model for
functional re-replication in mammals.
These data also suggest that, although Cdk1 and Cdk2 may
eventually participate in triggering DNA replication inmammalian
cells (Moore et al., 2003; Santamarı´a et al., 2007), they are both
dispensable for S phase entry, at least in the presence of other
interphase Cdks. Although dispensable for G1/S transition, our
work indicates that Cdk2 is essential to prevent re-replication
in the absence of Cdk1, an interesting observation given the
lack of essential functions for this protein in mammals (Berthet
et al., 2003; Malumbres and Barbacid, 2009; Ortega et al.,
2003), and the possible use of Cdk1/Cdk2 inhibitors to trigger
lethal re-replication in tumor cells.
Strikingly, by modulating Cdk activity in megakaryocytes
in vivo, we found that alternative polyploidization mechanisms
besides endomitosis can lead to highly polyploid and mature
megakaryocytes. The fact that reprogrammed megakaryocytes
are functional even in the presence of DNA damage and absence
of discrete ploidy peaks (Figure 5), suggests that the major,
if not the only, function of polyploidization is to increase cell
size for platelet generation (Thon and Italiano, 2012). Because
endomitosis is one of the modified cell cycles least variant
from the archetypal cell cycle, a simple interpretation suggests
that megakaryocytes (which do not reach the higher ploidy levels
observed in other cells such as trophoblast giant cells; >1,000C)
simply select the smaller degeneration of the mitotic cell cycle
required for expansion of progenitors to become polyploid.
The slight defects in platelet levels in Cdk1- or Cdk1; Cdk2 null
mice and the incomplete rescue induced by lack of these
kinases in Cdc20-deficient mice may indicate that, although
endocycling or re-replication can be functionally used during
megakaryocyte polyploidization, they may be less efficient
than endomitosis. As an attractive possibility, it has been
recently proposed that the multilobulated nuclei generated
during mitosis may participate in the establishment of the forces
required for membrane fragmentation during the formation of
proplatelets (Eckly et al., 2014).
In addition to its critical role as part of developmental or stress
programs, polyploidization can also be a quick route to aneu-
ploidy and genome instability (Davoli and de Lange, 2011; Pandit
et al., 2013). Recent data have shown that inhibition of Aurora
kinases as well as Cdk1 or Cdk2 in megakaryocytic leukemia
cells leads not only to increased ploidy, but also to the expres-
sion of differentiationmarkers (Wen et al., 2012). Thus, polyploid-
ization not only accompanies, but also can actually trigger the
differentiation process in megakaryocytes. Because Cdk1 is
essential for mitosis in all cells tested, it can be expected that
the differentiation process induced by Cdk1 inhibition (Wen
et al., 2012) is actually mediated by endocycling rather than
endomitosis, although this has not been tested in detail. The
fact that mitotic kinases such as Aurora A, Aurora B, or Cdk1
are not required for the function of endomitotic or endocycling
cells, while being essential for mitotic cell cycles, opens new
avenues in the use of inhibitors against these proteins in thera-
peutic approaches against specific human cancers (Krause
and Crispino, 2013).
EXPERIMENTAL PROCEDURES
Mouse Colony and Histological Analysis
Mice deficient in Aurora-B (Ferna´ndez-Miranda et al., 2011), Cdc20
(Manchado et al., 2010), or Cdk2 (Ortega et al., 2003), and the Pf4-Cre (Tiedt
et al., 2007) and LSL-Katushka (Die´guez-Hurtado et al., 2011) tool lines have
been described previously (Supplemental Experimental Procedures). Expres-
sion of Cre in bone marrow cells does not alter polyploidization of megakaryo-
cytes (Wen et al., 2009). The Cdk1 conditionally allele will be reported
elsewhere (C.E.S, D.S., and M.B., unpublished data). Mice were housed in
the pathogen-free animal facility of the Centro Nacional de Investigaciones
Oncolo´gicas (Madrid) following the animal care standards of the institution.
All animal protocols were approved by the local committee for animal care
and research. The following antibodies were used for immunohistochemistry
in tissue sections: von Willebrand factor (FVIII, Dako; 1:2000), phospho-his-
tone H3 (Ser10; Millipore; 1:2000) or g-H2AX (Ser139, Millipore; 1:2,000). For
quantification, paraffin sections stained with anti-VWF were examined using
an Olympus BX51 microscope equipped with objective lenses (40/0.75, 20/
0.4, 10/0.25, and 4/0.1). The relative amount of pixels positive for VWF was
used as a score.
Cytometry
Flow cytometric analysis of DNA content and surface markers of megakaryo-
cytes was determined by staining either whole bone marrow cells or hema-
topoietic progenitor cultures from 0 to 5 days in the presence of TPO with
fluorescein isothiocyanate (FITC)-conjugated anti-CD41 antibody (BD Biosci-
ences) followed by fixation with 4% paraformaldehyde at room temperature
for 30 min followed by staining with 2 mg/ml 40,6-diamidino-2-phenylindole
(DAPI; Sigma-Aldrich) or 5 mg/ml Hoechst (Sigma-Aldrich) for 1 hr. See
also the Supplemental Experimental Procedures.
Megakaryocyte Differentiation and Functional Assays
Cells from the bone marrow or fetal liver were isolated as indicated in the
Supplemental Experimental Procedures. Lin! cells were grown in Dulbecco’s
modified Eagle’s medium (DMEM; GIBCO) supplemented with antibiotics
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and 10% fetal bovine serum (FBS), and stimulated with 50–100 ng/ml murine
TPO (PeproTech) during at least 5 days. For functional assays, the cell pop-
ulation was enriched in mature megakaryocytes either by using a 1.5%/3%
BSA gradient under gravity (1 3 g) for 45 min or by cell sorting using
CD41 staining after 4–5 days of culture in the presence of TPO. Proplatelet
formation assays were performed essentially as described previously (Blu-
teau et al., 2014).
Protein Analysis and Immunofluorescence
For immunodetection in protein lysates, proteins were separated on SDS-
PAGE, transferred to nitrocellulose membranes (BioRad), and probed using
specific primary antibodies against Cdk1 (Santa Cruz Biotechnology; 1:500)
and vinculin (Sigma; 1:3,000) as a loading control. For immunofluorescence,
cells were fixedwith 4%paraformaldehyde in PBS for 10min at 37!C, permea-
bilized with PBS-Triton 0.15% for 2 min at 37!C, blocked with 3% BSA, and
subsequently incubated 1–3 hr with the primary antibody against Aurora B
(Abcam; 1:200) or a-tubulin (Sigma; 1:2,000). Matching secondary antibodies
with different Alexa dyes (488, 594, 647; Molecular Probes) and DAPI (Prolong
Gold antifade; Invitrogen) were used for depiction of the nuclei. Image acqui-
sition was performed using either a confocal ultra-spectral microscope (Leica
TCS-SP5) or a Leica DMI fluorescence 6000B microscope.
Time-Lapse Microscopy
Cells were transduced with lentiviruses or retroviruses encoding histone H2B-
GFP, lamin A-CFP (a gift from V. Andre´s, CNIC, Madrid), and geminin-mCherry
(Abe et al., 2013). Transduced cells were then plated on eight-well glass-
bottom dishes (Ibidi) embedded in methylcellulose containing Iscove’s
modified Dulbecco’s medium with 2% FBS and 100 ng/ml murine TPO, to
minimize cell movement. Time-lapse acquisition was performed with a Leica
DMI 6000B microscope equipped with a 633/1.5 N.A. objective lens or
DeltaVision RT imaging system (Applied Precision; IX70/71; Olympus) equip-
ped with a Plan Apochromatic 403/1.42 N.A. objective lens, and maintained
at 37!C in a humidified CO2 chamber. Images were acquired every 7 min for
up to 10 days. Quantitative analysis was performed with ImageJ software.
DNA Fiber Assay
For the analysis of DNA replication in stretched DNA fibers, cells were pro-
cessed using a protocol modified from Neelsen et al., 2013. Essentially, cells
were incubated in presence of 50 mM CldU (5-clorodeoxyuridine) for 2 hr
and pulsed for 30 min with 250 mM IdU (5-iododeoxyuridine). One drop con-
taining 500–700 cells was placed on a microscope slide and cells were lysed
with the addition of 10 ml lysis buffer (0.5%SDS, Tris [pH 7.4], EDTA 50mM) for
6 min at room temperature. Slides were tilted at a 10!–15! angle to allow the
DNA suspension to run slowly down the slide. Slides were air-dried and fixed
in 3:1 v/v methanol:acetic acid. Following DNA denaturation with 2.5 M HCl for
30 min, DNA fibers were washed and blocked with PBS, 1% BSA, 0.1% Triton
X-100, and incubated with primary antibodies against CldU and IdU (Abcam
and Becton Dickinson; 1:100). Matching secondary antibodies conjugated
to Alexa dyes (488, 594, 647) were used for signal depiction. Single-stranded
DNA (ssDNA) was stained with a specific antibody (anti-ssDNA mouse mono-
clonal IgG2a; Millipore) to ensure the analysis of individual fibers. Image acqui-
sition was performed using a Leica DMI fluorescence 6000B microscope.
At least 500 replication tracks containing green signal were scored in each
condition, and the percentage of re-replication events (yellow tracks) in the
total population of green tracks was analyzed.
Statistical Analysis
Statistical analysis was carried out using Prism 5 (GraphPad). All statistical
tests were performed using two-sided, unpaired Student’s t tests, or the
Fisher’s exact test. Data with p < 0.05 were considered statistically significant.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures
and five figures and can be found with this article online at http://dx.doi.org/
10.1016/j.devcel.2014.12.015.
AUTHOR CONTRIBUTIONS
M.T. performed most cellular and mouse experiments. M. Maroto helped with
the quantification of histological samples. M.T., S.R.-A., and J.M. performed
re-replication analyses in stretched DNA fibers. C.E.S, D.S., and M.B. gener-
ated the Cdk1(lox) allele and S.O. generated the Katushka allele. M. Malum-
bres conceived and supervised the project. M.T. and M. Malumbres analyzed
the data and wrote the manuscript.
ACKNOWLEDGMENTS
We are fully indebted to V. Andre´s (CNIC, Madrid, Spain) and A. Miyawaki
(RIKEN, Saitama, Japan) for reagents. We thank Ana Pe´rez for technical help,
Lola Martı´nez and Diego Megı´as (CNIO) for help with cytometry and micro-
scopy analysis, members of the Comparative Pathology and Transgenic Units
of the CNIO for excellent technical support, and Sara Leceta and Sheila Rueda
for help with animal management.We also thankMiguel Torres andGuadalupe
Sabio (CNIC) for help with blood counters. M.T. received a fellowship from the
Foundation La Caixa. This work was funded by grants from the Foundation Ra-
mo´n Areces, Spanish Ministry of Economy and Competitiveness (MINECO;
SAF2012-38215 to M.Malumbres, SAF2010-18765 to S.O., and BFU2010-
21467 and CSD2007-00015 to J.M.), Red Tema´tica CellSYS (BFU2014-
52125-REDT) and Red Consolider OncoBIO (SAF2014-57791-REDC), the
OncoCycle Programme (S2010/BMD-2470 to M. Malumbres and M.B.) from
the Comunidad de Madrid, and the European Union Seventh Framework Pro-
gramme (MitoSys project; HEALTH-F5-2010-241548 to M. Malumbres).
Received: July 7, 2014
Revised: October 31, 2014
Accepted: December 17, 2014
Published: January 26, 2015
REFERENCES
Abe, T., Sakaue-Sawano, A., Kiyonari, H., Shioi, G., Inoue, K., Horiuchi, T.,
Nakao, K., Miyawaki, A., Aizawa, S., and Fujimori, T. (2013). Visualization
of cell cycle in mouse embryos with Fucci2 reporter directed by Rosa26
promoter. Development 140, 237–246.
Arias, E.E., and Walter, J.C. (2007). Strength in numbers: preventing
rereplication via multiple mechanisms in eukaryotic cells. Genes Dev. 21,
497–518.
Berthet, C., Aleem, E., Coppola, V., Tessarollo, L., and Kaldis, P. (2003). Cdk2
knockout mice are viable. Curr. Biol. 13, 1775–1785.
Bluteau, D., Balduini, A., Balayn, N., Currao, M., Nurden, P., Deswarte, C.,
Leverger, G., Noris, P., Perrotta, S., Solary, E., et al. (2014).
Thrombocytopenia-associated mutations in the ANKRD26 regulatory region
induce MAPK hyperactivation. J. Clin. Invest. 124, 580–591.
Broek, D., Bartlett, R., Crawford, K., and Nurse, P. (1991). Involvement of
p34cdc2 in establishing the dependency of S phase on mitosis. Nature 349,
388–393.
Calvi, B.R., Lilly, M.A., and Spradling, A.C. (1998). Cell cycle control of chorion
gene amplification. Genes Dev. 12, 734–744.
Claycomb, J.M., Benasutti, M., Bosco, G., Fenger, D.D., and Orr-Weaver, T.L.
(2004). Gene amplification as a developmental strategy: isolation of two devel-
opmental amplicons in Drosophila. Dev. Cell 6, 145–155.
Dahmann, C., Diffley, J.F., and Nasmyth, K.A. (1995). S-phase-promoting
cyclin-dependent kinases prevent re-replication by inhibiting the transition of
replication origins to a pre-replicative state. Curr. Biol. 5, 1257–1269.
Davoli, T., and de Lange, T. (2011). The causes and consequences of poly-
ploidy in normal development and cancer. Annu. Rev. Cell Dev. Biol. 27,
585–610.
Die´guez-Hurtado, R., Martı´n, J., Martı´nez-Corral, I., Martı´nez, M.D.,
Megı´as, D., Olmeda, D., and Ortega, S. (2011). A Cre-reporter transgenic
mouse expressing the far-red fluorescent protein Katushka. Genesis 49,
36–45.
Developmental Cell 32, 155–167, January 26, 2015 ª2015 Elsevier Inc. 165
Diril, M.K., Ratnacaram, C.K., Padmakumar, V.C., Du, T., Wasser, M.,
Coppola, V., Tessarollo, L., and Kaldis, P. (2012). Cyclin-dependent kinase 1
(Cdk1) is essential for cell division and suppression of DNA re-replication but
not for liver regeneration. Proc. Natl. Acad. Sci. USA 109, 3826–3831.
Dorn, E.S., Chastain, P.D., 2nd, Hall, J.R., and Cook, J.G. (2009). Analysis of
re-replication from deregulated origin licensing by DNA fiber spreading.
Nucleic Acids Res. 37, 60–69.
Eckly, A., Heijnen, H., Pertuy, F., Geerts, W., Proamer, F., Rinckel, J.Y., Le´on,
C., Lanza, F., andGachet, C. (2014). Biogenesis of the demarcationmembrane
system (DMS) in megakaryocytes. Blood 123, 921–930.
Edgar, B.A., and Orr-Weaver, T.L. (2001). Endoreplication cell cycles: more for
less. Cell 105, 297–306.
Edgar, B.A., Zielke, N., andGutierrez, C. (2014). Endocycles: a recurrent evolu-
tionary innovation for post-mitotic cell growth. Nat. Rev. Mol. Cell Biol. 15,
197–210.
Ferna´ndez-Miranda, G., Trakala, M., Martı´n, J., Escobar, B., Gonza´lez, A.,
Ghyselinck, N.B., Ortega, S., Can˜amero, M., Pe´rez de Castro, I., and
Malumbres, M. (2011). Genetic disruption of aurora B uncovers an essential
role for aurora C during early mammalian development. Development 138,
2661–2672.
Gao, Y., Smith, E., Ker, E., Campbell, P., Cheng, E.C., Zou, S., Lin, S., Wang,
L., Halene, S., and Krause, D.S. (2012). Role of RhoA-specific guanine ex-
change factors in regulation of endomitosis in megakaryocytes. Dev. Cell 22,
573–584.
Garcı´a-Higuera, I., Manchado, E., Dubus, P., Can˜amero, M., Me´ndez, J.,
Moreno, S., andMalumbres,M. (2008). Genomic stability and tumour suppres-
sion by the APC/C cofactor Cdh1. Nat. Cell Biol. 10, 802–811.
Geddis, A.E., Fox, N.E., Tkachenko, E., and Kaushansky, K. (2007).
Endomitotic megakaryocytes that form a bipolar spindle exhibit cleavage
furrow ingression followed by furrow regression. Cell Cycle 6, 455–460.
Gupta, S. (2000). Hepatic polyploidy and liver growth control. Semin. Cancer
Biol. 10, 161–171.
Hassel, C., Zhang, B., Dixon, M., and Calvi, B.R. (2014). Induction of endo-
cycles represses apoptosis independently of differentiation and predisposes
cells to genome instability. Development 141, 112–123.
Hochegger, H., Dejsuphong, D., Sonoda, E., Saberi, A., Rajendra, E., Kirk, J.,
Hunt, T., and Takeda, S. (2007). An essential role for Cdk1 in S phase control
is revealed via chemical genetics in vertebrate cells. J. Cell Biol. 178,
257–268.
Josefsson, E.C., James, C., Henley, K.J., Debrincat, M.A., Rogers, K.L.,
Dowling, M.R., White, M.J., Kruse, E.A., Lane, R.M., Ellis, S., et al. (2011).
Megakaryocytes possess a functional intrinsic apoptosis pathway that
must be restrained to survive and produce platelets. J. Exp. Med. 208,
2017–2031.
Kaushansky, K. (2008). Historical review: megakaryopoiesis and thrombopoi-
esis. Blood 111, 981–986.
Krause, D.S., and Crispino, J.D. (2013). Molecular pathways: induction of poly-
ploidy as a novel differentiation therapy for leukemia. Clin. Cancer Res. 19,
6084–6088.
Lordier, L., Jalil, A., Aurade, F., Larbret, F., Larghero, J., Debili, N.,
Vainchenker,W., andChang, Y. (2008). Megakaryocyte endomitosis is a failure
of late cytokinesis related to defects in the contractile ring and Rho/Rock
signaling. Blood 112, 3164–3174.
Lordier, L., Chang, Y., Jalil, A., Aurade, F., Garc¸on, L., Le´cluse, Y., Larbret, F.,
Kawashima, T., Kitamura, T., Larghero, J., et al. (2010). Aurora B is dispens-
able for megakaryocyte polyploidization, but contributes to the endomitotic
process. Blood 116, 2345–2355.
Lordier, L., Bluteau, D., Jalil, A., Legrand, C., Pan, J., Rameau, P., Jouni, D.,
Bluteau, O., Mercher, T., Leon, C., et al. (2012). RUNX1-induced silencing of
non-muscle myosin heavy chain IIB contributes to megakaryocyte polyploid-
ization. Nat. Commun. 3, 717.
Machlus, K.R., and Italiano, J.E., Jr. (2013). The incredible journey: From
megakaryocyte development to platelet formation. J. Cell Biol. 201, 785–796.
Malumbres, M., and Barbacid, M. (2009). Cell cycle, CDKs and cancer: a
changing paradigm. Nat. Rev. Cancer 9, 153–166.
Malumbres, M., Harlow, E., Hunt, T., Hunter, T., Lahti, J.M., Manning, G.,
Morgan, D.O., Tsai, L.H., and Wolgemuth, D.J. (2009). Cyclin-dependent ki-
nases: a family portrait. Nat. Cell Biol. 11, 1275–1276.
Manchado, E., Guillamot, M., de Ca´rcer, G., Eguren, M., Trickey, M., Garcı´a-
Higuera, I., Moreno, S., Yamano, H., Can˜amero, M., and Malumbres, M.
(2010). Targeting mitotic exit leads to tumor regression in vivo: modulation
by Cdk1, Mastl, and the PP2A/B55a,d phosphatase. Cancer Cell 18,
641–654.
Mehrotra, S., Maqbool, S.B., Kolpakas, A., Murnen, K., and Calvi, B.R. (2008).
Endocycling cells do not apoptose in response to DNA rereplication genotoxic
stress. Genes Dev. 22, 3158–3171.
Moore, J.D., Kirk, J.A., andHunt, T. (2003). Unmasking the S-phase-promoting
potential of cyclin B1. Science 300, 987–990.
Neelsen, K.J., Zanini, I.M., Mijic, S., Herrador, R., Zellweger, R., Ray
Chaudhuri, A., Creavin, K.D., Blow, J.J., and Lopes, M. (2013). Deregulated
origin licensing leads to chromosomal breaks by rereplication of a gapped
DNA template. Genes Dev. 27, 2537–2542.
Nezi, L., and Musacchio, A. (2009). Sister chromatid tension and the spindle
assembly checkpoint. Curr. Opin. Cell Biol. 21, 785–795.
Ortega, S., Prieto, I., Odajima, J., Martı´n, A., Dubus, P., Sotillo, R., Barbero,
J.L., Malumbres, M., and Barbacid, M. (2003). Cyclin-dependent kinase 2 is
essential for meiosis but not for mitotic cell division in mice. Nat. Genet. 35,
25–31.
Pandit, S.K., Westendorp, B., and de Bruin, A. (2013). Physiological
significance of polyploidization in mammalian cells. Trends Cell Biol. 23,
556–566.
Papadantonakis, N., Makitalo, M., McCrann, D.J., Liu, K., Nguyen, H.G.,
Martin, G., Patel-Hett, S., Italiano, J.E., and Ravid, K. (2008). Direct visualiza-
tion of the endomitotic cell cycle in living megakaryocytes: differential patterns
in low and high ploidy cells. Cell Cycle 7, 2352–2356.
Peters, J.M. (2006). The anaphase promoting complex/cyclosome: a machine
designed to destroy. Nat. Rev. Mol. Cell Biol. 7, 644–656.
Ravid, K., Lu, J., Zimmet, J.M., and Jones, M.R. (2002). Roads to polyploidy:
the megakaryocyte example. J. Cell. Physiol. 190, 7–20.
Sakaue-Sawano, A., Kurokawa, H., Morimura, T., Hanyu, A., Hama, H.,
Osawa, H., Kashiwagi, S., Fukami, K., Miyata, T., Miyoshi, H., et al. (2008).
Visualizing spatiotemporal dynamics of multicellular cell-cycle progression.
Cell 132, 487–498.
Sakaue-Sawano, A., Hoshida, T., Yo, M., Takahashi, R., Ohtawa, K., Arai, T.,
Takahashi, E., Noda, S., Miyoshi, H., and Miyawaki, A. (2013). Visualizing
developmentally programmed endoreplication in mammals using ubiquitin os-
cillators. Development 140, 4624–4632.
Santamarı´a, D., Barrie`re, C., Cerqueira, A., Hunt, S., Tardy, C., Newton, K.,
Ca´ceres, J.F., Dubus, P., Malumbres, M., and Barbacid, M. (2007). Cdk1 is
sufficient to drive the mammalian cell cycle. Nature 448, 811–815.
Sher, N., Von Stetina, J.R., Bell, G.W., Matsuura, S., Ravid, K., and Orr-
Weaver, T.L. (2013). Fundamental differences in endoreplication in mammals
and Drosophila revealed by analysis of endocycling and endomitotic cells.
Proc. Natl. Acad. Sci. USA 110, 9368–9373.
Thon, J.N., and Italiano, J.E., Jr. (2012). Does size matter in platelet produc-
tion? Blood 120, 1552–1561.
Tiedt, R., Schomber, T., Hao-Shen, H., and Skoda, R.C. (2007). Pf4-Cre
transgenic mice allow the generation of lineage-restricted gene knockouts
for studying megakaryocyte and platelet function in vivo. Blood 109, 1503–
1506.
Trakala, M., Ferna´ndez-Miranda, G., Pe´rez de Castro, I., Heeschen, C., and
Malumbres, M. (2013). Aurora B prevents delayed DNA replication and prema-
ture mitotic exit by repressing p21(Cip1). Cell Cycle 12, 1030–1041.
Ullah, Z., Kohn, M.J., Yagi, R., Vassilev, L.T., and DePamphilis, M.L. (2008).
Differentiation of trophoblast stem cells into giant cells is triggered by p57/
Kip2 inhibition of CDK1 activity. Genes Dev. 22, 3024–3036.
166 Developmental Cell 32, 155–167, January 26, 2015 ª2015 Elsevier Inc.
Vitrat, N., Cohen-Solal, K., Pique, C., Le Couedic, J.P., Norol, F., Larsen, A.K.,
Katz, A., Vainchenker, W., and Debili, N. (1998). Endomitosis of human mega-
karyocytes are due to abortive mitosis. Blood 91, 3711–3723.
Wen, Q., Leung, C., Huang, Z., Small, S., Reddi, A.L., Licht, J.D., and Crispino,
J.D. (2009). Survivin is not required for the endomitotic cell cycle of megakar-
yocytes. Blood 114, 153–156.
Wen, Q., Goldenson, B., Silver, S.J., Schenone, M., Dancik, V., Huang, Z.,
Wang, L.Z., Lewis, T.A., An,W.F., Li, X., et al. (2012). Identification of regulators
of polyploidization presents therapeutic targets for treatment of AMKL. Cell
150, 575–589.
Zhang, Y., Wang, Z., and Ravid, K. (1996). The cell cycle in polyploid megakar-
yocytes is associated with reduced activity of cyclin B1-dependent cdc2 ki-
nase. J. Biol. Chem. 271, 4266–4272.
Zhu, Y. (2004). Amodel for CDK2 inmaintaining genomic stability. Cell Cycle 3,
1358–1362.
Zielke, N., Edgar, B.A., and DePamphilis, M.L. (2013). Endoreplication. Cold
Spring Harb. Perspect. Biol. 5, a012948.
Zimmet, J., and Ravid, K. (2000). Polyploidy: occurrence in nature, mecha-
nisms, and significance for the megakaryocyte-platelet system. Exp.
Hematol. 28, 3–16.
Developmental Cell 32, 155–167, January 26, 2015 ª2015 Elsevier Inc. 167
Developmental Cell 
Supplemental Information 
Functional Reprogramming of Polyploidization  
in Megakaryocytes 
Marianna Trakala, Sara Rodríguez-Acebes, María Maroto, Catherine E. Symonds, David 
Santamaría, Sagrario Ortega, Mariano Barbacid, Juan Méndez, and Marcos Malumbres 
 
 
Supplementary Figures 
 
 
Figure S1. Genetic tools for megakaryocyte-specific ablation of cell cycle regulators (related to Figure 
1). a) Schematic representation of the LoxP-STOP-LoxP (LSL)- Katushka-fluorescent protein (KFP) reporter. 
b) Validation of Pf4-Cre activity using the LSL-KFP reporter in polyploid megakaryocytes. Bone marrow 
progenitors (lin-) carrying the Pf4-Cre and LSL-KFP alleles were stimulated in vitro in the presence of TPO and 
Cre activity was monitored by analyzing KFP. As shown in the histograms, three or four days after TPO 
treatment, most polyploid (≥8C) megakaryocytes express KFP as a consequence of the Cre-dependent 
excision of the STOP cassette, wheras less than half of the 4C cells and a very reduced percentage of 2C 
cells are positive for this marker. c) Immunodetection of Aurora B in low ploidy (2C-4C) or high ploidy (≥4C) 
megakaryocytes (CD41-positive cells) in the bone marrow from the indicated genotypes. E-actin was used as 
a loading control. d) The cumulative percentage of CD41+ cells (mean ± SEM) is similar in Aurkb('') and 
Aurkb() cultures (P>0.05; Student’s t-test) on days 2-5 after TPO stimulation of E13.5 fetal liver cells. e) 
Representative images of fetal liver-derived megakaryocytes 5 days after stimulation with TPO showing similar 
number and appearance of large megakaryocytes. Pro-platelet formation occurs in the absence of Aurora B as 
indicated by arrows in right lower panel. Scale bars, 50 Pm. 
 
 
 
 
 
Figure S2. High levels of hematopoietic progenitors as a consequence of severe thrombocytopenia in 
Cdc20('') mice (related to Figure 2). a) Immunodetection of Cdc20 in high ploidy (≥4C) megakaryocytes 
(CD41-positive cells) in the bone marrow from the indicated genotypes. E-actin was used as a loading control.  
b) Hematoxylin and eosin (H&E) staining and immunohistochemical staining for Von Willebrand Factor (VWF) 
in spleen sections from in 8-12 week-old animals with the indicated genotypes. Scale bars, 50 Pm. c) 
Percentage of hematopoietic progenitors from the bone marrow of Cdc20('') and control in 8-12 week-old 
mice after FACS analysis with specific markers (see Extended Experimental Protocols). HSCs, Hematopoetic 
stem cells; CLPs, common lympoid progenitors; CMPs, Common myeloid progenitors; MEPs, megakaryocyte-
erythrocyte progenitors; GMPs, granulocyte-macrophage progenitors. n=5 mice per group d) Representative 
data and quantification of the CD41+ population after FACS analysis of total fetal liver (FL) cells from E12.5 
embryos or cells from the bone marrow (BM) of 8 week-old mice. n=3 mice per group. All graphs show mean ± 
SEM. Statistics were performed by Student’s t-test; ns, not significant; **, p<0.01; ***, p<0.001. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure S3. Time-lapse microscopy of endomitotic polyploidization in vitro (related to Figure 4). Time-
lapse microscopy of bone marrow derived megakaryocytes stably expressing histone-GFP (H2B-GFP; green), 
lamin-CFP (blue) and geminin-mCherry (Red). a) Representative pictures of an individual cell during the G1-S 
transition. Time=0 represents the exit from endomitosis characterized by degradation of geminin (red), 
decondensation of chromatin (green) and nuclear envelope reformation (blue). During G1-phase cells are 
negative for geminin and start to express it upon G1-S transition. During S-phase the increase in nuclear 
volume can be appreciated. b) Representative images of an individual cell during endomitosis. Endomitosis is 
characterized by chromatin condensation and the absence of nuclear envelope, resulting in the pancellular 
distribution of geminin, which is exclusively nuclear during interphase. In late stages of endomitosis, geminin is 
degraded and nuclear envelope reforms and chromatin decondenses. c) Plots showing the relative units of 
geminin-mCherry mean fluorescent intensity, H2B-GFP mean fluorescent intensity, and nuclear and cellular 
volume during the endomitotic cell cycle in a representative megakaryocyte. The purple frame depicts 
endomitosis (M). 
 
 
 
 
 
 
Figure S4. Time-lapse microscopy of endocycling Cdk1-deficient cells in vitro (related to Figure 4). a) 
Time-lapse microscopy of bone marrow derived Cdk1('') megakaryocytes stably expressing histone-GFP 
(H2B-GFP; green) and geminin-mCherry (Red). Time=0 was arbitrarily set. Geminin is degraded (at ~17-18 h) 
in the absence of mitosis; i.e. without nuclear envelope breakdown (as detected by the absence of nuclear-to-
cytoplasmic redistribution of geminin, and absence of DNA condensation). During G1 cells are negative for 
geminin and start to express it at the G1-S transition. b) Plots showing the relative units of geminin-mCherry 
mean fluorescent intensity, H2B-GFP mean fluorescent intensity, and nuclear and cellular volume during the 
endoreplication process in a representative Cdk1('') megakaryocyte. c) Time-lapse microscopy of 
megakaryocytes expressing geminin (green), lamin (blue) and KFP (red). d) Immunodetection of Cdk1 in 
CD41-positive cells isolated from the bone marrow of Pf4-Cre; Cdk1('/'); LSL-KFP or Pf4-Cre; Cdk1(/); 
LSL-KFP animals. KFP-positive (+) or negative (-) cells were isolated by flow cytometry. E-actin was used as a 
loading control. e) Quantification from (c); most KFP-positive Cdk1-null megakaryocytes (n=12) undergo S-G-
S (endocycles) whereas all (n=14) KFP-positive control megakaryocytes display typical endomitotic cycles (M, 
endomitosis). 
 
 
 
  
Figure S5. Polyploidization and cell fate of megakaryocytes with Cdk1 and Cdk2-mutant alleles in a 
Cdc20-null background (related to Figure 6). a) Immunodetection of the indicated proteins in total 
megakaryocytes (CD41-positive cells) or high ploidy (≥4C) CD41-positive cells from the bone marrow. E-actin 
was used as a loading control. b) Analysis of mitosis (phospho-histone H3; P-H3 signal) in CD41+ bone 
marrow cells from wild-type or Cdc20(''); Cdk1(''); Cdk2() mice. The ploidy profiles of the whole 
CD41+ population (green), P-H3-positive (red) or P-H3-negative (blue) cells are shown. c) Quantification of 
cells with intermediate levels of ploidy (arrows). Three animals per genotype were analyzed. Data indicate 
mean ± SEM; *, p<0.5; Student’s t-test. d) Cell fate of individual Cdc20(''); Cdk1('') [left] or Cdc20(''); 
Cdk1(''); Cdk2() [right] bone marrow-derived megakaryocytes recorded by time-lapse microscopy. Cells 
stably expressed histone H2B-GFP, lamin-CFP and geminin-mCherry. Red and green boxes represent S-G2 
(gemininhigh) or G1 (gemininlow) phases, respectively. Endomitosis, prolonged in all cases as a consequence of 
lack of Cdc20, is illustrated as a black box surrounded by a purple frame and red circles represent cell death. 
 
 
 
Supplemental Experimental Procedures 
Mouse colony and histological analysis 
For genotyping the different alleles from the mouse models tail DNA was isolated from 3-4-week old 
mice and PCR amplification reactions were performed using the oligonucleotides described in the 
original manuscripts (Dieguez-Hurtado et al., 2011; Fernandez-Miranda et al., 2011; Manchado et al., 
2010; Ortega et al., 2003; Tiedt et al., 2007) Cdk1 mutant mice were genotyped using 
oligonucleotides Fw: 5’-GAGATGTAGGATGACTCAGTG-3’ and Rv: 5’-
TAGCTTATCTACCTCAGCCTG-3’, which generate amplification bands of 650 bp (wild-type allele) or 
800 bp (mutant allele). The following amplification conditions were used: 94ºC during 4 minutes 
followed by 35 cycles of DNA denaturalization at 94ºC during 30 seconds, primer annealing at 60ºC 
during 30 seconds and polymerase extension at 72ºC during 60 seconds ending with a single 
elongation cycle of 7 minutes at 72ºC. For histology sections, sterna and spleens were fixed 
overnight in 4% formalin. Sterna were then decalcified in Decalcifier I solution (Surgipath) for 2 hours. 
Samples were dehydrated in 70% ethanol and processed by the Histopathology Facility Unit at CNIO 
for 3-5 Pm longitudinal paraffin sections, hematoxylin and eosin staining, or immunohistochemistry. 
 
Isolation of bone marrow or fetal liver cells and cytometry 
For bone marrow derived megakaryocytes, the tibia and femur were isolated from 8-12 week old 
mice and bone marrow was flushed out by the addition of ice-cold PBS buffer (PBS, 0.5% BSA, 5mM 
EDTA) through the lumen of the bone. Marrow was mechanically disrupted to achieve single cell 
suspension followed by filtering through a 40Pm nylon strainer to remove bone debris and 
subsequently subjected to erythrocyte lysis. For red blood cell lysis the bone marrow cell pellet from 1 
mouse was resuspended in 1 ml of ACK lysis buffer (150 mM ammonium chloride, 1 mM potassium 
bicarbonate, 0.1 mM EDTA) and incubated for 1.5 min on ice. The lysis was stopped by the addition 
of 10 ml PBS buffer and cells were centrifuged at 200g for 10 min. Cells were counted and subjected 
either directly to surface antigen staining for flow cytometry analysis or to lineage depletion with the 
Miltenyi MACS (magnetic cell shorting) Hematopoietic Progenitor (Stem) Cell Enrichment Set, 
according to manufacturer’s protocol. For fetal liver derived megakaryocytes, cells were obtained 
from whole livers recovered from mouse fetuses between embryonic days 12.5 and 13.5. Single-cell 
suspensions were prepared by successive passage through 19-, 22-, and 25-gauge needles. 
To determine mouse bone marrow hematopoietic stem cells (HSC; Lin IL7R c-kit+ Sca+), 
common lymphoid progenitors (CLP; Lin IL7R+ c-kit+ Sca+), common myeloid progenitors (CMP; Lin 
IL7R c-kit+ Sca CD34+, FcJRlow), megakaryocyte, erythroid progenitors (MEP;  Lin IL7R- c-kit+ Sca 
CD34, FcJRlow), granulocyte, macrophage progenitors (GMP; Lin IL7R c-kit+ Sca CD34+, 
FcJRhigh), and megakaryocyte progenitors (LinCD41+) cells, freshly obtained BM cells were stained 
with phycoerythrin (PE) anti-CD34 (BD Biosciences), Alexa Fluor 488 anti- IL7Ra,  peridinin 
chlorophyll Protein Cyanin 5.5 (PerCP-Cy 5.5 anti–Sca-1, allophycocyanin-H7 (APC-H7) anti-cKit (BD 
 
 
Biosciences), phycoerythrin-cyanin 7 (PE-Cy7) anti-FcJR (BD Biosciences) and allophycocyanin 
(APC) -labeled lineage cell detection cocktail (BD Biosciences). Flow cytometric analysis was 
performed with a FACS-Canto flow cytometer or a LSRII flow cytometer (BD Biosciences) and 
FlowJo Version 8.8.7 software (TreeStar). 
 
Virus preparation 
For preparation of viruses, low passage 293T cells were transfected with the vector of interest and 
the three packaging vectors expressing gag, pol and rev proteins necessary for virion production as 
well the envelope protein vsvg (Tiscornia et al., 2006). 48 h post transfection supernatants containing 
viruses were collected and concentrated by centrigufation at 19.400 rpm for 2 hours at 20 ºC. Viral 
pellets were resuspended in 1x HBSS. This viral preparation is of in vitro grade quality. For 
retroviruses, 293T cells were transfected with the vector of interest and the packaging vector PCL-
Eco. Supernatants were collected and 48 hours post transfection. Packaging vectors are a gift from 
Dr. Verma´s lab. Transduction of primary megakaryocytes and Lin- bone marrow cells were 
performed by adding 10 Pl of concentrated virus (stock 109 viral particles per mL) per million of cells 
(MOI 10) for 12 h. 
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Genetic Characterization of the Role of the Cip/Kip Family of
Proteins as Cyclin-Dependent Kinase Inhibitors and Assembly Factors
Antonio Cerqueira,a* Alberto Martín,a* Catherine E. Symonds,a Junko Odajima,a* Pierre Dubus,b Mariano Barbacid,a
David Santamaríaa
Experimental Oncology, Molecular Oncology Program, Centro Nacional de Investigaciones Oncológicas (CNIO), Madrid, Spaina; Université Bordeaux, Bordeaux, Franceb
The Cip/Kip family, namely, p21Cip1, p27Kip1, and p57Kip2, are stoichiometric cyclin-dependent kinase inhibitors (CKIs). Para-
doxically, they have been proposed to also act as positive regulators of Cdk4/6-cyclin D by stabilizing these heterodimers. Loss of
p21Cip1 and p27Kip1 reduces Cdk4/6-cyclin D complexes, although with limited phenotypic consequences compared to the em-
bryonic lethality of Cdk4/6 or triple cyclin D deficiency. This milder phenotype was attributed to Cdk2 compensatory mecha-
nisms. To address this controversy using a genetic approach, we generated Cdk2!/! p21!/! p27!/!mice. Triple-knockout
mouse embryonic fibroblasts (MEFs) displayed minimal levels of D-type cyclins and Cdk4/6-cyclin D complexes. p57Kip2 down-
regulation in the absence of p21Cip1 and p27Kip1 aggravated this phenotype, yet MEFs lacking all Cip/Kip proteins exhibited in-
creased retinoblastoma phosphorylation, together with enhanced proliferation and transformation capacity. In vivo, Cdk2 abla-
tion induced partial perinatal lethality in p21!/! p27!/!mice, suggesting partial Cdk2-dependent compensation. However,
Cdk2!/! p21!/! p27!/! survivors displayed all phenotypes described for p27!/!mice, including organomegalia and pituitary
tumors. Thus, Cip/Kip deficiency does not impair interphasic Cdk activity even in the absence of Cdk2, suggesting that their
Cdk-cyclin assembly function is dispensable for homeostatic control in most cell types.
Extracellular signals that promote cell proliferation are trans-duced via growth factor receptor-associated protein kinases
and a plethora of downstream signaling pathways. A significant
fraction of these pathways converges on the regulation of the cell
cycle by the cyclin-dependent kinases (Cdks) (1). In a simplified
scenario, Cdk activity is controlled not only by cyclin binding but
also by interaction with Ink4 and the Cip/Kip family of cyclin-
dependent kinase inhibitors (CKIs). However, formation of
Cdk4-cyclin D functional heterodimers is largely inefficient, sug-
gesting the requirement of assembly factors for stable complex
formation (2). Indeed, Cip/Kip inhibitors have been implicated in
the assembly of functional Cdk4/6-cyclin D complexes as well as
on their import to the nucleus (3–5). Remarkably, some reports
suggest that the Cdk4/6-cyclin D-Cip/Kip complexes remain ac-
tive, since the majority of the Cdk4/6-cyclin D kinase activity in
culture cells is found to be associated with Cip/Kip inhibitors (3,
6).Moreover, Cdk4/6-cyclin D complexes are nearly undetectable
in extracts from mouse embryonic fibroblasts (MEFs), liver cells,
or thymocytes frommice devoid of p21Cip1 and p27Kip1 (4). In this
scenario, the unopposed activity of Cdk2 has been proposed to
compensate for the severe reduction in Cdk4/6-cyclin D levels
caused by Cip/Kip deficiency (4, 5). Together, these observations
led to the hypothesis that Cip/Kip inhibitors are assembly fac-
tors for the formation of Cdk4/6-cyclin D complexes and that a
substantial fraction of these ternary complexes retains catalytic
activity (7).
However, other reports have described that Cdk4/6-cyclin D
complexes, albeit reduced and short-lived, readily form in the ab-
sence of p21Cip1 and p27Kip1 either in asynchronous cultures (8, 9)
or during cell cycle reentry from quiescence (5). Even though the
levels of Cdk4/6-cyclin D complexes were undetectable by West-
ern blot analysis, cells remained sensitive to p16Ink4a, suggesting
the existence of active Cdk4/6-cyclin D complexes (4). In addi-
tion, there are different reports regarding the extent of inhibition
caused by Cip/Kip binding on the catalytic activity of Cdk4-cyclin
D complexes (3–6, 8, 10, 11). These observations have led to the
hypothesis that p21Cip1 and p27Kip1 are dispensable for the forma-
tion of active Cdk4/6-cyclin D complexes and that their binding
results in stable but inactive ternary complexes (9).
To evaluate in vivo the impact of Cip/Kip deficiency on the
formation and stability of Cdk4/6-cyclin D complexes, we set up
crosses to eliminate Cdk2 inmice doubly deficient for p21Cip1 and
p27Kip1. We have analyzed the proliferation and transformation
properties of Cdk2!/! p21!/! p27!/! MEFs as well as evaluated
the impact of Cdk2 elimination in the phenotypes found in
p21Cip1- and p27Kip1-deficient mice. The findings reported here
support the notion that the Cip/Kip function as pan-Cdk inhibi-
tors prevails over their role as Cdk4/6-cyclin assembly factors. As
a consequence p21!/! p27!/! cells and mice display various hy-
perproliferative phenotypes that are all preserved even in the con-
comitant absence of Cdk2.
MATERIALS AND METHODS
Mouse strains. Cdk2!/!, p21!/!, and p27!/!mice have been previously
described (12). Tissue samples were fixed in 10% buffered formalin for 24
h and embedded in paraffin, and 3-"m sections were analyzed after stain-
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ing with hematoxylin-eosin (H&E). Histopathological analysis of p21!/!
p27!/! Cdk2!/! embryonic day 18.5 (E18.5) embryos and paired con-
trols was performed by thorough inspection of H&E-stained serially sec-
tioned specimens (n " 7). The mice used in this study have been main-
tained in amixed 129/SvJ#C57BL/6J background according to theGuide
for the Care andUse of Laboratory Animals (13) and in accordancewith the
Spanish Animal Protection Law (RD1201/2005) and the European Direc-
tive (86/609/CEE) established by the European Union to regulate animal
care standards. Animal experiments received approval from the CNIO
ethical committee (CEUCA code 032-03).
Cell culture assays. MEFs were isolated from E13.5 embryos and
propagated according to standard protocols. No less than 10 independent
early-passage primary MEF preparations per genotype were used to per-
form the experiments. Proliferation assays and S-phase entry analysis
were carried out with primaryMEFs as previously described (14). Knock-
down of p57Kip2 was mediated with lentiviral Mission short hairpin RNA
(shRNA) plasmids (Sigma no. SHGLY-NM_009876.2) according to the
manufacturer’s instructions. After infection, cells were selected with 2
$g/ml puromycin for 48 h. Focus formation assays were performed as
described previously (12).
Protein analysis. Protein lysates were prepared and used for immu-
noblotting as previously described (12). Antibodies against the following
proteins were used: Cdk2 (M2; Santa Cruz), Cdk4 (C22; Santa Cruz),
Cdk6 (our own rabbit polyclonal antibodies), cyclin D1 (DCS6; Neo
Markers), cyclin D2 (M-20; Santa Cruz), cyclin D3 (DCS22; Cell Signal-
ing), cyclin A2 (H432; Santa Cruz), p21Kip1 (C19; Santa Cruz), p27Kip1
(catalog no. 610242; BD Transduction Laboratories), p57Kip2 (catalog no.
P0357; Sigma), %-actin (clone AC15; Sigma), and phospho-specific anti-
body to phosphorylated residues S807/811 of the retinoblastoma protein
(pRb; catalog no. 9308; Cell Signaling). As secondary antibodies, peroxi-
dase-conjugated IgG (Dako) was used, followed by chemiluminescence
detection (ECL kit; Amersham).
RESULTS
Formation of Cdk4/6-cyclinD complexes in the absence of Cip/
Kip proteins. As illustrated in Fig. 1a, p21!/! p27!/!MEFs dis-
played a significant reduction in the overall cellular levels of the
three D-type cyclins and retained 5 to 10% of the cyclin D levels
present in wild-type cells. To determine whether the third mem-
ber of the Cip/Kip family of CKIs, p57Kip2, may contribute to the
stabilization of active Cdk-cyclin D complexes, we generated len-
tiviral particles expressing an shRNA against p57Kip2 and analyzed
its impact on cyclin D levels in wild-type and p21!/! p27!/! dou-
ble mutant MEFs. p57Kip2 depletion in p21!/! p27!/!MEFs, ir-
respective of the presence or absence of Cdk2, caused a further
decrease in the levels of expression of cyclins D1 and D2 and a
moderate decrease in the case of cyclin D3 (Fig. 1a). Interestingly,
we observed a negligible impact in wild-type controls. As ex-
pected, the reduction in the overall cellular levels of the D-type
cyclins resulted in a similar decrease in the amount of Cdk4-cyclin
D complexes, as determined by immunoprecipitation of the ki-
nase subunit (Fig. 1b). These results suggest that p57Kip2 contrib-
utes to the stabilization of Cdk4/6-cyclin D complexes, at least in
the absence of p21Cip1 and p27Kip1.
In order to determine whether the Cip/Kip proteins are essen-
tial for the formation or stabilization of the Cdk4-cyclin D1 com-
plexes, we matched the total levels of cyclin D1 in the immuno-
FIG1 Stability of Cdk-cyclinD complexes in the absence of Cip/Kip inhibitors. (a) Early-passage primaryMEFswere infectedwith lentiviral particles expressing
either an shRNA against p57Kip2 (p57) or a scramble control (Ct). Protein extracts were prepared, and the levels of a panel of cell cycle regulators were analyzed
by immunoblotting with antibodies elicited against the indicated proteins. Expression of%-actin served as a loading control. Results from two independentMEF
cultures are shown for p21!/! p27!/! (DKO) andCdk2!/! p21!/! p27!/! (TKO)mice. Cyc, cyclin. (b)Wild-type, p21!/! p27!/! (DKO), andCdk2!/! p21!/!
p27!/! (TKO) primary MEFs were infected with lentiviral particles expressing either an shRNA against p57Kip2 (p57) or a scramble control (Ct). Exponentially
growing cells were used to prepare whole-cell extracts, and the amount of Cdk4-cyclinD complexes was estimated by coprecipitation of cyclinD1with anti-Cdk4
antibodies. The levels of Cdk4, used as a loading control, are shown. WB, Western blotting. (c) The amount of starting whole-cell extract from both p21!/!
p27!/! (DKO) andCdk2!/! p21!/! p27!/! (TKO)MEFs was augmented to equal the cyclin D1 levels in the wild-type controls. The amount of Cdk4 (top) and
Cdk6 (middle) that was coimmunoprecipitatedwith cyclinD1 antibodies was detected byWestern blotting. CyclinD1 levels (bottom) are shown to demonstrate
equal estimation of the amount of starting material. Results from two independent MEF cultures are shown. (d) Western blotting of Cdk1 protein levels in
whole-cell extracts fromwild-type, p21!/! p27!/! (DKO), andCdk2!/! p21!/! p27!/! (TKO)MEFs. Expression of %-actin, which served as a loading control,
is shown. Results from two independentMEF cultures are shown. (e) In vitro kinase activity associated with Cdk1 immunoprecipitates obtained fromwild-type,
p21!/! p27!/! (DKO), and Cdk2!/! p21!/! p27!/! (TKO) MEFs. Histone H1 was used as the substrate (S). Results from two independent MEF cultures are
shown. Lanes WCE, whole-cell extract at a 1:10 dilution before immunoprecipitation (IP); lanes M, mock immunoprecipitate.
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precipitation assays by scaling up 9-fold the amount of the starting
whole-cell extract from p21!/! p27!/! and Cdk2!/! p21!/!
p27!/! MEFs. Technical difficulties owing to the much greater
decrease of cyclin D levels upon p57Kip2 knockdown prevented us
from including this condition in the assay. Nevertheless, under
these conditionswe compensated for the diminution in the overall
levels of cyclin D1 caused by the concomitant absence of p21Cip1
and p27Kip1, and when immunoprecipitated, it pulled down an
equal amount of Cdk4 and Cdk6 in all genotypes (Fig. 1c). This
result is in good agreement with those described in a previous
report suggesting that free D-type cyclins rapidly associate with
their Cdk4/6 cognate catalytic subunits (9), thus suggesting that
the kinetics of this association is independent of the Cip/Kip pro-
teins, limiting their role to the stabilization of preformed binary
complexes.
Finally, we investigated the expression levels and activity of
Cdk1, as it is a likely candidate to compensate for the reduced
activity of interphase Cdks.We found that whereas the expression
levels of Cdk1 are comparable in MEFs from mice of the three
genotypes, its activity is increased in p21!/! p27!/! and Cdk2!/!
p21!/! p27!/! cells compared to its activity in the wild-type con-
trols (Fig. 1d and e).
Proliferation properties ofCdk2!/!MEFs devoid of Cip/Kip
proteins. To determine the consequences of the reduced levels of
Cdk4/6-cyclin D complexes on cell cycle progression in the ab-
sence of Cip/Kip proteins, we examined the proliferation proper-
ties of primary p21!/! p27!/!MEFs. In parallel, we also analyzed
the proliferation of Cdk2!/! p21!/! p27!/! cells since it has been
proposed that in the absence of both Cip/Kip inhibitors Cdk2
could play a compensatory role by functionally replacing Cdk4/6-
cyclin D complexes (4, 5). As illustrated in Fig. 2a, p21!/! p27!/!
cells reproducibly displayed a growth advantage compared to the
wild-type controls under standard serum conditions. This growth
advantage was even more evident when cells were grown in 2%
serum, since under these conditions wild-type cells failed to
thrive, whereas MEFs devoid of p21Cip1 and p27Kip1 managed to
proliferate (Fig. 2b). Similar results were obtained in primary
MEFs also devoid of Cdk2, indicating that Cdk2 activity is not
responsible for driving cell proliferation in the absence of these
inhibitors. Finally, we assessed the effect of knocking down the
third member of the Cip/Kip family of CIKs, p57Kip2. shRNA-
mediated depletion of p57Kip2 caused a reduction in the prolifer-
ative rate compared to that for MEFs infected with control
shRNA, particularly under low-serum conditions (Fig. 2). This
result, together with the further decrease in the levels of the three
D-type cyclins (Fig. 1a), suggests that p57Kip2 may function as a
Cdk4/6-cyclinD assembly factor inMEFs, at least in the absence of
p21Cip1 and p27Kip1, yet the proliferation rate observed in the con-
comitant absence of the three CKIs, even in a Cdk2-null back-
ground, was consistently higher than that of wild-typeMEFs (Fig.
2). Altogether, these experiments suggest that in terms of cell pro-
liferation, the function of the Cip/Kip proteins as Cdk inhibitors
prevails over their putative role as Cdk4/6-cyclin D assembly fac-
tors inMEFs. The lack of an effect observed upon ablation of Cdk2
expression suggests that the cell cycle inhibitory activity of the
Cip/Kip proteins must be mediated through another Cdk, possi-
bly Cdk1, or by a Cdk-independent mechanism.
Next, we focused our attention on cell cycle reentry, a process
particularly reliant on Cdk activity (14). As illustrated in Fig. 3a,
serum-starved p21!/! p27!/!MEFs entered S phase with a higher
efficiency than wild-type control cells. Similar results were ob-
tained withCdk2!/! p21!/! p27!/!MEFs (Fig. 3a). Accordingly,
the phosphorylation of the Ser807/811 residues of the retinoblas-
toma protein (Rb) and the appearance of cyclin A2 were detected
at earlier time points compared to the times of appearance for the
wild-type controls (Fig. 3b). Importantly, when the G0 exit was
assessed in p57Kip2-depleted cells, the higher efficiency observed in
both p21!/! p27!/! and Cdk2!/! p21!/! p27!/! MEFs was no
longer evident (Fig. 3c), thus adding further evidence that p57Kip2
may participate in the assembly of Cdk4/6-cyclin complexes in
MEFs. This role of p57Kip2, which appears to be negligible in wild-
type cells (Fig. 1a), becomes evident in the absence of p21Cip1 and
p27Kip1, particularly under conditions that aremore dependent on
interphase Cdk activity, such as during proliferation under low-
serum conditions or during exit from quiescence.
Cellular transformation in the absence of p21Cip1 and
p27Kip1. To study the role of p21Cip1 and p27Kip1 in cellular trans-
formation, we infected primaryMEFs with retroviral particles ex-
pressing combinations of different oncogenes. Transformation
was subsequently assessed by focus formation (Fig. 4a). Single
H-RasG12V or E1a oncogenes did not significantly enhance trans-
formation, irrespective of the genotype (data not shown). The
maximal efficiency was achieved using concomitant expression of
both oncoproteins. In this context, cells lacking p27Kip1 expres-
sion displayed a minor (15%) increase in their transformation
ability compared to that for the wild-type controls. However, in-
FIG 2 Proliferation of primaryMEFs in the absence of Cip/Kip inhibitors. (a)
The proliferation of wild-type (Wt), p21!/! p27!/! (DKO), and Cdk2!/!
p21!/! p27!/! (TKO) primary MEFs in 10% fetal bovine serum (FBS) was
assessed upon infection with lentiviral particles expressing an shRNA against
p57Kip2 (sh p57) or a scramble control (sh Ctrl). Data are shown as means "
SDs (n# 3). (b) Same as for panel a, butMEFsweremaintained under limiting
serum conditions (2% fetal bovine serum). arb., arbitrary.
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fection of p21!/!MEFs or p21!/! p27!/! double mutant MEFs
resulted in a 2-fold increase, indicating that p21Cip1 and p27Kip1 do
not cooperate to prevent malignant transformation, at least in
vitro. Interestingly, loss of Cdk2 expression had no effect on the
ability of p21!/! p27!/! MEFs to become transformed by
H-RasG12V and E1a oncoproteins, indicating that Cdk2 does not
compensate for the low levels of Cdk4/6-cyclin D complexes.
Moreover, this also illustrates that Cdk2 does not play a role in
promoting cell transformation. Finally, we submitted these cells to
a standard 3T3 immortalization protocol. As expected, wild-type
primary MEFs entered replicative senescence after a few passages,
whereas p21!/! p27!/! cells bypassed the crisis period irrespec-
tive of their Cdk2 status (Fig. 4b).
Phenotypic characterization of p21!/! p27!/! Cdk2!/!
mice. In order to determine whether Cdk2 might compensate for
the reduced formation of Cdk4/6-cyclin D complexes in vivo, we
crossed p21!/!, p27"/!, and Cdk2"/!mice and scored the result-
ing genotypes at weaning (n# 439). As shown in Table 1, all the
possible genotypes matched the expected Mendelian ratio except
for those carrying a single Cdk2 allele (17.3% versus 25%; ratio,
0.69) or noCdk2 alleles (5.9% versus 12.5%; ratio, 0.47). Lethality
did not appear to occur in utero, since all possible genotypes were
present at the expected ratios when assayed during late embryo-
genesis (E18.5) (data not shown). We previously reported that
Cdk2 ablation in p27!/!mice did not result in increasedmortality
(15). Thus, the cause of death of p21!/! p27!/!Cdk2!/!neonates
must be associated with p21Cip1 deficiency. This postnatal lethality
appears to result from insufficient overall interphase Cdk activity,
since neonatal mortality was also observed in p21!/! p27!/!
Cdk2"/!mice, albeit to a lesser extent (ratio of surviving mice at
weaning, 0.69 versus 0.47). Previous studies using Cdk mutant
mice have linked interphase Cdk deficiency with embryonic or
neonatal lethality. For instance, mice lacking Cdk4 and Cdk2 died
at birth due to cardiac abnormalities, and mice deficient for the
three interphase Cdks, Cdk4, Cdk6, and Cdk2, died at midgesta-
tion primarily due to hematopoietic defects similar to those ob-
served in Cdk4 and Cdk6 double mutant mice. Careful histo-
pathological analysis in serial sections of E18.5 embryos failed to
uncover obvious defects that could account for their postnatal
lethality, including in those tissues affected by interphase Cdk de-
ficiency, such as fetal hematopoietic organs and heart. Thus, the
cause of death of Cdk2!/! p21!/! p27!/! mice before weaning
remains unknown.
We next focused our attention on the characterization of adult
mice. Ablation of p27 alleles results in increased body size, espe-
cially in females (12, 16, 17). This and other phenotypic changes
associated with p27!/! deficiency were mainly attributed to aug-
mented Cdk activity. Thus, we examined whether the reduced
levels of Cdk4/6-cyclin D activity in p21!/! p27!/! mice might
revert the phenotypic changes seen in p27!/! animals. Parallel
experiments were carried out in p21!/! p27!/! Cdk2!/! mice,
which displayed even lower levels of interphase Cdk activity. To
this end, we monitored body weight changes from weaning. As
represented in Fig. 5, all compound strains devoid of p27Kip1 dis-
played elevated body weights, regardless of their intrinsic Cdk
activity. Moreover, all organs with the exception of liver showed
FIG3 Role ofCip/Kip proteins in cell cycle reentry. (a) Percentage ofwild-type (Wt), p21!/! p27!/! (DKO), andCdk2!/! p21!/! p27!/! (TKO)primaryMEFs
in S phase at the indicated times following serum stimulation from quiescence. Data are shown as means$ SDs (n# 3). (b) Whole-cell extracts from cells for
which the results are shown in panel awere prepared at the times (in hours) following serum stimulation fromquiescence indicated above each lane. The presence
of cyclinD1 and cyclinA2 and the phosphorylation of the Ser807/811 residues of the retinoblastomaprotein (pRb)were detected byWestern blotting. Expression
of%-actin, which served as a loading control, is shown. (c) p57Kip2was depleted inwild-type, p21!/! p27!/! (DKO), andCdk2!/! p21!/! p27!/! (TKO)primary
MEFs by lentivirus-mediated shRNA delivery. Infected MEFs were subsequently made quiescent by serum deprivation. The percentage of S-phase cells at the
indicated times (in hours) following serum stimulation from quiescence is shown. Data are shown as means$ SDs (n# 3).
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an increased weight (12, 16–18). Pathological examination of liv-
ers from p21!/! p27!/! Cdk2!/! mice showed that they did not
display detectable architectural or cytological defects, yet we
found that the hepatocyte density was consistently reduced com-
pared to that in age-matched p21!/! p27!/! controls (Fig. 5b and
c). Since the livers of newborn p21!/! p27!/!Cdk2!/!mice were
phenotypically normal (data not shown), the liver hypoplasiamay
progressively arise during postnatal development. Taken together,
these results suggest that the majority of tissues and cell types in
adult mice tolerate the combined deficiency of p21Cip1 and
p27Kip1.
Finally, we examined whether these p21!/! p27!/! and/or
p21!/! p27!/! Cdk2!/! mutant mice may show defects in the
proliferation of insulin-producing pancreatic "-cells, which are
exquisitely dependent on the presence of Cdk4 activity for proper
proliferation (18–20). All mutant mice were normoglycemic dur-
ing the course of the study (data not shown). Unlike Cdk4!/!
animals, histological analysis of pancreatic sections failed to detect
either quantitative or qualitative variations in"-cell islets in any of
the tested mice (n# 21) (data not shown). These results illustrate
that in vivo, the decline in Cdk4/6-cyclin D complexes caused by
ablation of the p21Cip1 and p27Kip1 alleles is not sufficient to phe-
nocopy the defects caused by the loss of Cdk4 activity.
Tumorigenesis in p21!/! p27!/! mice. Finally, we analyzed
the tumor spectrum of p21!/! p27!/! double-knockout mice. As
previously reported, p21Cip1-null mice developed a variety of
spontaneous tumors at an average age of 16 months (21). p27Kip1
deficiency resulted in the appearance of aggressive pituitary tu-
mors, and allmice succumbed by 1 year of age (12, 16, 17). p21Cip1
p27Kip1-null animals died of pituitary tumors with a timing and
pathology indistinguishable from those for the single mutant
p27!/! controls, indicating that p21Cip1 does not compensate for
the absence of p27Kip1 (Fig. 6). In contrast, the loss of p27Kip1
appears to cooperate with the absence of p21Cip1, at least in accel-
erating tumor development, since about a quarter of the p21!/!
p27!/!mice displayed histiocytic sarcomas at a time (10months)
when none of the p21!/! animals had developed such tumors
(21–23) (Table 2). We also recorded the appearance of new pa-
thologies in p21!/! p27!/! double mutant mice that were absent
in either single-knockout strain. They included a panel of precan-
cerous lesions, such as gastric hyperplasia, pancreatic intraepithe-
lial neoplasia (PanIN), andmyeloproliferation (Table 2). The pre-
mature death associated with p27Kip1 deficiency prevented us
from studying the evolution of these lesions.
DISCUSSION
In our hands, primary p21!/! p27!/!MEFs displayed enhanced
proliferative properties compared to the wild-type controls (Fig.
2). Interestingly, and in agreement with previous reports, these
cells retained only 5% of the cellular Cdk4-cyclin D1 complexes
found in thewild-type controls. As a side note, this is equivalent to
the fraction of p27Kip1 that appears to be tyrosine phosphorylat-
ed—and presumably noninhibitory—in asynchronous cells (23),
suggesting that a minor proportion of active Cdk4/6-cyclin D
complexes suffices to support unperturbed proliferation. Impor-
tantly, the enhanced proliferative capacity observed in p21!/!
p27!/!MEFs was also present in Cdk2!/! p21!/! p27!/!MEFs
(Fig. 2), discarding the possibility that Cdk2 is the putative com-
pensatory mechanism that has been postulated to ameliorate the
proliferation of p21!/! p27!/! cells (4, 5). Altogether, these re-
sults suggest that in terms of cell proliferation, the Cip/Kip func-
tion as pan-Cdk inhibitors is overwhelmingly more relevant than
their role as Cdk4/6-cyclin D assembly factors.
It has also been proposed that Cdk4/6-cyclin D complexes per-
form a relevant noncatalytic role to favor cell proliferation. Ac-
cording to this model, these complexes act as a molecular sink for
Cip/Kip proteins, titrating them away from Cdk2 and therefore
facilitating its subsequent activation (7). Indeed, no free p27Kip1
can be detected in vivo (23). Cdk4/6 double-knockout cells have a
lower proliferative capacity than wild-type controls (24). Interest-
FIG 4 Cip/Kip factors and cellular transformation. (a) Equal amounts of
wild-type, p21!/!, p27!/!, as well as compound mutant p21!/! p27!/!
(DKO) and Cdk2!/! p21!/! p27!/! (TKO)MEFs were infected with retrovi-
ral particles coexpressing H-Ras and E1a oncogenes. (Left) At 3 weeks after
infection, the number of detectable foci was scored for the different genotypes.
Data are shown as means$ SDs (n# 3). (Right) A representative image upon
crystal violet staining is shown. (b) Immortalization of wild-type, p21!/! and
p27!/! single-knockout, p21!/! p27!/! (DKO), andCdk2!/! p21!/! p27!/!
(TKO) primary MEFs following a classical 3T3 protocol. Data are shown as
means$ SDs (n# 3).
TABLE 1 Influence of p21Cip1, p27Kip1, and Cdk2 deficiency on
postnatal survivala
Genotype Mendelian ratiob (%)
Cdk2 p21 p27 Expected Observed
%/% !/! %/! 12.5 18.7
%/% !/! !/! 12.5 11.6
%/! !/! %/! 25 31
%/! !/! !/! 25 17.3
!/! !/! %/! 12.5 15.5
!/! !/! !/! 12.5 5.9
a Data are for 439 mice.
b The expected and observed Mendelian ratios of the indicated genotypes were scored at
weaning (postnatal day 21).
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ingly, p21!/! p27!/! MEFs, which display a severe (20-fold) re-
duction of Cdk-cyclinD complexes, have the opposite phenotype.
This suggests that in wild-type MEFs, the Cip/Kip titration func-
tion of Cdk4/6-cyclin Dmight prevail over their catalytic activity.
Indeed, a cyclin D1 mutant that forms kinase-inactive complexes
with Cdk4/6 efficiently rescues the developmental defects present
in cyclin D1!/!mice (25). Although this could also be attributed
to Cdk-independent functions of cyclin D1, we cannot rule out
the possibility that in particular cellular contexts the sequestration
function of Cdk4/6-cyclin D complexes is dominant over their
catalytic activity.
We have also shown that p57Kip2, the third component of the
Cip/Kip family, participates in vivo in the stabilization of Cdk4-
FIG 5 Influence of p21Cip1 and p27Kip1 deficiency in adult homeostasis. (a) Total body weight and the weight of the indicated individual organs of mice at 11
weeks of age. Values for p27!/!, p21!/! p27!/! (DKO), andCdk2!/! p21!/! p27!/! (TKO)mice normalized to those for wild-type controls of the same age are
represented. Data are shown as means" SDs (n# 4). (b) Representative images of hematoxylin-eosin-stained liver sections from 11-week-old p21!/! p27!/!
(DKO) andCdk2!/! p21!/! p27!/! (TKO)mice. Bars, 20$m. (c)Quantification of the total number of hepatocytes in four randomly selected%400microscope
fields of liver sections from p21!/! p27!/! (DKO) and Cdk2!/! p21!/! p27!/! (TKO) mice. Data are shown as means" SDs (n# 7).
FIG 6 Cooperation between p21Cip1 and p27Kip1 tumor suppressors. Survival
curve of p21!/!, p27!/!, p21!/! p27!/! (DKO), andCdk2!/! p21!/! p27!/!
(TKO) mice.
TABLE 2 Tumor susceptibility in mice lacking p21Cip1 and p27Kip1
Lesion type and lesion or
pathology
% of mice that developed lesions or
pathologya
p21!/! p27!/!
mice (n# 21)
p27!/!
mice
(n# 11)
p21!/!
mice
(n# 13)
Hyperplasia/tumor-related
lesions
Gastric neuroendocrine
hyperplasia
43 0 0
Gastric mucosa hyperplasia 57 0 0
Histiocytic sarcoma 24 0 0
Myeloproliferation 43 0 0
PanIN 10 0 0
Inflammation/non-tumor-
related lesions
Arteritis 14 0 0
Bone metaplasia 24 0 0
Chronic nephropathy 81 45 23
Chronic pancreatitis 29 0 0
Retinal dysplasia 38 19 0
a Animals were sacrificed at 10 months of age. Numbers are rounded up to the nearest
digit.
Genetic Analysis of Cip/Kip Family Cell Cycle Function
April 2014 Volume 34 Number 8 mcb.asm.org 1457
 on M
ay 24, 2015 by CNIO
http://m
cb.asm
.org/
Downloaded from
 
cyclin D complexes, at least in the absence of p21Cip1 and p27Kip1.
shRNA-mediated depletion of p57Kip2 in p21!/! p27!/! MEFs
caused a further reduction ofCdk4-cyclinD1 complexes, reaching
levels undetectable by Western blotting (Fig. 1b), yet it is signifi-
cant that upon p57Kip2 depletion, Cdk2!/! p21!/! p27!/!MEFs
exited G0 with kinetics comparable to that of the wild-type con-
trols. In this scenario, the Cdk1-cyclin D complexes that become
detectable in the absence of Cdk4 (14) may functionally replace
Cdk4/6-cyclin D complexes. This would imply that the assembly
of Cdk1-cyclin D complexes does not require Cip/Kip proteins or
may be facilitated by alternative assembly factors. In this respect,
p34Sei1 has been described to be an alternative Cdk-cyclin D as-
sembly factor, particularly during quiescence exit (5). We believe
that our Cdk2!/! p21!/! p27!/! mouse model may become a
useful tool to elucidate whether indeed other assembly factors
exist or if Cdk-cyclin D complexes can form de novo.
It is also possible that the required levels of Cdk-cyclin D com-
plexes (and, therefore, the importance of their assembly factors)
are cell type specific. Whereas p21!/! p27!/! mice reach adult-
hood with the expected Mendelian ratio, Cdk4/6 double-knock-
out (DKO) mice die in utero as a consequence of hematopoietic
defects (24). This suggests that in vivo, redundant mechanisms or
the inherent plasticity of the system may bypass the requirement
for p21Cip1 and p27Kip1 proteins as Cdk4/6-cyclin D assembly fac-
tors in most cell types. We cannot rule out the possibility that this
adaptation was facilitated in part by the use of germ line null
alleles. For instance, whereas chronic deficiency of the retinoblas-
toma protein in MEFs allows adaptation and compensation
among other familymembers, this is largely inefficient upon acute
gene ablation (26). In any case, and in support of the functional
redundancy model, we show here that p57Kip2 stabilizes Cdk4-
cyclin D1 in p21!/! p27!/! MEFs but not in wild-type controls
(Fig. 1). In addition, others have demonstrated that a knockin of
p27Kip1 expressed from the p57Kip2 promoter can rescue most of
the developmental defects present in p57!/!mice, suggesting that
they perform partially redundant roles in vivo (27). Interestingly,
as described above, p57Kip2 knockdown in p21!/! p27!/! MEFs
caused an additional reduction of Cdk-cyclin complexes and af-
fected their proliferation rate, which, nevertheless, remained
higher than that of wild-type cells (Fig. 2b). Moreover, unlike
single- and double-knockout strains, 53% of Cdk2!/! p21!/!
p27!/! mice died perinatally (Table 1). The fact that this was
reduced to 31% by introducing a single Cdk2 allele suggests that
the lethality is a dose-dependent phenotype associated with insuf-
ficient interphase Cdk activity. Nevertheless, 47%of triple-knock-
out (TKO) animals reached adulthood and displayed a normal life
span, suggesting that the attainment of a Cdk activity threshold
compatible with life in the relevant target tissue(s) may rely on
several overlapping mechanisms yet to be fully characterized.
This also suggests that the cellular contextmay dictate which of
the seemingly opposed roles of Cip/Kip as Cdk-cyclin D assembly
factors versus Cdk inhibitors prevail, to an extent that under some
circumstances the Cip/Kip tumor suppressors counterintuitively
display oncogenic properties. For instance, oligodendrogliomas
with elevated p21Cip1 result in more aggressive disease (28). Inter-
estingly, in this tumor type the oncogenic function of p21Cip1 is a
direct consequence of its role as a Cdk4-cyclin D assembly factor
and is directly controlled by tyrosine phosphorylation (29, 30).
p27Kip1 is equally subject to regulation by tyrosine phosphoryla-
tion (23, 31, 32). Unfortunately, the only mouse model in which
p27Kip1 has been shown to promote tumor development relies on
a Cdk-independent function (33), thereby invalidating the option
to weigh the importance of the tyrosine phosphorylation control
(i.e., its role as an assembly factor) in p27Kip1-mediated cancer
promotion.
In sum, and in good agreement with previous observations
from different laboratories (34), our results emphasize the notion
that Cdk-dependent cell cycle control in multicellular organisms
is extremely robust and several overlapping mechanisms facilitate
not only the proper execution of cell division but also its timely
coordination with developmental processes, even in the concom-
itant absence of allegedly essential factors.
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The Cip/Kip family, namely, p21Cip1, p27Kip1, and p57Kip2, are stoichiometric cyclin-dependent kinase inhibitors (CKIs). Para-
doxically, they have been proposed to also act as positive regulators of Cdk4/6-cyclin D by stabilizing these heterodimers. Loss of
p21Cip1 and p27Kip1 reduces Cdk4/6-cyclin D complexes, although with limited phenotypic consequences compared to the em-
bryonic lethality of Cdk4/6 or triple cyclin D deficiency. This milder phenotype was attributed to Cdk2 compensatory mecha-
nisms. To address this controversy using a genetic approach, we generated Cdk2!/! p21!/! p27!/!mice. Triple-knockout
mouse embryonic fibroblasts (MEFs) displayed minimal levels of D-type cyclins and Cdk4/6-cyclin D complexes. p57Kip2 down-
regulation in the absence of p21Cip1 and p27Kip1 aggravated this phenotype, yet MEFs lacking all Cip/Kip proteins exhibited in-
creased retinoblastoma phosphorylation, together with enhanced proliferation and transformation capacity. In vivo, Cdk2 abla-
tion induced partial perinatal lethality in p21!/! p27!/!mice, suggesting partial Cdk2-dependent compensation. However,
Cdk2!/! p21!/! p27!/! survivors displayed all phenotypes described for p27!/!mice, including organomegalia and pituitary
tumors. Thus, Cip/Kip deficiency does not impair interphasic Cdk activity even in the absence of Cdk2, suggesting that their
Cdk-cyclin assembly function is dispensable for homeostatic control in most cell types.
Extracellular signals that promote cell proliferation are trans-duced via growth factor receptor-associated protein kinases
and a plethora of downstream signaling pathways. A significant
fraction of these pathways converges on the regulation of the cell
cycle by the cyclin-dependent kinases (Cdks) (1). In a simplified
scenario, Cdk activity is controlled not only by cyclin binding but
also by interaction with Ink4 and the Cip/Kip family of cyclin-
dependent kinase inhibitors (CKIs). However, formation of
Cdk4-cyclin D functional heterodimers is largely inefficient, sug-
gesting the requirement of assembly factors for stable complex
formation (2). Indeed, Cip/Kip inhibitors have been implicated in
the assembly of functional Cdk4/6-cyclin D complexes as well as
on their import to the nucleus (3–5). Remarkably, some reports
suggest that the Cdk4/6-cyclin D-Cip/Kip complexes remain ac-
tive, since the majority of the Cdk4/6-cyclin D kinase activity in
culture cells is found to be associated with Cip/Kip inhibitors (3,
6).Moreover, Cdk4/6-cyclin D complexes are nearly undetectable
in extracts from mouse embryonic fibroblasts (MEFs), liver cells,
or thymocytes frommice devoid of p21Cip1 and p27Kip1 (4). In this
scenario, the unopposed activity of Cdk2 has been proposed to
compensate for the severe reduction in Cdk4/6-cyclin D levels
caused by Cip/Kip deficiency (4, 5). Together, these observations
led to the hypothesis that Cip/Kip inhibitors are assembly fac-
tors for the formation of Cdk4/6-cyclin D complexes and that a
substantial fraction of these ternary complexes retains catalytic
activity (7).
However, other reports have described that Cdk4/6-cyclin D
complexes, albeit reduced and short-lived, readily form in the ab-
sence of p21Cip1 and p27Kip1 either in asynchronous cultures (8, 9)
or during cell cycle reentry from quiescence (5). Even though the
levels of Cdk4/6-cyclin D complexes were undetectable by West-
ern blot analysis, cells remained sensitive to p16Ink4a, suggesting
the existence of active Cdk4/6-cyclin D complexes (4). In addi-
tion, there are different reports regarding the extent of inhibition
caused by Cip/Kip binding on the catalytic activity of Cdk4-cyclin
D complexes (3–6, 8, 10, 11). These observations have led to the
hypothesis that p21Cip1 and p27Kip1 are dispensable for the forma-
tion of active Cdk4/6-cyclin D complexes and that their binding
results in stable but inactive ternary complexes (9).
To evaluate in vivo the impact of Cip/Kip deficiency on the
formation and stability of Cdk4/6-cyclin D complexes, we set up
crosses to eliminate Cdk2 inmice doubly deficient for p21Cip1 and
p27Kip1. We have analyzed the proliferation and transformation
properties of Cdk2!/! p21!/! p27!/! MEFs as well as evaluated
the impact of Cdk2 elimination in the phenotypes found in
p21Cip1- and p27Kip1-deficient mice. The findings reported here
support the notion that the Cip/Kip function as pan-Cdk inhibi-
tors prevails over their role as Cdk4/6-cyclin assembly factors. As
a consequence p21!/! p27!/! cells and mice display various hy-
perproliferative phenotypes that are all preserved even in the con-
comitant absence of Cdk2.
MATERIALS AND METHODS
Mouse strains. Cdk2!/!, p21!/!, and p27!/!mice have been previously
described (12). Tissue samples were fixed in 10% buffered formalin for 24
h and embedded in paraffin, and 3-"m sections were analyzed after stain-
Received 3 September 2013 Returned for modification 16 October 2013
Accepted 25 January 2014
Published ahead of print 10 February 2014
Address correspondence to David Santamaría, dsantamaria@cnio.es.
* Present address: Antonio Cerqueira, Progenitor Labs, Stevenage Bioscience
Catalyst, Stevenage, United Kingdom; Alberto Martín, Departamento de
Bioquímica, Instituto de Investigaciones Biomédicas Alberto Sols, CSIC-UAM,
Madrid, Spain; Junko Odajima, Department of Cancer Biology, Dana-Farber Cancer
Institute, Boston, Massachusetts, USA.
A.C. and A.M. contributed equally to this work.
Copyright © 2014, American Society for Microbiology. All Rights Reserved.
doi:10.1128/MCB.01163-13
1452 mcb.asm.org Molecular and Cellular Biology p. 1452–1459 April 2014 Volume 34 Number 8
 on M
ay 24, 2015 by CNIO
http://m
cb.asm
.org/
Downloaded from
 
ing with hematoxylin-eosin (H&E). Histopathological analysis of p21!/!
p27!/! Cdk2!/! embryonic day 18.5 (E18.5) embryos and paired con-
trols was performed by thorough inspection of H&E-stained serially sec-
tioned specimens (n " 7). The mice used in this study have been main-
tained in amixed 129/SvJ#C57BL/6J background according to theGuide
for the Care andUse of Laboratory Animals (13) and in accordancewith the
Spanish Animal Protection Law (RD1201/2005) and the European Direc-
tive (86/609/CEE) established by the European Union to regulate animal
care standards. Animal experiments received approval from the CNIO
ethical committee (CEUCA code 032-03).
Cell culture assays. MEFs were isolated from E13.5 embryos and
propagated according to standard protocols. No less than 10 independent
early-passage primary MEF preparations per genotype were used to per-
form the experiments. Proliferation assays and S-phase entry analysis
were carried out with primaryMEFs as previously described (14). Knock-
down of p57Kip2 was mediated with lentiviral Mission short hairpin RNA
(shRNA) plasmids (Sigma no. SHGLY-NM_009876.2) according to the
manufacturer’s instructions. After infection, cells were selected with 2
$g/ml puromycin for 48 h. Focus formation assays were performed as
described previously (12).
Protein analysis. Protein lysates were prepared and used for immu-
noblotting as previously described (12). Antibodies against the following
proteins were used: Cdk2 (M2; Santa Cruz), Cdk4 (C22; Santa Cruz),
Cdk6 (our own rabbit polyclonal antibodies), cyclin D1 (DCS6; Neo
Markers), cyclin D2 (M-20; Santa Cruz), cyclin D3 (DCS22; Cell Signal-
ing), cyclin A2 (H432; Santa Cruz), p21Kip1 (C19; Santa Cruz), p27Kip1
(catalog no. 610242; BD Transduction Laboratories), p57Kip2 (catalog no.
P0357; Sigma), %-actin (clone AC15; Sigma), and phospho-specific anti-
body to phosphorylated residues S807/811 of the retinoblastoma protein
(pRb; catalog no. 9308; Cell Signaling). As secondary antibodies, peroxi-
dase-conjugated IgG (Dako) was used, followed by chemiluminescence
detection (ECL kit; Amersham).
RESULTS
Formation of Cdk4/6-cyclinD complexes in the absence of Cip/
Kip proteins. As illustrated in Fig. 1a, p21!/! p27!/!MEFs dis-
played a significant reduction in the overall cellular levels of the
three D-type cyclins and retained 5 to 10% of the cyclin D levels
present in wild-type cells. To determine whether the third mem-
ber of the Cip/Kip family of CKIs, p57Kip2, may contribute to the
stabilization of active Cdk-cyclin D complexes, we generated len-
tiviral particles expressing an shRNA against p57Kip2 and analyzed
its impact on cyclin D levels in wild-type and p21!/! p27!/! dou-
ble mutant MEFs. p57Kip2 depletion in p21!/! p27!/!MEFs, ir-
respective of the presence or absence of Cdk2, caused a further
decrease in the levels of expression of cyclins D1 and D2 and a
moderate decrease in the case of cyclin D3 (Fig. 1a). Interestingly,
we observed a negligible impact in wild-type controls. As ex-
pected, the reduction in the overall cellular levels of the D-type
cyclins resulted in a similar decrease in the amount of Cdk4-cyclin
D complexes, as determined by immunoprecipitation of the ki-
nase subunit (Fig. 1b). These results suggest that p57Kip2 contrib-
utes to the stabilization of Cdk4/6-cyclin D complexes, at least in
the absence of p21Cip1 and p27Kip1.
In order to determine whether the Cip/Kip proteins are essen-
tial for the formation or stabilization of the Cdk4-cyclin D1 com-
plexes, we matched the total levels of cyclin D1 in the immuno-
FIG1 Stability of Cdk-cyclinD complexes in the absence of Cip/Kip inhibitors. (a) Early-passage primaryMEFswere infectedwith lentiviral particles expressing
either an shRNA against p57Kip2 (p57) or a scramble control (Ct). Protein extracts were prepared, and the levels of a panel of cell cycle regulators were analyzed
by immunoblotting with antibodies elicited against the indicated proteins. Expression of%-actin served as a loading control. Results from two independentMEF
cultures are shown for p21!/! p27!/! (DKO) andCdk2!/! p21!/! p27!/! (TKO)mice. Cyc, cyclin. (b)Wild-type, p21!/! p27!/! (DKO), andCdk2!/! p21!/!
p27!/! (TKO) primary MEFs were infected with lentiviral particles expressing either an shRNA against p57Kip2 (p57) or a scramble control (Ct). Exponentially
growing cells were used to prepare whole-cell extracts, and the amount of Cdk4-cyclinD complexes was estimated by coprecipitation of cyclinD1with anti-Cdk4
antibodies. The levels of Cdk4, used as a loading control, are shown. WB, Western blotting. (c) The amount of starting whole-cell extract from both p21!/!
p27!/! (DKO) andCdk2!/! p21!/! p27!/! (TKO)MEFs was augmented to equal the cyclin D1 levels in the wild-type controls. The amount of Cdk4 (top) and
Cdk6 (middle) that was coimmunoprecipitatedwith cyclinD1 antibodies was detected byWestern blotting. CyclinD1 levels (bottom) are shown to demonstrate
equal estimation of the amount of starting material. Results from two independent MEF cultures are shown. (d) Western blotting of Cdk1 protein levels in
whole-cell extracts fromwild-type, p21!/! p27!/! (DKO), andCdk2!/! p21!/! p27!/! (TKO)MEFs. Expression of %-actin, which served as a loading control,
is shown. Results from two independentMEF cultures are shown. (e) In vitro kinase activity associated with Cdk1 immunoprecipitates obtained fromwild-type,
p21!/! p27!/! (DKO), and Cdk2!/! p21!/! p27!/! (TKO) MEFs. Histone H1 was used as the substrate (S). Results from two independent MEF cultures are
shown. Lanes WCE, whole-cell extract at a 1:10 dilution before immunoprecipitation (IP); lanes M, mock immunoprecipitate.
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precipitation assays by scaling up 9-fold the amount of the starting
whole-cell extract from p21!/! p27!/! and Cdk2!/! p21!/!
p27!/! MEFs. Technical difficulties owing to the much greater
decrease of cyclin D levels upon p57Kip2 knockdown prevented us
from including this condition in the assay. Nevertheless, under
these conditionswe compensated for the diminution in the overall
levels of cyclin D1 caused by the concomitant absence of p21Cip1
and p27Kip1, and when immunoprecipitated, it pulled down an
equal amount of Cdk4 and Cdk6 in all genotypes (Fig. 1c). This
result is in good agreement with those described in a previous
report suggesting that free D-type cyclins rapidly associate with
their Cdk4/6 cognate catalytic subunits (9), thus suggesting that
the kinetics of this association is independent of the Cip/Kip pro-
teins, limiting their role to the stabilization of preformed binary
complexes.
Finally, we investigated the expression levels and activity of
Cdk1, as it is a likely candidate to compensate for the reduced
activity of interphase Cdks.We found that whereas the expression
levels of Cdk1 are comparable in MEFs from mice of the three
genotypes, its activity is increased in p21!/! p27!/! and Cdk2!/!
p21!/! p27!/! cells compared to its activity in the wild-type con-
trols (Fig. 1d and e).
Proliferation properties ofCdk2!/!MEFs devoid of Cip/Kip
proteins. To determine the consequences of the reduced levels of
Cdk4/6-cyclin D complexes on cell cycle progression in the ab-
sence of Cip/Kip proteins, we examined the proliferation proper-
ties of primary p21!/! p27!/!MEFs. In parallel, we also analyzed
the proliferation of Cdk2!/! p21!/! p27!/! cells since it has been
proposed that in the absence of both Cip/Kip inhibitors Cdk2
could play a compensatory role by functionally replacing Cdk4/6-
cyclin D complexes (4, 5). As illustrated in Fig. 2a, p21!/! p27!/!
cells reproducibly displayed a growth advantage compared to the
wild-type controls under standard serum conditions. This growth
advantage was even more evident when cells were grown in 2%
serum, since under these conditions wild-type cells failed to
thrive, whereas MEFs devoid of p21Cip1 and p27Kip1 managed to
proliferate (Fig. 2b). Similar results were obtained in primary
MEFs also devoid of Cdk2, indicating that Cdk2 activity is not
responsible for driving cell proliferation in the absence of these
inhibitors. Finally, we assessed the effect of knocking down the
third member of the Cip/Kip family of CIKs, p57Kip2. shRNA-
mediated depletion of p57Kip2 caused a reduction in the prolifer-
ative rate compared to that for MEFs infected with control
shRNA, particularly under low-serum conditions (Fig. 2). This
result, together with the further decrease in the levels of the three
D-type cyclins (Fig. 1a), suggests that p57Kip2 may function as a
Cdk4/6-cyclinD assembly factor inMEFs, at least in the absence of
p21Cip1 and p27Kip1, yet the proliferation rate observed in the con-
comitant absence of the three CKIs, even in a Cdk2-null back-
ground, was consistently higher than that of wild-typeMEFs (Fig.
2). Altogether, these experiments suggest that in terms of cell pro-
liferation, the function of the Cip/Kip proteins as Cdk inhibitors
prevails over their putative role as Cdk4/6-cyclin D assembly fac-
tors inMEFs. The lack of an effect observed upon ablation of Cdk2
expression suggests that the cell cycle inhibitory activity of the
Cip/Kip proteins must be mediated through another Cdk, possi-
bly Cdk1, or by a Cdk-independent mechanism.
Next, we focused our attention on cell cycle reentry, a process
particularly reliant on Cdk activity (14). As illustrated in Fig. 3a,
serum-starved p21!/! p27!/!MEFs entered S phase with a higher
efficiency than wild-type control cells. Similar results were ob-
tained withCdk2!/! p21!/! p27!/!MEFs (Fig. 3a). Accordingly,
the phosphorylation of the Ser807/811 residues of the retinoblas-
toma protein (Rb) and the appearance of cyclin A2 were detected
at earlier time points compared to the times of appearance for the
wild-type controls (Fig. 3b). Importantly, when the G0 exit was
assessed in p57Kip2-depleted cells, the higher efficiency observed in
both p21!/! p27!/! and Cdk2!/! p21!/! p27!/! MEFs was no
longer evident (Fig. 3c), thus adding further evidence that p57Kip2
may participate in the assembly of Cdk4/6-cyclin complexes in
MEFs. This role of p57Kip2, which appears to be negligible in wild-
type cells (Fig. 1a), becomes evident in the absence of p21Cip1 and
p27Kip1, particularly under conditions that aremore dependent on
interphase Cdk activity, such as during proliferation under low-
serum conditions or during exit from quiescence.
Cellular transformation in the absence of p21Cip1 and
p27Kip1. To study the role of p21Cip1 and p27Kip1 in cellular trans-
formation, we infected primaryMEFs with retroviral particles ex-
pressing combinations of different oncogenes. Transformation
was subsequently assessed by focus formation (Fig. 4a). Single
H-RasG12V or E1a oncogenes did not significantly enhance trans-
formation, irrespective of the genotype (data not shown). The
maximal efficiency was achieved using concomitant expression of
both oncoproteins. In this context, cells lacking p27Kip1 expres-
sion displayed a minor (15%) increase in their transformation
ability compared to that for the wild-type controls. However, in-
FIG 2 Proliferation of primaryMEFs in the absence of Cip/Kip inhibitors. (a)
The proliferation of wild-type (Wt), p21!/! p27!/! (DKO), and Cdk2!/!
p21!/! p27!/! (TKO) primary MEFs in 10% fetal bovine serum (FBS) was
assessed upon infection with lentiviral particles expressing an shRNA against
p57Kip2 (sh p57) or a scramble control (sh Ctrl). Data are shown as means "
SDs (n# 3). (b) Same as for panel a, butMEFsweremaintained under limiting
serum conditions (2% fetal bovine serum). arb., arbitrary.
Cerqueira et al.
1454 mcb.asm.org Molecular and Cellular Biology
 on M
ay 24, 2015 by CNIO
http://m
cb.asm
.org/
Downloaded from
 
fection of p21!/!MEFs or p21!/! p27!/! double mutant MEFs
resulted in a 2-fold increase, indicating that p21Cip1 and p27Kip1 do
not cooperate to prevent malignant transformation, at least in
vitro. Interestingly, loss of Cdk2 expression had no effect on the
ability of p21!/! p27!/! MEFs to become transformed by
H-RasG12V and E1a oncoproteins, indicating that Cdk2 does not
compensate for the low levels of Cdk4/6-cyclin D complexes.
Moreover, this also illustrates that Cdk2 does not play a role in
promoting cell transformation. Finally, we submitted these cells to
a standard 3T3 immortalization protocol. As expected, wild-type
primary MEFs entered replicative senescence after a few passages,
whereas p21!/! p27!/! cells bypassed the crisis period irrespec-
tive of their Cdk2 status (Fig. 4b).
Phenotypic characterization of p21!/! p27!/! Cdk2!/!
mice. In order to determine whether Cdk2 might compensate for
the reduced formation of Cdk4/6-cyclin D complexes in vivo, we
crossed p21!/!, p27"/!, and Cdk2"/!mice and scored the result-
ing genotypes at weaning (n# 439). As shown in Table 1, all the
possible genotypes matched the expected Mendelian ratio except
for those carrying a single Cdk2 allele (17.3% versus 25%; ratio,
0.69) or noCdk2 alleles (5.9% versus 12.5%; ratio, 0.47). Lethality
did not appear to occur in utero, since all possible genotypes were
present at the expected ratios when assayed during late embryo-
genesis (E18.5) (data not shown). We previously reported that
Cdk2 ablation in p27!/!mice did not result in increasedmortality
(15). Thus, the cause of death of p21!/! p27!/!Cdk2!/!neonates
must be associated with p21Cip1 deficiency. This postnatal lethality
appears to result from insufficient overall interphase Cdk activity,
since neonatal mortality was also observed in p21!/! p27!/!
Cdk2"/!mice, albeit to a lesser extent (ratio of surviving mice at
weaning, 0.69 versus 0.47). Previous studies using Cdk mutant
mice have linked interphase Cdk deficiency with embryonic or
neonatal lethality. For instance, mice lacking Cdk4 and Cdk2 died
at birth due to cardiac abnormalities, and mice deficient for the
three interphase Cdks, Cdk4, Cdk6, and Cdk2, died at midgesta-
tion primarily due to hematopoietic defects similar to those ob-
served in Cdk4 and Cdk6 double mutant mice. Careful histo-
pathological analysis in serial sections of E18.5 embryos failed to
uncover obvious defects that could account for their postnatal
lethality, including in those tissues affected by interphase Cdk de-
ficiency, such as fetal hematopoietic organs and heart. Thus, the
cause of death of Cdk2!/! p21!/! p27!/! mice before weaning
remains unknown.
We next focused our attention on the characterization of adult
mice. Ablation of p27 alleles results in increased body size, espe-
cially in females (12, 16, 17). This and other phenotypic changes
associated with p27!/! deficiency were mainly attributed to aug-
mented Cdk activity. Thus, we examined whether the reduced
levels of Cdk4/6-cyclin D activity in p21!/! p27!/! mice might
revert the phenotypic changes seen in p27!/! animals. Parallel
experiments were carried out in p21!/! p27!/! Cdk2!/! mice,
which displayed even lower levels of interphase Cdk activity. To
this end, we monitored body weight changes from weaning. As
represented in Fig. 5, all compound strains devoid of p27Kip1 dis-
played elevated body weights, regardless of their intrinsic Cdk
activity. Moreover, all organs with the exception of liver showed
FIG3 Role ofCip/Kip proteins in cell cycle reentry. (a) Percentage ofwild-type (Wt), p21!/! p27!/! (DKO), andCdk2!/! p21!/! p27!/! (TKO)primaryMEFs
in S phase at the indicated times following serum stimulation from quiescence. Data are shown as means$ SDs (n# 3). (b) Whole-cell extracts from cells for
which the results are shown in panel awere prepared at the times (in hours) following serum stimulation fromquiescence indicated above each lane. The presence
of cyclinD1 and cyclinA2 and the phosphorylation of the Ser807/811 residues of the retinoblastomaprotein (pRb)were detected byWestern blotting. Expression
of%-actin, which served as a loading control, is shown. (c) p57Kip2was depleted inwild-type, p21!/! p27!/! (DKO), andCdk2!/! p21!/! p27!/! (TKO)primary
MEFs by lentivirus-mediated shRNA delivery. Infected MEFs were subsequently made quiescent by serum deprivation. The percentage of S-phase cells at the
indicated times (in hours) following serum stimulation from quiescence is shown. Data are shown as means$ SDs (n# 3).
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an increased weight (12, 16–18). Pathological examination of liv-
ers from p21!/! p27!/! Cdk2!/! mice showed that they did not
display detectable architectural or cytological defects, yet we
found that the hepatocyte density was consistently reduced com-
pared to that in age-matched p21!/! p27!/! controls (Fig. 5b and
c). Since the livers of newborn p21!/! p27!/!Cdk2!/!mice were
phenotypically normal (data not shown), the liver hypoplasiamay
progressively arise during postnatal development. Taken together,
these results suggest that the majority of tissues and cell types in
adult mice tolerate the combined deficiency of p21Cip1 and
p27Kip1.
Finally, we examined whether these p21!/! p27!/! and/or
p21!/! p27!/! Cdk2!/! mutant mice may show defects in the
proliferation of insulin-producing pancreatic "-cells, which are
exquisitely dependent on the presence of Cdk4 activity for proper
proliferation (18–20). All mutant mice were normoglycemic dur-
ing the course of the study (data not shown). Unlike Cdk4!/!
animals, histological analysis of pancreatic sections failed to detect
either quantitative or qualitative variations in"-cell islets in any of
the tested mice (n# 21) (data not shown). These results illustrate
that in vivo, the decline in Cdk4/6-cyclin D complexes caused by
ablation of the p21Cip1 and p27Kip1 alleles is not sufficient to phe-
nocopy the defects caused by the loss of Cdk4 activity.
Tumorigenesis in p21!/! p27!/! mice. Finally, we analyzed
the tumor spectrum of p21!/! p27!/! double-knockout mice. As
previously reported, p21Cip1-null mice developed a variety of
spontaneous tumors at an average age of 16 months (21). p27Kip1
deficiency resulted in the appearance of aggressive pituitary tu-
mors, and allmice succumbed by 1 year of age (12, 16, 17). p21Cip1
p27Kip1-null animals died of pituitary tumors with a timing and
pathology indistinguishable from those for the single mutant
p27!/! controls, indicating that p21Cip1 does not compensate for
the absence of p27Kip1 (Fig. 6). In contrast, the loss of p27Kip1
appears to cooperate with the absence of p21Cip1, at least in accel-
erating tumor development, since about a quarter of the p21!/!
p27!/!mice displayed histiocytic sarcomas at a time (10months)
when none of the p21!/! animals had developed such tumors
(21–23) (Table 2). We also recorded the appearance of new pa-
thologies in p21!/! p27!/! double mutant mice that were absent
in either single-knockout strain. They included a panel of precan-
cerous lesions, such as gastric hyperplasia, pancreatic intraepithe-
lial neoplasia (PanIN), andmyeloproliferation (Table 2). The pre-
mature death associated with p27Kip1 deficiency prevented us
from studying the evolution of these lesions.
DISCUSSION
In our hands, primary p21!/! p27!/!MEFs displayed enhanced
proliferative properties compared to the wild-type controls (Fig.
2). Interestingly, and in agreement with previous reports, these
cells retained only 5% of the cellular Cdk4-cyclin D1 complexes
found in thewild-type controls. As a side note, this is equivalent to
the fraction of p27Kip1 that appears to be tyrosine phosphorylat-
ed—and presumably noninhibitory—in asynchronous cells (23),
suggesting that a minor proportion of active Cdk4/6-cyclin D
complexes suffices to support unperturbed proliferation. Impor-
tantly, the enhanced proliferative capacity observed in p21!/!
p27!/!MEFs was also present in Cdk2!/! p21!/! p27!/!MEFs
(Fig. 2), discarding the possibility that Cdk2 is the putative com-
pensatory mechanism that has been postulated to ameliorate the
proliferation of p21!/! p27!/! cells (4, 5). Altogether, these re-
sults suggest that in terms of cell proliferation, the Cip/Kip func-
tion as pan-Cdk inhibitors is overwhelmingly more relevant than
their role as Cdk4/6-cyclin D assembly factors.
It has also been proposed that Cdk4/6-cyclin D complexes per-
form a relevant noncatalytic role to favor cell proliferation. Ac-
cording to this model, these complexes act as a molecular sink for
Cip/Kip proteins, titrating them away from Cdk2 and therefore
facilitating its subsequent activation (7). Indeed, no free p27Kip1
can be detected in vivo (23). Cdk4/6 double-knockout cells have a
lower proliferative capacity than wild-type controls (24). Interest-
FIG 4 Cip/Kip factors and cellular transformation. (a) Equal amounts of
wild-type, p21!/!, p27!/!, as well as compound mutant p21!/! p27!/!
(DKO) and Cdk2!/! p21!/! p27!/! (TKO)MEFs were infected with retrovi-
ral particles coexpressing H-Ras and E1a oncogenes. (Left) At 3 weeks after
infection, the number of detectable foci was scored for the different genotypes.
Data are shown as means$ SDs (n# 3). (Right) A representative image upon
crystal violet staining is shown. (b) Immortalization of wild-type, p21!/! and
p27!/! single-knockout, p21!/! p27!/! (DKO), andCdk2!/! p21!/! p27!/!
(TKO) primary MEFs following a classical 3T3 protocol. Data are shown as
means$ SDs (n# 3).
TABLE 1 Influence of p21Cip1, p27Kip1, and Cdk2 deficiency on
postnatal survivala
Genotype Mendelian ratiob (%)
Cdk2 p21 p27 Expected Observed
%/% !/! %/! 12.5 18.7
%/% !/! !/! 12.5 11.6
%/! !/! %/! 25 31
%/! !/! !/! 25 17.3
!/! !/! %/! 12.5 15.5
!/! !/! !/! 12.5 5.9
a Data are for 439 mice.
b The expected and observed Mendelian ratios of the indicated genotypes were scored at
weaning (postnatal day 21).
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ingly, p21!/! p27!/! MEFs, which display a severe (20-fold) re-
duction of Cdk-cyclinD complexes, have the opposite phenotype.
This suggests that in wild-type MEFs, the Cip/Kip titration func-
tion of Cdk4/6-cyclin Dmight prevail over their catalytic activity.
Indeed, a cyclin D1 mutant that forms kinase-inactive complexes
with Cdk4/6 efficiently rescues the developmental defects present
in cyclin D1!/!mice (25). Although this could also be attributed
to Cdk-independent functions of cyclin D1, we cannot rule out
the possibility that in particular cellular contexts the sequestration
function of Cdk4/6-cyclin D complexes is dominant over their
catalytic activity.
We have also shown that p57Kip2, the third component of the
Cip/Kip family, participates in vivo in the stabilization of Cdk4-
FIG 5 Influence of p21Cip1 and p27Kip1 deficiency in adult homeostasis. (a) Total body weight and the weight of the indicated individual organs of mice at 11
weeks of age. Values for p27!/!, p21!/! p27!/! (DKO), andCdk2!/! p21!/! p27!/! (TKO)mice normalized to those for wild-type controls of the same age are
represented. Data are shown as means" SDs (n# 4). (b) Representative images of hematoxylin-eosin-stained liver sections from 11-week-old p21!/! p27!/!
(DKO) andCdk2!/! p21!/! p27!/! (TKO)mice. Bars, 20$m. (c)Quantification of the total number of hepatocytes in four randomly selected%400microscope
fields of liver sections from p21!/! p27!/! (DKO) and Cdk2!/! p21!/! p27!/! (TKO) mice. Data are shown as means" SDs (n# 7).
FIG 6 Cooperation between p21Cip1 and p27Kip1 tumor suppressors. Survival
curve of p21!/!, p27!/!, p21!/! p27!/! (DKO), andCdk2!/! p21!/! p27!/!
(TKO) mice.
TABLE 2 Tumor susceptibility in mice lacking p21Cip1 and p27Kip1
Lesion type and lesion or
pathology
% of mice that developed lesions or
pathologya
p21!/! p27!/!
mice (n# 21)
p27!/!
mice
(n# 11)
p21!/!
mice
(n# 13)
Hyperplasia/tumor-related
lesions
Gastric neuroendocrine
hyperplasia
43 0 0
Gastric mucosa hyperplasia 57 0 0
Histiocytic sarcoma 24 0 0
Myeloproliferation 43 0 0
PanIN 10 0 0
Inflammation/non-tumor-
related lesions
Arteritis 14 0 0
Bone metaplasia 24 0 0
Chronic nephropathy 81 45 23
Chronic pancreatitis 29 0 0
Retinal dysplasia 38 19 0
a Animals were sacrificed at 10 months of age. Numbers are rounded up to the nearest
digit.
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cyclin D complexes, at least in the absence of p21Cip1 and p27Kip1.
shRNA-mediated depletion of p57Kip2 in p21!/! p27!/! MEFs
caused a further reduction ofCdk4-cyclinD1 complexes, reaching
levels undetectable by Western blotting (Fig. 1b), yet it is signifi-
cant that upon p57Kip2 depletion, Cdk2!/! p21!/! p27!/!MEFs
exited G0 with kinetics comparable to that of the wild-type con-
trols. In this scenario, the Cdk1-cyclin D complexes that become
detectable in the absence of Cdk4 (14) may functionally replace
Cdk4/6-cyclin D complexes. This would imply that the assembly
of Cdk1-cyclin D complexes does not require Cip/Kip proteins or
may be facilitated by alternative assembly factors. In this respect,
p34Sei1 has been described to be an alternative Cdk-cyclin D as-
sembly factor, particularly during quiescence exit (5). We believe
that our Cdk2!/! p21!/! p27!/! mouse model may become a
useful tool to elucidate whether indeed other assembly factors
exist or if Cdk-cyclin D complexes can form de novo.
It is also possible that the required levels of Cdk-cyclin D com-
plexes (and, therefore, the importance of their assembly factors)
are cell type specific. Whereas p21!/! p27!/! mice reach adult-
hood with the expected Mendelian ratio, Cdk4/6 double-knock-
out (DKO) mice die in utero as a consequence of hematopoietic
defects (24). This suggests that in vivo, redundant mechanisms or
the inherent plasticity of the system may bypass the requirement
for p21Cip1 and p27Kip1 proteins as Cdk4/6-cyclin D assembly fac-
tors in most cell types. We cannot rule out the possibility that this
adaptation was facilitated in part by the use of germ line null
alleles. For instance, whereas chronic deficiency of the retinoblas-
toma protein in MEFs allows adaptation and compensation
among other familymembers, this is largely inefficient upon acute
gene ablation (26). In any case, and in support of the functional
redundancy model, we show here that p57Kip2 stabilizes Cdk4-
cyclin D1 in p21!/! p27!/! MEFs but not in wild-type controls
(Fig. 1). In addition, others have demonstrated that a knockin of
p27Kip1 expressed from the p57Kip2 promoter can rescue most of
the developmental defects present in p57!/!mice, suggesting that
they perform partially redundant roles in vivo (27). Interestingly,
as described above, p57Kip2 knockdown in p21!/! p27!/! MEFs
caused an additional reduction of Cdk-cyclin complexes and af-
fected their proliferation rate, which, nevertheless, remained
higher than that of wild-type cells (Fig. 2b). Moreover, unlike
single- and double-knockout strains, 53% of Cdk2!/! p21!/!
p27!/! mice died perinatally (Table 1). The fact that this was
reduced to 31% by introducing a single Cdk2 allele suggests that
the lethality is a dose-dependent phenotype associated with insuf-
ficient interphase Cdk activity. Nevertheless, 47%of triple-knock-
out (TKO) animals reached adulthood and displayed a normal life
span, suggesting that the attainment of a Cdk activity threshold
compatible with life in the relevant target tissue(s) may rely on
several overlapping mechanisms yet to be fully characterized.
This also suggests that the cellular contextmay dictate which of
the seemingly opposed roles of Cip/Kip as Cdk-cyclin D assembly
factors versus Cdk inhibitors prevail, to an extent that under some
circumstances the Cip/Kip tumor suppressors counterintuitively
display oncogenic properties. For instance, oligodendrogliomas
with elevated p21Cip1 result in more aggressive disease (28). Inter-
estingly, in this tumor type the oncogenic function of p21Cip1 is a
direct consequence of its role as a Cdk4-cyclin D assembly factor
and is directly controlled by tyrosine phosphorylation (29, 30).
p27Kip1 is equally subject to regulation by tyrosine phosphoryla-
tion (23, 31, 32). Unfortunately, the only mouse model in which
p27Kip1 has been shown to promote tumor development relies on
a Cdk-independent function (33), thereby invalidating the option
to weigh the importance of the tyrosine phosphorylation control
(i.e., its role as an assembly factor) in p27Kip1-mediated cancer
promotion.
In sum, and in good agreement with previous observations
from different laboratories (34), our results emphasize the notion
that Cdk-dependent cell cycle control in multicellular organisms
is extremely robust and several overlapping mechanisms facilitate
not only the proper execution of cell division but also its timely
coordination with developmental processes, even in the concom-
itant absence of allegedly essential factors.
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